<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Hematol Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Exp Hematol Oncol</journal-id><journal-title-group><journal-title>Experimental Hematology &#x00026; Oncology</journal-title></journal-title-group><issn pub-type="epub">2162-3619</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786567</article-id><article-id pub-id-type="publisher-id">603</article-id><article-id pub-id-type="doi">10.1186/s40164-025-00603-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xinyu</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhao</surname><given-names>Haiying</given-names></name><address><email>zhaohaiying@cmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012sz4c50</institution-id><institution-id institution-id-type="GRID">grid.412644.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 5909 0696</institution-id><institution>Department of General Surgery, </institution><institution>Fourth Affiliated Hospital of China Medical University, </institution></institution-wrap>Shenyang City, 110032 Liaoning Province China </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>14</volume><elocation-id>12</elocation-id><history><date date-type="received"><day>13</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Secretory autophagy is a classical form of unconventional secretion that integrates autophagy with the secretory process, relying on highly conserved autophagy-related molecules and playing a critical role in tumor progression and treatment resistance. Traditional autophagy is responsible for degrading intracellular substances by fusing autophagosomes with lysosomes. However, secretory autophagy uses autophagy signaling to mediate the secretion of specific substances and regulate the tumor microenvironment (TME). Cytoplasmic substances are preferentially secreted rather than directed toward lysosomal degradation, involving various selective mechanisms. Moreover, substances released by secretory autophagy convey biological signals to the TME, inducing immune dysregulation and contributing to drug resistance. Therefore, elucidating the mechanisms underlying secretory autophagy is essential for improving clinical treatments. This review systematically summarizes current knowledge of secretory autophagy, from initiation to secretion, considering inter-tumor heterogeneity, explores its role across different tumor types. Furthermore, it proposes future research directions and highlights unresolved clinical challenges.</p></abstract><funding-group><award-group><funding-source><institution>Basic scientific research project of Education Department of Liaoning Province</institution></funding-source><award-id>LJ212410159084</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; YUMED Inc. and BioMed Central Ltd. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Macroautophagy, often referred to as autophagy, is a highly conserved regulatory mechanism responsible for degrading cellular substances to recycle energy and materials [<xref ref-type="bibr" rid="CR1">1</xref>]. Most organisms/cells rely on autophagy to maintain metabolic processes. For example, autophagy activation promotes the clearance of misfolded proteins associated with neurodegeneration [<xref ref-type="bibr" rid="CR2">2</xref>]. The effective strategies of clinical treatment targeting autophagic mechanisms are fraught with complexities and associated with tumor stage, biology, and the surrounding microenvironment [<xref ref-type="bibr" rid="CR3">3</xref>]. As an intracellular dynamic process, it accepted autophagy-related genes (ATGs) regulation to finish the formation of two-membrane vesicles (autophagosomes) and encapsulate cellular cargos to fuse with lysosomes, leading to cargos degradation in assistance with hydrolase in the lysosomes [<xref ref-type="bibr" rid="CR4">4</xref>]. In detail, when energy or metabolic intermediates are insufficient, rapamycin complex 1 (mTORC1) senses metabolic imbalances. This activates unc-51-like kinase (ULK) complexes, including ULK1, ULK2, focal adhesion kinase family-interacting protein of 200&#x000a0;kDa (FIP200), ATG13, and ATG101, to initiate autophagy and regulate autophagosome formation [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Activation of ULK complex catalyzes phosphatidylinositol-3-phosphate (PI3P) production <italic>via</italic> autophagy-specific vacuolar protein sorting 34 (VPS34) complex I (including VPS34, Beclin-1, ATG14, and VPS15), PI3P located on autophagosome membrane triggers the recruitment of ATGs [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Initiation and maturation of autophagosome need ATG8 family proteins (microtubule-associated proteins 1&#x000a0;A/1B-light chain 3 (LC3) and GABA(A) receptor-associated protein (GABARAP)) lipid coupling in assistance of ATG16L1-ATG5-ATG12 complex, ATG3, and ATG7 [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Under nutrient-deficient conditions, autophagosome cargo loading can occur through non-selective or selective mechanisms, with passive selection dependent on autophagy cargo receptors (ACRs) [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition to classical ATG-mediated autophagy, chaperone-assisted autophagy, involving chaperone-mediated activity and lysosomal membrane invagination, also contributes to the degradation of cellular materials [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Due to the extensive membrane distribution of ATGs and its effect on membrane structure elongation and maturation, ATGs are also associated with cell endocytosis, cytokine secretion [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], phagocytosis [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], intracellular vesicle transport [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>] and exosome secretion [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>]. The release of specific substances mediated by ATGs or autophagosomes, known as secretory autophagy, facilitates the autophagy-related secretion process [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Secretory autophagy delivers functional payloads to the tumor microenvironment (TME), mediating intercellular communication and TME remodeling. Understanding the mechanisms of secretory autophagy, including cargo selection and substance release, is essential for elucidating its role in tumor progression. This review highlights the biological processes (cargo selection, substance release) underpinning secretory autophagy, emphasizing its function and significance within the TME. Advancing knowledge in this field has the potential to inform the development of novel anti-tumor therapies.</p></sec><sec id="Sec13"><title>Secretory autophagy: an unconventional protein secretion</title><p id="Par4">Large granules labeled with Golgi reassembly and stacking protein (GRASP), located near the endoplasmic reticulum exit, are recognized by ATGs, which gradually induce secretory autophagosome membrane elongation and maturation [<xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. Secretory autophagosomes can directly fuse with the plasma membrane to release packaged substances or fuse with the multivesicular body (MVB) to form amphisomes. Amphisome fuses with the plasma membrane to release the encapsulated substances outside the cell [<xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. Studies in yeast have demonstrated that Acb1 secretion depends on ATGs-mediated autophagosome formation and GRASP involvement (Grh1 in yeast) [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. In mammalian cells, secretory autophagy of IL-1&#x003b2; is dependent on GRASP and RAB8a-mediated vectorial sorting to plasma membrane [<xref ref-type="bibr" rid="CR26">26</xref>]. RAB8a has been found to regulate the secretory autophagy process of alpha-synuclein in the nervous system [<xref ref-type="bibr" rid="CR27">27</xref>]. Inhibition of autophagy flux using the pharmacological inhibitor 3-methyladenine (3-MA) or ATG5-targeting siRNA significantly increased the secretory autophagy of &#x003b1;-synuclein [<xref ref-type="bibr" rid="CR27">27</xref>]. Moreover, inhibition of the fusion of autophagosomes and lysosomes by bafilomycin A1 (BafA1) also promoted the secretion of &#x003b1;-synuclein rather than degradation [<xref ref-type="bibr" rid="CR27">27</xref>]. Increased microtubule acetylation, induced by histone deacetylase 6 (HDAC6) down-regulation, reduces autophagosome-lysosome fusion and enhances &#x003b1;-synuclein secretion [<xref ref-type="bibr" rid="CR27">27</xref>]. Inhibiting the fusion of autophagosome and lysosome or changing the acetylation level of microtubules will change the kinetics of the autophagosome, leading to its switch to the secretory pathway. The soluble <italic>N</italic>-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family plays a key role in plasma membrane fusion. Plasma membrane SNARE (SSO1) is essential for secretory autophagy-mediated membrane fusion, whereas degradation-associated fusion relies on the SNARE complex (vesicle-associated membrane protein [VAM]3/7) [<xref ref-type="bibr" rid="CR25">25</xref>]. Similarly, RAB8a acts as a regulator of polarization sorting into the plasma membrane [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], while RAB8b regulates the maturation of degrading autophagosomes [<xref ref-type="bibr" rid="CR29">29</xref>]. Autophagosome fuses with MVB to form amphisome, transferring cargos to plasma membrane/lysosomes to determine the destination of transport.</p></sec><sec id="Sec15"><title>Autophagy and secretory autophagy differences</title><p id="Par6">Classical autophagy and secretory autophagy share some similarities but also show distinct differences in their mechanisms and functions. For example, both require the formation of separate vesicles from the endoplasmic reticulum, but secretory autophagy can also occur in the absence of the ULK complex [<xref ref-type="bibr" rid="CR30">30</xref>]. The vesicles in the secretory autophagy pathway contain more proteins involved in plasma membrane fusion compared to those associated with lysosome fusion, highlighting a key distinction between the two pathways [<xref ref-type="bibr" rid="CR25">25</xref>]. Both are highly dependent on ATGs, and some ATGs play dual regulatory roles, such as ATG5 [<xref ref-type="bibr" rid="CR20">20</xref>]. For example, in the classical autophagy pathway, ATG5, ATG12, and ATG16L form a functional complex to promote LC3I to LC3II conversion, thereby promoting autophagosome elongation. In the secretory autophagy pathway, ATG5 maintains the acidification of secretory vesicles, contributing to substance secretion [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Further, LC3 performs distinct functions in the two pathways. In classical autophagy, LC3 mediates the elongation and closure of autophagosomes, whereas, in secretory autophagy, it facilitates the sorting of substances, particularly RNA and RNA-binding proteins (RBPs) [<xref ref-type="bibr" rid="CR32">32</xref>]. This topic is explored in greater detail in the following sections.</p><sec id="Sec27"><title>Origin differences</title><p id="Par8">The omega-shaped domains (omegasomes) of the endoplasmic reticulum (ER) are considered primary contributors to autophagosome biogenesis, although their exact function remains unknown [<xref ref-type="bibr" rid="CR33">33</xref>]. Secretory autophagy is partly derived from a relatively special ER-derived precursor structure (unconventional protein secretion compartments (CUPS)), which is similar to the mammalian omegasome [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Studies have shown that classical autophagy inducers facilitate the simultaneous formation of CUPS and omegasomes, as both express PI3P and ATGs [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. However, whether these represent the same structure requires further investigation. Classical autophagy usually requires the involvement of the ULK1 complex to promote isolation membrane formation from the omegasome [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. ATG9 and ZFYVE1/DFCP1 are recruited to the omegasome to facilitate vesicle biogenesis and elongation during classical autophagy [<xref ref-type="bibr" rid="CR31">31</xref>]. In noncanonical autophagy, <italic>de novo</italic> autophagosome synthesis is unnecessary; instead, vesicle recycling facilitates the transport of substances [<xref ref-type="bibr" rid="CR30">30</xref>]. This provides new insights into the vesicular origin of secretory autophagy versus conventional autophagy. Omegasomes are characterized by the dual FYVE domain protein ZFYVE1/DFCP1. While depletion of ZFYVE1/DFCP1 does not prevent starvation-induced autophagy, amino acid starvation, a classical omegasome inducer, may explain this outcome. ZFYVE1/DFCP1 appears to affect contraction only when omegasome diameters are sufficiently large. Although ZFYVE1/DFCP1 does not impact macroautophagy, it inhibits selective autophagy of mitochondria, protein aggregates, and micronuclei [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. These findings provide insights into the distinct molecular mechanisms underlying selective autophagy and macroautophagy, suggesting that different signaling pathways mediate these processes. It is worth noting that ATP binding and hydrolysis control the multimerization state of ZFYVE1/DFCP1, thereby driving the large omegasome to shrink and become smaller by mechano-chemical energy [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. This suggests that secretory autophagy may also be dependent on the hydrolysis of ATP by ZFYVE1/DFCP1. However, the specific mechanisms of both are still unclear and need to be further determined.</p><p id="Par9">CUPS are membrane-like structures that are thought to contain some specific Golgi-associated proteins, for example, Grh1 (yeast equivalent of GRASP), Bug1, the membrane tethering factor Uso1, the t-SNARE Sed5, Sec7, and Pik1 [<xref ref-type="bibr" rid="CR39">39</xref>]. Moreover, the SNARE protein (SSO1) expression required for plasma membrane fusion is critical for secretory autophagy-derived vesicles but independent of traditional autophagy SNARE complex (VAM3/VAM7)-related degradation [<xref ref-type="bibr" rid="CR25">25</xref>]. Vacuolar protein-sorting 34 (VPS34) as a phosphatidylinositol 3-kinase is needed for maintaining the biological functions of CUPS [<xref ref-type="bibr" rid="CR39">39</xref>]. It is worth mentioning that VPS34 functions as a key regulator involved in vesicle release, as well as the SNARE family [<xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. This, in part, suggests that part of SNARE family proteins can be recruited during the formation of secretory autophagic vesicles to provide a basis for subsequent plasma membrane secretion. RAB8 is essential for vesicle trafficking to the plasma membrane, a feature that distinguishes secretory autophagy from classical autophagy [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Differences in specific protein expression and recruitment likely drive the distinct vesicle transport pathways that separate secretory autophagy from traditional autophagy (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par10">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Mechanisms of secretory autophagy and interactions with classical autophagy</p></caption><graphic xlink:href="40164_2025_603_Fig1_HTML" id="d33e378"/></fig>
</p></sec><sec id="Sec311"><title>Cargo differences</title><sec id="Sec312"><title>TRIM16-mediated cargo selection</title><p id="Par13">The nuclear protein high mobility group box-1 (HMGB1) is secreted in response to stress stimuli, suggesting its role as a danger-associated molecular pattern [<xref ref-type="bibr" rid="CR45">45</xref>&#x02013;<xref ref-type="bibr" rid="CR47">47</xref>]. Lacking an ER-targeting signal peptide, HMGB1 is secreted <italic>via</italic> an unconventional, ER-Golgi-independent pathway [<xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref>]. Studies have found that heat shock protein 90&#x003b1; family class A member 1 (HSP90AA1) acts as a stress-related protein, which can regulate the transport of HMGB1 from the nucleus to the cytoplasm by direct binding [<xref ref-type="bibr" rid="CR51">51</xref>]. Geldamycin, an inhibitor of HSP90AA1, blocks HMGB1 secretion by disrupting its intrinsic trafficking signal. Similarly, HMGB1 secretion is strongly inhibited during secretory autophagy when early autophagy inhibitors or ATG5 knockouts are employed [<xref ref-type="bibr" rid="CR51">51</xref>]. This suggests that differences between secretory and conventional autophagy may depend primarily on substrate-specific structural engagement or functional regulation (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Secretory cargos typically lack endoplasmic reticulum targeting signal peptides and are secreted through unconventional pathways. These substances may exhibit substrate-specific secretion mechanisms. Further research is needed to clarify the mechanisms of cargo selection and to determine whether substrate selectivity is active or passive. It is worth noting that viruses and insulin can also be released through secretory autophagy at baseline housekeeping levels [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. The biological significance and mechanisms of cargo sorting in secretory autophagy are not fully understood, but current evidence suggests a role for ubiquitination and TRIM-mediated selectivity [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Tripartite motif-containing protein 16 (TRIM16) interacts with IL-1&#x003b2; [<xref ref-type="bibr" rid="CR56">56</xref>], and its absence significantly reduces the interaction between IL-1&#x003b2; and LC3, as well as the interaction between Sec22b and TRIM16<sup>&#x00394;373&#x02013;564</sup>. This impairs IL-1&#x003b2; autophagy-dependent secretion, which requires ATG5 and Galectin-8 [<xref ref-type="bibr" rid="CR57">57</xref>]. Sec22b knockdown does not affect autophagosome formation or autolysosome function. However, reduced Sec22b levels impair IL-1&#x003b2; autophagy-dependent secretion independently of ATG9, Syntaxin 17 (responsible for autophagosome-lysosome fusion), and p62 [<xref ref-type="bibr" rid="CR57">57</xref>]. Based on the function of TRIM16, IL-1&#x003b2; autophagy and secretory autophagy appear to share common early-stage mechanisms. However, their distinct outcomes are determined during the middle and late regulatory stages. Galectin family members should be considerable in the cargo selectivity because of the recognition of &#x003b2;-(1&#x02013;4) linked galactosides [<xref ref-type="bibr" rid="CR58">58</xref>&#x02013;<xref ref-type="bibr" rid="CR61">61</xref>]. Serum ferritin, another unconventional secreted protein associated with inflammation, has also been shown to be secreted through unconventional pathways [<xref ref-type="bibr" rid="CR62">62</xref>]. TRIM16, galectin-8 (but not galectin-3), and Sec22b (but not syntaxin 17) mediated secretory autophagy [<xref ref-type="bibr" rid="CR57">57</xref>]. However, TRIM16 cross-links with the p62-KEAP1-NRF2 complex under oxidative and proteotoxic stress conditions to promote autophagic degradation of misfolded proteins [<xref ref-type="bibr" rid="CR63">63</xref>]. TRIM16-mediated protein degradation may require oxidative and proteotoxic stress environments as well as protein misfolding, while for functionally/conventionally secreted proteins, TRIM16 may play a cargo-loading function. Cargo selection provides an optional termination (lysosome or exportation) in the autophagosome-related process to enable the exportation of leaderless cytosolic substances from intracellular metabolism. Different substrates may be selected differently, depending on the structure and function of the protein, peptide, or vesicle itself.</p><p id="Par14">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Secretory autophagy: cargo selection</p></caption><graphic xlink:href="40164_2025_603_Fig2_HTML" id="d33e459"/></fig>
</p></sec><sec id="Sec315"><title>LC3-dependent extracellular vesicle (EV) loading</title><p id="Par16">Debnath et al. described the LC3-dependent EV loading and secretion (LDELS) mechanism for RNA and RBPs, which relies on the LC3-conjugation machinery (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) and requires the recruitment of nSMase2 and Fanconi anemia-associated nuclease (FAN) [<xref ref-type="bibr" rid="CR32">32</xref>]. Ceramides produced by nSMase2 may play a functionally unique membrane regulation role (negative membrane curvature) by driving membrane microdomain formation, leading to endosomal sorting complex required for the transport (ESCRT)-independent luminal budding at MVB-restricted membranes [<xref ref-type="bibr" rid="CR32">32</xref>]. Unlike nSMase2, FAN cannot be detected on EVs, indicating that FAN may only transiently interact with LC3 or act on endoplasmic reticulum/Golgi apparatus to participate in the secretory process. Recent studies have outlined inter-organelle communication in MVB cargo sorting, providing new insights into the relationship between FAN and secretory autophagy [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. As an F-actin binding protein, FAN contributes to cytoskeleton reorganization, which reveals the critical role of FAN in membrane transport and formation during the LDELS process [<xref ref-type="bibr" rid="CR66">66</xref>]. LC3 selectivity for cargos may be primarily restricted to proteins or RNAs through specific structural motifs. In general, the structures of ATG8 family proteins contain functional domains that interact with RBPs (LIR motif), and mutations in the LIR motif are sufficient to impair EV secretion [<xref ref-type="bibr" rid="CR67">67</xref>]. This aligns with the observation that many LDELS-related molecules are positively expressed in RNA delivery particles, such as stress granules and P-bodies [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. A recent original study has reported a previously unrecognized protein named transferrin receptor (TFRC), which acts as a specific integral membrane protein. Its secretion is strongly dependent on the binding sites with ATG8 family proteins but not other essential ATGs for autophagosome formation. Mechanistically, ATG8 family proteins directly bind to the cytoplasmic domain of TFRC (LIR motif) and selectively load TFRC into EVs [<xref ref-type="bibr" rid="CR70">70</xref>]. EV-TFRC secretion requires the participation of ESCRT components and the small GTPase RAB27a [<xref ref-type="bibr" rid="CR70">70</xref>], which is extremely similar to the traditional EV secretion process [<xref ref-type="bibr" rid="CR71">71</xref>&#x02013;<xref ref-type="bibr" rid="CR75">75</xref>]. It is implied that TFRC secretion and traditional EV secretion processes possess unified regulatory pathways. This suggests the critical role of ATG8 family proteins in secretory autophagy, as well as non-classical autophagy processes.</p><p id="Par17">This observation aligns with the non-classical autophagy pathway described earlier. While classical autophagy relies on the ATG8 protein family binding to lipids, such as phosphatidylethanolamine (PE), to mediate autophagy, the non-classical autophagy pathway is primarily mediated by the conjugation of ATG8s to single membranes (CASM), including late endosomes and lysosomes [<xref ref-type="bibr" rid="CR30">30</xref>]. Unlike classical autophagy, the non-classical pathway does not depend on <italic>de novo</italic> autophagosome synthesis but requires ATG8 lipidation. This highlights that the regulation of ATG8 by proteins such as ATG3, ATG4, ATG5, ATG7, ATG10, ATG12, and ATG16L1 is consistent with the mechanisms of classical autophagy [<xref ref-type="bibr" rid="CR30">30</xref>]. Interestingly, an increased ATG8-PS/ATG8-PE ratio has been observed in the CASM pathway, suggesting that ATG8-PS may serve as a potential marker of non-classical autophagy [<xref ref-type="bibr" rid="CR30">30</xref>]. Although secretory autophagy shares molecular regulatory features with CASM and classical autophagy, the precise relationship between these pathways requires further investigation.</p><p id="Par18">
<fig id="Fig3"><label>Fig. 3</label><caption><p>The mechanisms of LDELS</p></caption><graphic xlink:href="40164_2025_603_Fig3_HTML" id="d33e528"/></fig>
</p></sec></sec><sec id="Sec219"><title>Vesicle transport differences</title><p id="Par20">RAB37 GTPase regulates the exocytosis of intracellular cargo by binding to the GDP/GTP form. RAB37 can interfere with the activation of autophagy and the secretion of tissue inhibitors of metalloproteinase-1 (TIMP1) in lung cancer cells under starvation conditions. As a motile protein, RAB37 hydrolyzates GTP to provide sufficient energy for material transport and subsequently participates in the fusion of vesicles and plasma membranes in a Sec22B-dependent manner, thereby regulating the secretion of TIMP1 [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. It has been reported that a novel autophagy inducer, niclosamide (an anti-helminth drug), significantly increased autophagic flux and promoted insulin secretion through an autophagy-dependent secretion pathway with the involvement of RAB37, which improved blood insulin and glucose concentrations [<xref ref-type="bibr" rid="CR53">53</xref>]. RAB37 is also involved in regulating autophagy, suggesting that secretory autophagy and conventional autophagy have many overlapping regulatory mechanisms, but SNARE family proteins, especially Sec22B, may be the key factors.</p><p id="Par21">Multiple studies have demonstrated that mATG8 proteins and their coupling systems are not essential for autophagosome formation [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. Unlike the traditional autophagy pathway, this process occurs independently of ATG7. Interestingly, RAB7, a key protein responsible for autophagosome-lysosome fusion, has been shown to regulate secretory autophagy. Knockdown of RAB7 increases secretory autophagy, while knockdown of SNAP23 inhibits this process [<xref ref-type="bibr" rid="CR80">80</xref>&#x02013;<xref ref-type="bibr" rid="CR82">82</xref>]. SNAP23, a well-characterized regulator of vesicle-plasma membrane fusion, is critical for the fusion process during secretory autophagy [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. RAB7, an endosomal protein, primarily regulates the fusion of autophagosomes with lysosomes [<xref ref-type="bibr" rid="CR84">84</xref>&#x02013;<xref ref-type="bibr" rid="CR87">87</xref>]. Furthermore, RAB7 knockdown may interfere with the early stages of exosome formation. In autophagosome membranes and other single-membrane organelles, mATG8 lipidation is required for the formation of single-membrane structures. This process involves recruiting ATG12, ATG7, and ATG10. With the persistent activity of ATG7 and ATG10, the ATG5-ATG12 complex associates with ATG16L1, leading to ATG8 conjugation (atg8ylation) [<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. This conjugation facilitates cargo sequestration within autophagosomes [<xref ref-type="bibr" rid="CR90">90</xref>], membrane remodeling [<xref ref-type="bibr" rid="CR91">91</xref>], structural perturbation [<xref ref-type="bibr" rid="CR92">92</xref>], and membrane expansion. These mechanisms collectively contribute to the repair and maintenance of single-membrane organelles.</p></sec></sec><sec id="Sec122"><title>Status of secretory autophagy in tumour progression</title><p id="Par23">Secretory molecules act as critical information carriers, transmitting biological signals within the TME [<xref ref-type="bibr" rid="CR93">93</xref>&#x02013;<xref ref-type="bibr" rid="CR96">96</xref>]. These molecules have been recognized for their potential in prognosis evaluation and early diagnosis of various tumors [<xref ref-type="bibr" rid="CR97">97</xref>&#x02013;<xref ref-type="bibr" rid="CR99">99</xref>]. Autophagy has traditionally been characterized as a cellular mechanism essential for degrading damaged organelles and misfolded proteins, providing materials and energy for cellular reuse [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. However, further investigation shows that autophagy has two distinct pathways: one involves delivering cargo to lysosomes for degradation, while the other transports cargo to the cell membrane for secretion [<xref ref-type="bibr" rid="CR20">20</xref>]. This autophagy-dependent secretory process plays an essential role in both physiological and pathological cellular metabolism, including processes such as insulin secretion, mitochondrial clearance, and the secretion of HMGB1 protein [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Given these dual roles, a critical question arises about the significance of secretory autophagy in cancer cells.</p><p id="Par24">Excessive activation of autophagy is a classic characteristic of various solid tumors, and in-depth basic exploration and clinical trials have been conducted to target autophagy [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Abnormally high expression of ATGs contributes to the malignant progression of solid tumors by enhancing baseline autophagy or regulating organelle acidification [<xref ref-type="bibr" rid="CR103">103</xref>&#x02013;<xref ref-type="bibr" rid="CR105">105</xref>]. ATG5 specifically decreases late endosome acidification by removing ATP6V1E1, leading to a shift from autophagic degradation to secretory process [<xref ref-type="bibr" rid="CR20">20</xref>]. Almost all solid tumors highly express ATG5, ATG7, ATG6L1, and secretion-related genes such as RABs [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR106">106</xref>&#x02013;<xref ref-type="bibr" rid="CR108">108</xref>], revealing the interaction between tumor progression and intracellular cargos transport. Cells with a high level of autophagy release more secretory substances and exhibit exosome heterogeneity to a certain extent [<xref ref-type="bibr" rid="CR109">109</xref>]. Theoretically, exosomes can carry ATGs and RABs, and the distribution of these proteins in exosomes also provides more options for cargo loading. A better understanding of protein conformation and molecular docking may provide a basis for precise treatment. To survive, tumor cells increase their metabolism to produce more intermediate metabolites/energy and accelerate internal circulation [<xref ref-type="bibr" rid="CR110">110</xref>&#x02013;<xref ref-type="bibr" rid="CR113">113</xref>]. When excess metabolic byproducts exceed the cell&#x02019;s digestive capacity, they are expelled through the secretory pathway, highlighting the requirement of secretory autophagy, which couples autophagy to secretion (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR114">114</xref>&#x02013;<xref ref-type="bibr" rid="CR120">120</xref>]. Moreover, high mutation rates in oncogenes such as <italic>TP53</italic> and <italic>KRAS</italic> [<xref ref-type="bibr" rid="CR121">121</xref>&#x02013;<xref ref-type="bibr" rid="CR124">124</xref>] may induce structural changes in proteins, forcing alterations in secretion pathways. These changes contribute to the enhanced survival of tumor cells under stress conditions. Given the heterogeneity of tumors, this study categorizes different solid tumors to elucidate the mechanisms, significance, and potential exploration strategies for secretory autophagy in tumor progression (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).</p><p id="Par25">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>The function of secretory autophagy-related molecules released by solid tumour cells</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Cell types</th><th align="left">In vivo/In vitro</th><th align="left">Inducer</th><th align="left">Mechanisms</th><th align="left">Effection</th><th align="left">PMID</th></tr></thead><tbody><tr><td align="left">Colorectal cancer</td><td align="left">HT29, LoVo, HCT116, and RKO</td><td align="left">In vivo and In vitro</td><td align="left">Thioridazine</td><td align="left">&#x02014;&#x02014;</td><td align="left">Immunogenic cell death</td><td align="left">[<xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td align="left">Colorectal cancer</td><td align="left">HCT116</td><td align="left">In vitro</td><td align="left">shATG16L1</td><td align="left">&#x02014;&#x02014;</td><td align="left">Exosome decreasing</td><td align="left">[<xref ref-type="bibr" rid="CR20">20</xref>]</td></tr><tr><td align="left">Glioblastoma</td><td align="left">U251, LN229, Primary human GB1 and GB2</td><td align="left">In vivo and In vitro</td><td align="left">DT-EGF</td><td align="left">HMGB1/RAGE/ERK/IKB/NF-kB</td><td align="left">Promoting immunogenicity and M1-like polarization of TAM</td><td align="left">[<xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td align="left">Prostate cancer</td><td align="left">LNCaP, PC3</td><td align="left">In vivo and In vitro</td><td align="left">Cell membrane invaginated</td><td align="left">CAV1 and Ca2&#x02009;+&#x02009;influx</td><td align="left">Increasing malignant ability</td><td align="left">[<xref ref-type="bibr" rid="CR114">114</xref>]</td></tr><tr><td align="left">Breast cancer</td><td align="left">MDA-MB-231, MCF7 and 4T1</td><td align="left">In vitro</td><td align="left">shATG5</td><td align="left">ATP6V1E1</td><td align="left">Promoting migration and in vivo metastasis</td><td align="left">[<xref ref-type="bibr" rid="CR20">20</xref>]</td></tr><tr><td align="left">Cervical cancer</td><td align="left">HeLa</td><td align="left">In vivo and In vitro</td><td align="left">Serum starvation</td><td align="left">SKP1 phosphorylation</td><td align="left">&#x02014;&#x02014;</td><td align="left">[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td align="left">Cholangiocarcinoma</td><td align="left">RBE, HCCC-9810,SK-CHA-1 and MZ-CHA-1</td><td align="left">In vivo and In vitro</td><td align="left">shPTEN</td><td align="left">TFEB phosphorylation</td><td align="left">Cell proliferation and invasion enhancing</td><td align="left">[<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td align="left">Esophageal squamous cell carcinoma</td><td align="left">TE-1 and ECA-109</td><td align="left">In vitro</td><td align="left">Sulforaphane</td><td align="left">mTOR/TFE3</td><td align="left">Senescence</td><td align="left">[<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td align="left">Pancreatic cancer</td><td align="left">AsPC-1 and PANC-1</td><td align="left">In vitro</td><td align="left">GIPC</td><td align="left">ABCG2</td><td align="left">Resistance to gemcitabine</td><td align="left">[<xref ref-type="bibr" rid="CR115">115</xref>]</td></tr><tr><td align="left">Head and neck squamous cell carcinoma</td><td align="left">UM-SCC-1, OSC19, HN5</td><td align="left">In vivo and In vitro</td><td align="left">shBeclin-1/shATG7</td><td align="left">&#x02014;&#x02014;</td><td align="left">Inhibiting IL-6 and IL-8 secretion</td><td align="left">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr></tbody></table></table-wrap>
</p><p id="Par26">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Regulation of secretory autophagy in tumour progression</p></caption><graphic xlink:href="40164_2025_603_Fig4_HTML" id="d33e922"/></fig>
</p><sec id="Sec227"><title>Colorectal cancer</title><p id="Par28">Colorectal cancer (CRC) is one of the most prevalent malignant tumors of the digestive system globally. According to statistical data from 2020, CRC accounted for nearly 1,000,000 deaths worldwide [<xref ref-type="bibr" rid="CR125">125</xref>]. The development and progression of CRC are associated with the loss of function in tumor suppressor genes and the overactivation of oncogenes [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. Drug resistance and immune evasion present significant challenges to clinical treatment. In the search for novel therapeutic strategies, researchers have evaluated the anticancer potential of existing drugs and found that thioridazine (THD), an antipsychotic drug, demonstrates strong antitumor activity by inducing apoptosis and inhibiting angiogenesis. Moreover, THD has antimicrobial properties [<xref ref-type="bibr" rid="CR128">128</xref>&#x02013;<xref ref-type="bibr" rid="CR132">132</xref>]. THD-induced autophagy can be reversed in CRC cells by treatment with 3-MA, which reduces LC3<sup>+</sup> autophagosome formation. Conversely, BafA1 did not significantly alter LC3 expression, indicating that THD-induced autophagy occurs during the early stages of the process without excessive LC3<sup>+</sup> autophagosome accumulation. This suggests that LC3<sup>+</sup> autophagosomes are released through secretory autophagy during THD treatment [<xref ref-type="bibr" rid="CR119">119</xref>]. Furthermore, THD has been shown to induce the secretion of EVs in a time-dependent manner, enhancing oxaliplatin-induced immunogenic cell death [<xref ref-type="bibr" rid="CR119">119</xref>]. These findings highlight the importance of considering drug dosage and timing in clinical applications. Adjusting the dose and timing to avoid significantly affecting basal secretion could provide further therapeutic options for CRC treatment.</p><p id="Par29">Exosomes are specialized EVs that play a key role in maintaining cellular homeostasis. They mediate functional regulatory processes by targeting adjacent and distant cells, making them crucial indicators for the diagnosis and treatment of CRC [<xref ref-type="bibr" rid="CR133">133</xref>&#x02013;<xref ref-type="bibr" rid="CR135">135</xref>]. Loss of ATG16L1 in HCT-116 cells has been shown to significantly reduce exosome release [<xref ref-type="bibr" rid="CR20">20</xref>]. Previous studies have demonstrated that ATG16L1 localizes to endosomes, phagosomes, and lysosome-like granules [<xref ref-type="bibr" rid="CR136">136</xref>]. Its widespread membrane distribution suggests an association with multivesicular bodies (MVBs) independent of double-membrane autophagosomes. In addition to directly regulating ATG16L1, emerging evidence indicates that growth factors and metabolic cues can induce ATG16L1 phosphorylation [<xref ref-type="bibr" rid="CR137">137</xref>&#x02013;<xref ref-type="bibr" rid="CR139">139</xref>], which may provide a theoretical foundation for novel drug development. Molecules targeting ATG16L1 are currently under investigation. For instance, the 3&#x02019; untranslated region of ATG16L1 mRNA contains functional binding sites for miR-223. miR-223 mimics can effectively interfere with protein translation <italic>via</italic> post-transcriptional regulation [<xref ref-type="bibr" rid="CR140">140</xref>]. Similarly, miR-106b and miR-93 have demonstrated comparable functions in regulating ATG16L1 expression [<xref ref-type="bibr" rid="CR141">141</xref>]. ATG16L1 also shows RAB-binding protein properties, inducing active RAB conformations even in the absence of nucleotide exchange. ATG16L1 and RAB33B mutually influence their membrane localization within organelles [<xref ref-type="bibr" rid="CR142">142</xref>]. Cargo transport <italic>via</italic> secretory autophagy is ATG16L1-dependent, and miRNA mimics or RAB33B antibodies offer practical and clinically feasible treatment strategies. Furthermore, recent studies have highlighted the role of ATG16L1 in promoting the secretion of exosomal a-disintegrin-and-metalloprotease-10 (ADAM10), contributing to cell protection during bacterial infections. These findings highlight the critical role of ATG16L1 in secretory autophagy [<xref ref-type="bibr" rid="CR143">143</xref>]. However, whether ATG16L1 is the primary factor driving secretory autophagy in CRC cells remains unclear. Thus, further exploration of the relationship between intestinal microorganisms and secretory autophagy in CRC cells, as well as the potential of targeted therapies, is essential.</p></sec><sec id="Sec230"><title>Glioblastoma (GB)</title><p id="Par31">GB is a highly malignant tumor of the nervous system, characterized by a high mortality rate and limited effective treatment options. Following diagnosis, the median survival time is typically less than 15 months [<xref ref-type="bibr" rid="CR144">144</xref>, <xref ref-type="bibr" rid="CR145">145</xref>]. Therapeutic interventions often fail to provide long-term benefits for most patients undergoing extended clinical treatment. Previous studies have highlighted the role of secretory autophagy in cancer therapy, with a specific focus on exosomal substances secreted <italic>via</italic> autophagy. Interestingly, an autophagy-dependent protein secretion process has been identified in glioma cells. Beyond its role in cellular death intervention, autophagy induced by DT-EGF has been shown to regulate necrotic cell characteristics by selectively promoting the release of HMGB1 protein [<xref ref-type="bibr" rid="CR146">146</xref>]. Interestingly, HMGB1-related secretory autophagy is more readily observed in glioblastomas than in epithelial tumor cell lines, underscoring the need for further studies to elucidate the differences among cell types and the specific mechanisms involved. The release of HMGB1 enhances the immunogenicity of apoptotic cells [<xref ref-type="bibr" rid="CR147">147</xref>], and when HMGB1 is secreted by dying tumor cells, it augments tumor-specific immune responses through toll-like receptor 4 (TLR4) signaling [<xref ref-type="bibr" rid="CR148">148</xref>]. These findings suggest that enhancing cellular immunogenicity by modulating specific death mechanisms, such as HMGB1 release, could significantly improve the long-term efficacy of anticancer therapies. Understanding and targeting the mechanisms of secretory autophagy may pave the way for novel therapeutic strategies to overcome this resistance and improve patient outcomes.</p><p id="Par32">Temozolomide (TMZ)-induced autophagic cell death represents a primary mechanism underlying its pharmacological action. In vivo studies have demonstrated that chloroquine (CQ) and HCQ disrupt lysosomal acidification and exhibit anticancer activity in mice. However, combining TMZ with autophagy inhibitors did not significantly improve the overall survival of GB patients [<xref ref-type="bibr" rid="CR149">149</xref>]. The presence of secretory autophagy redirects cargo from the degradative autophagy pathway to the secretory mode, enabling extensive biological functions. Studies have shown that extracellular HMGB1 protein, released <italic>via</italic> secretory autophagy, acts as a key regulator of crosstalk between tumor cells and the immune microenvironment. TMZ-induced HMGB1 secretion facilitates M1-like polarization of tumor-associated macrophages (TAMs) through the receptor for advanced glycation end-products (RAGE)/extracellular signal-regulated kinase (ERK)/inhibitor of kappa B (I&#x003ba;B)/nuclear factor kappa B (NF-&#x003ba;B) signaling pathway. This polarization promotes the secretion of pro-inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-8 (IL-8), and C-C motif chemokine ligand 2 (CCL2), thereby activating effective anti-tumor immunity [<xref ref-type="bibr" rid="CR118">118</xref>]. As a cell surface receptor, RAGE is widely expressed on both tumor and immune cells and recognizes multiple secretory substrates, including HMGB1 and S100 proteins, triggering downstream inflammation-related signaling cascades [<xref ref-type="bibr" rid="CR150">150</xref>&#x02013;<xref ref-type="bibr" rid="CR152">152</xref>]. Intracellular HMGB1 is predominantly associated with promoting tumor cell survival, invasion, and drug resistance [<xref ref-type="bibr" rid="CR153">153</xref>&#x02013;<xref ref-type="bibr" rid="CR155">155</xref>]. This dual role of HMGB1 underscores its complex and diverse functions within the TME. Tumor cell-released HMGB1 serves as an immune regulator through classical RAGE-mediated signaling. However, the distinct functional differences between extracellular and intracellular HMGB1 suggest that targeting HMGB1 may not consistently achieve the desired therapeutic effects across different stages of tumor development. Understanding the clear roles of HMGB1 in the TME is critical for developing effective and targeted therapeutic interventions.</p></sec><sec id="Sec233"><title>Prostate cancer</title><p id="Par34">Prostate cancer remains the most prevalent solid tumor in men globally and a leading cause of male-specific mortality despite advances in various treatment strategies [<xref ref-type="bibr" rid="CR156">156</xref>]. Early diagnostic and targeted therapeutic strategies are actively being explored. Serum caveolin-1 (CAV1) levels have been shown to correlate with tumor stage, grade, angiogenesis, and poor prognosis in prostate cancer patients [<xref ref-type="bibr" rid="CR157">157</xref>&#x02013;<xref ref-type="bibr" rid="CR161">161</xref>]. However, the precise mechanisms underlying abnormal CAV1 expression in serum remain insufficiently understood. Recent findings suggest that prostate cancer cells secrete CAV1 through distinct mechanisms. In PC3 cells, CAV1 secretion is dependent on MVBs and plasma membrane fusion mediated by calcium (Ca&#x000b2;&#x0207a;) flux, following the classical exosome secretion pathway. On the contrary, in LNCaP cells, CAV1 is secreted <italic>via</italic> both the conventional exosome secretion pathway and an autophagy-dependent mechanism [<xref ref-type="bibr" rid="CR114">114</xref>]. Exosomes derived from these pathways exhibit heterogeneity, with varying CAV1 expression and distribution patterns depending on the secretion mechanism [<xref ref-type="bibr" rid="CR162">162</xref>]. Importantly, Ca&#x000b2;&#x0207a; dependency is observed in both cell types, indicating its pivotal role in facilitating vesicle transport [<xref ref-type="bibr" rid="CR162">162</xref>]. Increased cytosolic Ca&#x000b2;&#x0207a; triggers rapid exosome secretion <italic>via</italic> RAB27a and Munc13-4 [<xref ref-type="bibr" rid="CR163">163</xref>, <xref ref-type="bibr" rid="CR164">164</xref>], with Ca&#x000b2;&#x0207a; influx being influenced by plasma membrane perforation or overexpression of Ca&#x000b2;&#x0207a; transporters. This influx initiates repair cascades involving lysosomal mobilization and fusion with the plasma membrane [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR165">165</xref>]. Therefore, Ca&#x000b2;&#x0207a; serves as a selective cofactor in exosome release, highlighting the requirement of ion signaling and dynein in the CAV1 transport pathway. The knockdown of ATGs, such as ATG5, ATG9, and ATG12, and the use of autophagosome inhibitors effectively reduce CAV1 secretion in LNCaP cells but not in PC3 cells [<xref ref-type="bibr" rid="CR162">162</xref>]. For patients with elevated serum CAV1 levels, gene profiling to evaluate ATG expression may provide actionable insights. Patients with high basal autophagy activity could benefit from treatment with 3-MA alone or in combination with calcium channel antagonists to enhance therapeutic efficacy. Similarly, the distribution and localization of CAV1<sup>+</sup> exosomes could guide the selection of autophagosome inhibitors. Moreover, targeting S100 exosomes with monoclonal antibodies against CAV1 may offer improved outcomes, as demonstrated in preliminary breast cancer studies [<xref ref-type="bibr" rid="CR166">166</xref>].</p><p id="Par35">The secretory autophagy process of CAV1 may also intersect significantly with glycolysis. As a membrane protein, CAV1 provides a docking site for glycolytic enzymes, including phosphofructokinase (PFK) and aldolase, through its scaffold domain [<xref ref-type="bibr" rid="CR167">167</xref>]. In vascular smooth muscle cells and lymphocytes, CAV1 cross-links with these enzymes to regulate glycolysis. Metabolomic analyses revealed that intermediate glycolytic metabolites, such as 3-phosphoglycerate, fructose-6-phosphate, and glucose-6-phosphate, were reduced following CAV1 knockdown, indicating their regulatory role in glycolysis [<xref ref-type="bibr" rid="CR168">168</xref>]. These findings suggest a potential link between CAV1-mediated secretory autophagy and glucose metabolism, although further investigation in prostate cancer is warranted to confirm this association.</p></sec><sec id="Sec236"><title>Breast cancer</title><p id="Par37">Breast cancer remains one of the most prevalent solid tumors in women. Despite advancements in medical treatment and the development of molecular-targeted therapy strategies, many breast cancer patients fail to achieve long-term benefits, highlighting the need for identifying new therapeutic targets [<xref ref-type="bibr" rid="CR169">169</xref>]. Research on exosomes has provided new ways for the diagnosis and treatment of breast cancer. Exosomes are nanoscale vesicles with a bilayer lipid membrane structure, initially thought to serve as a cellular waste disposal mechanism. However, recent studies highlight their key roles in intercellular communication and potential applications in clinical treatment [<xref ref-type="bibr" rid="CR170">170</xref>&#x02013;<xref ref-type="bibr" rid="CR172">172</xref>]. In breast cancer studies, loss of ATG5 was found to significantly reduce exosome release without affecting the cellular uptake of exosomes. This process, intriguingly, was not regulated by ATG7 expression. Mechanistically, ATG5 plays a critical role in recruiting ATP6V1E1 to modulate the acidification of MVBs, thereby controlling exosome production. These ATG5-dependent exosomes significantly enhance the migration and metastasis of breast cancer cells [<xref ref-type="bibr" rid="CR20">20</xref>]. ATG5, as a component of the E3 ligase, facilitates ATG8 lipidation, a central process in classical autophagy. ATG8 is associated with double-membrane structures (autophagosomes) and single-membrane intracellular vesicles, elucidating the potential roles of ATG5 and ATG8 in maintaining membrane stability and facilitating material transport in non-autophagic pathways [<xref ref-type="bibr" rid="CR173">173</xref>&#x02013;<xref ref-type="bibr" rid="CR176">176</xref>]. Existing literature highlights unresolved questions regarding the influence of ATGs on exosome homeostasis. For example, ATG6 (Beclin1) has been implicated in exosome release during viral infections [<xref ref-type="bibr" rid="CR22">22</xref>]. ATG6 impacts exosome production by forming complexes with PI3K, promoting ATG14L1 complex formation, and partitioning cargos during MVB formation [<xref ref-type="bibr" rid="CR177">177</xref>]. This regulatory role is achieved by inducing PI3K association with MVB budding [<xref ref-type="bibr" rid="CR178">178</xref>]. However, the specific mechanisms underlying the functions of most ATGs in exosome production remain unclear. While ATG5-associated exosome production in breast cancer cells appears to be independent of ATG7, inhibitors of the V1V0-ATPase complex were shown to increase exosome production, even in ATG5-deficient (ATG5<sup>&#x02212;/&#x02212;</sup>) cells [<xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR180">180</xref>]. This indicates that ATG5-dependent secretory autophagy operates independently of classical autophagy. Importantly, LC3-II expression is not regulated by ATG5, indicating that ATG5 can transport LC3 into exosomes [<xref ref-type="bibr" rid="CR20">20</xref>]. This observation aligns with the LDELS process described previously. Molecules that directly bind to LC3, ATG5, or other related proteins may undergo selective sorting into MVBs and subsequent release <italic>via</italic> exosomes. Although direct evidence is currently lacking, the role of ATGs in the selective cargo-loading process of exosomes warrants further investigation. Similar to the previously discussed role of CAV1, ATG-related secretory molecules could potentially serve as serodiagnostic markers in breast cancer. This possibility underscores the importance of future studies to elucidate their diagnostic and prognostic utility. It is also noteworthy that the p53 status influences ATG5-related autophagy to some extent [<xref ref-type="bibr" rid="CR181">181</xref>]. The rational use of arsenic trioxide has been proposed as a potential intervention strategy in this context [<xref ref-type="bibr" rid="CR182">182</xref>, <xref ref-type="bibr" rid="CR183">183</xref>].</p><p id="Par38">In addition to the autophagy-exosome regulatory network, IL-6 secretion is modulated by autophagy in breast cancer. The breast cancer stem cell (CSC) population plays a critical role in promoting malignant proliferation, metastasis, and recurrence [<xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR185">185</xref>]. Studies have shown that the activation of ATG7-related autophagy in CSCs facilitates the release of IL-6 [<xref ref-type="bibr" rid="CR186">186</xref>]. There is a significant positive correlation between IL-6 and pSTAT3 levels in primary breast tumors, as IL-6 triggers the activation of STAT3 signaling [<xref ref-type="bibr" rid="CR187">187</xref>]. This indicates that autophagy-dependent IL-6 secretion effectively promotes the malignant progression of breast cancer through the STAT3 pathway. However, other IL-6 secretion mechanisms should also be considered, as it remains uncertain whether blocking the autophagy-dependent secretion pathway alone can fully prevent IL-6 secretion. Interestingly, pyrazolopyrimidine sulfamate compounds have been identified as potent and selective inhibitors of ATG7 [<xref ref-type="bibr" rid="CR188">188</xref>]. These inhibitors provide a promising basis for combination strategies in clinical treatment, potentially offering a new therapeutic avenue for targeting autophagy and its related secretory pathways in breast cancer.</p></sec><sec id="Sec239"><title>Cervical cancer</title><p id="Par40">Cervical cancer is one of the most significant malignancies affecting women&#x02019;s health globally. According to previous statistics, over half a million new cases are diagnosed annually, with approximately 90% occurring in low- and middle-income countries [<xref ref-type="bibr" rid="CR189">189</xref>]. In pursuing targeted therapeutic strategies, researchers have identified several molecular targets and signaling pathways that offer insights for developing conversion therapies [<xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR191">191</xref>]. Among these, mTOR, a highly conserved serine/threonine protein kinase, plays a pivotal role as a master regulator of autophagy in multiple cellular processes [<xref ref-type="bibr" rid="CR192">192</xref>, <xref ref-type="bibr" rid="CR193">193</xref>]. In cervical cancer, the activation of mTORC1 signaling effectively inhibits exosomal release, whereas the administration of rapamycin significantly stimulates exosome secretion [<xref ref-type="bibr" rid="CR194">194</xref>]. Similarly, conditions such as serum starvation and amino acid pretreatment also trigger substantial exosome release [<xref ref-type="bibr" rid="CR194">194</xref>]. None of these autophagy-inducing factors altered the cargo content of exosomes, indicating that mTORC1&#x02019;s impact on exosomes in stress-related autophagy models is associated with secretion processes rather than selective cargo loading. The connection between ubiquitinated proteins and secretory autophagy has been elucidated in a separate study. S-phase kinase-associated protein 1 (SKP1), a core component of the SKP1-Cullin 1-F-box protein (SCF) complex, functions as a conserved E3 ligase responsible for the polyubiquitination and proteasomal degradation of numerous proteins [<xref ref-type="bibr" rid="CR195">195</xref>, <xref ref-type="bibr" rid="CR196">196</xref>]. In HeLa cells, SKP1 phosphorylation at Thr131 facilitates its direct binding to V-ATPase, independent of F-box proteins, leading to V-ATPase reorganization and MVB acidification under nutrient-replete conditions [<xref ref-type="bibr" rid="CR117">117</xref>]. This ultimately triggers the endolysosomal degradation of cargo. Conversely, under nutrient-depleted conditions, SKP1 dephosphorylation occurs, activating a secretory autophagy pathway mediated by SKP1-SEC22B binding within the amphisome compartment [<xref ref-type="bibr" rid="CR117">117</xref>]. These findings highlight the role of SKP1 in cellular nutrient sensing and its function as a bridge between cellular logistics and metabolism. SKP1 phosphorylation ensures efficient protein degradation and amino acid recycling during energy deficiency, maintaining biosynthetic functions in nutrient-poor environments [<xref ref-type="bibr" rid="CR197">197</xref>]. On the contrary, reduced SKP1 phosphorylation under sufficient energy conditions promotes excessive transport of metabolic substances <italic>via</italic> autophagy-dependent secretion (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Post-translational modifications of SKP1 appear to coordinate protein breakdown and efflux, enabling rapid cellular stress responses. This regulatory mechanism offers potential strategies for cancer treatment in pathological environments. Furthermore, recent studies have revealed the involvement of ATG5 in secretory autophagy. In HeLa cells, ATG5 recruits ESCRTs to repair damaged lysosomes. Mutations or reductions in ATG5 impair the autophagy-lysosomal pathway, triggering secretory autophagy [<xref ref-type="bibr" rid="CR198">198</xref>]. Similarly, in ovarian cancer cells, MVB acidification and lysosomal structure/function regulators play critical roles in secretory autophagy. Along with understanding the expression of key molecules, elucidating cellular metabolic mechanisms is vital for translating these findings into clinical applications.</p><p id="Par41">
<fig id="Fig5"><label>Fig. 5</label><caption><p>Role of cellular nutrients metabolism in regulating secretory autophagy</p></caption><graphic xlink:href="40164_2025_603_Fig5_HTML" id="d33e1233"/></fig>
</p></sec><sec id="Sec242"><title>Hepatocellular carcinoma (HCC)</title><p id="Par43">HCC, primarily caused by chronic liver diseases such as hepatitis B virus infection, is the predominant type of liver cancer. The 5-year survival rate for HCC remains below 50%, with some studies indicating rates as low as 30% for advanced stages [<xref ref-type="bibr" rid="CR199">199</xref>]. These statistics underscore the urgent need for the development of novel therapeutic strategies. During the exploration of molecular targets, the critical role of ATG family proteins in the initiation and progression of HCC has been increasingly recognized. Several ATGs have been identified as playing pivotal roles in disease development and progression [<xref ref-type="bibr" rid="CR200">200</xref>&#x02013;<xref ref-type="bibr" rid="CR202">202</xref>]. In ATG5 wild-type Huh7 cells, the formation of the ATG5-ATG12 complex enables ALIX to bind with ESCRTs, facilitating lysosomal repair. Upon ATG5 knockout, the ATG3-ATG12 complex adsorbs ALIX, thereby preventing ALIX-mediated lysosomal repair [<xref ref-type="bibr" rid="CR203">203</xref>]. These findings align with previous reports demonstrating the role of the ALIX-ESCRT system in maintaining lysosomal stability and repairing damaged lysosomes [<xref ref-type="bibr" rid="CR204">204</xref>&#x02013;<xref ref-type="bibr" rid="CR206">206</xref>]. This evidence suggests that the lysosomal damage repair mechanism in HCC cells represents a critical pathway for regulating secretory autophagy, particularly through lysosomal damage repair and quality control. In addition to the classical role of V-ATPase in regulating intracellular pH and influencing material transport outcomes, other lysosome-associated proteins contribute to similar regulatory functions. For example, lactate dehydrogenase B (LDHB) is highly expressed in cancer cells and catalyzes lactate metabolism to control lysosomal acidification and vesicle maturation [<xref ref-type="bibr" rid="CR207">207</xref>]. Although this mechanism is observed in both oxidative and glycolytic cancer cells, its applicability may be limited. Hypermetabolic cancer cells are likely to depend more heavily on this metabolic coupling mechanism for survival and progression. These insights into the role of lysosomal repair and metabolic coupling in HCC highlight potential therapeutic targets for addressing the challenges posed by this aggressive disease.</p></sec><sec id="Sec244"><title>Cholangiocarcinoma (CCA)</title><p id="Par45">CCA is a highly heterogeneous tumor of the digestive system. Due to the high heterogeneity of tumor cells and significant drug resistance, the prognosis and survival time of CCA patients are severely compromised. The incidence of CCA has remained persistently high over the past decades [<xref ref-type="bibr" rid="CR208">208</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]. As a refractory tumor, current studies focus on innovative strategies, including targeted therapies for protein degradation pathways [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR210">210</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]. The proteasomal degradation pathway and the autolysosome-related degradation pathway represent two parallel yet interconnected systems for protein degradation in eukaryotic cells. The tumor suppressor phosphatase and tensin homolog (PTEN) has been shown to inhibit the ubiquitin-mediated proteolytic system while promoting the lysosomal degradation pathway in CCA cells [<xref ref-type="bibr" rid="CR116">116</xref>]. PTEN primarily relies on its lipid phosphatase activity to modulate TFEB<sup>Ser211</sup> phosphorylation, independent of PI3K/AKT signaling, thereby enhancing lysosome biogenesis and acidification. When PTEN is deficient, the lysosomal degradation of MVB cargos is impaired, leading to the production of exosomes. These functional exosomes further facilitate cell proliferation and invasion [<xref ref-type="bibr" rid="CR116">116</xref>]. The transcription factor EB (TFEB) has a conformation that enables direct binding to the coordinated lysosomal expression and regulation (CLEAR) element, promoting the expression of genes associated with lysosomal function. TFEB activation or overexpression significantly enhances lysosome-related protein expression, thereby increasing lysosomal activity [<xref ref-type="bibr" rid="CR212">212</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]. Phosphorylation of TFEB serves as a critical regulatory mechanism for its cellular localization and activity. Two serine residues, Ser142 and Ser211, determine TFEB&#x02019;s state. When both residues are phosphorylated, TFEB remains inactive and localized in the cytoplasm. Dephosphorylation of either residue activates TFEB, allowing it to enter the nucleus to regulate transcription [<xref ref-type="bibr" rid="CR214">214</xref>&#x02013;<xref ref-type="bibr" rid="CR216">216</xref>]. These findings highlight the importance of post-transcriptional modifications in secretory autophagy. High CD63 expression and low PTEN levels in CCA tissues are associated with poor patient prognosis, indicating a relationship between PTEN and exosome production during secretory autophagy. PTEN is essential for regulating lysosomal function, suggesting that lysosome acidification regulators are key mediators restraining MVB-lysosome fusion and exosome release [<xref ref-type="bibr" rid="CR116">116</xref>]. PTEN loss or overexpression has been identified as a prognostic marker for evaluating CCA responsiveness to proteasome inhibitors [<xref ref-type="bibr" rid="CR217">217</xref>]. Although PTEN-mediated secretory autophagy in CCA is independent of AKT signaling, the cholangitis-to-CCA continuum requires both AKT signaling and Aurora kinase A (Aurka) [<xref ref-type="bibr" rid="CR218">218</xref>]. Pharmacological inhibition of Aurka effectively halts disease progression [<xref ref-type="bibr" rid="CR218">218</xref>]. This study highlights the multi-faceted regulatory role of PTEN in CCA progression and underscores its significance in the interplay between tumor cells and their microenvironment.</p></sec><sec id="Sec246"><title>Esophageal squamous cell carcinoma (ESCC)</title><p id="Par47">Esophageal cancer is categorized into two pathological types: ESCC and adenocarcinoma. ESCC primarily develops from precancerous lesions, with a 5-year survival rate of less than 20%, highlighting the need for molecular-targeted therapies [<xref ref-type="bibr" rid="CR219">219</xref>]. Developing novel compounds targeting cell death pathways offers a promising therapeutic strategy for the clinical management of ESCC. Cellular senescence, a mechanism of cell death, prevents tumorigenesis and progression by inhibiting cell proliferation, making senescence-inducing agents a promising anti-cancer strategy, particularly in combination with pro-senescence drugs and conventional therapies [<xref ref-type="bibr" rid="CR220">220</xref>]. Sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables, shows significant anti-tumor activity. Mechanistically, SFN modulates the mTOR/TFE3 axis to inhibit autophagy by regulating lysosome biogenesis and triggering the secretion of functional exosomes, which induce senescence in surrounding cells through paracrine signaling [<xref ref-type="bibr" rid="CR120">120</xref>]. Transcription factor binding to IGHM enhancer 3 (TFE3), a master regulator of lysosomal activity, is regulated by mTORC1-dependent multisite phosphorylation (TFE3<sup>Ser321</sup>) [<xref ref-type="bibr" rid="CR221">221</xref>]. SFN activates mTOR signaling, inducing TFE3 phosphorylation, which is crucial for initiating secretory autophagy. This underscores the critical role of mTOR signaling in secretory autophagy. SFN&#x02019;s role in anti-tumor therapy has become increasingly evident, including its ability to improve inflammatory responses and inhibit pseudopodia formation in tumor cells [<xref ref-type="bibr" rid="CR222">222</xref>, <xref ref-type="bibr" rid="CR223">223</xref>]. Combining SFN with various clinical chemoradiotherapy strategies could provide new therapeutic approaches. However, the emergence of senescence-associated secretory phenotype (SASP), which triggers the release of inflammatory factors, may partially counteract SFN&#x02019;s anti-tumor effects [<xref ref-type="bibr" rid="CR224">224</xref>]. Careful consideration of SASP-related impacts is essential when designing SFN-based therapeutic strategies.</p></sec><sec id="Sec248"><title>Pancreatic cancer</title><p id="Par49">The incidence of pancreatic cancer doubled between 1990 and 2017, with the risk increasing with age and being higher in high-income countries [<xref ref-type="bibr" rid="CR225">225</xref>]. Effective treatment options for pancreatic cancer remain limited, particularly for advanced-stage patients. Targeted therapy has emerged as a promising approach, with GAIP-interacting protein C-terminus (GIPC) identified as a potential candidate target. GIPC functions as a scaffold protein through its PDZ motif, regulating receptor-mediated transport. Upon receptor internalization, GIPC directly participates in vesicle trafficking by interacting with endocytic vesicles near the plasma membrane [<xref ref-type="bibr" rid="CR226">226</xref>]. A study has shown that GIPC is involved in the autophagy-exosome interaction within pancreatic cancer cells. Although Beclin1 and ATG7 expression levels remain unchanged in GIPC-deficient cells, these cells exhibit an excessive accumulation of MVBs, leading to increased exosome secretion [<xref ref-type="bibr" rid="CR115">115</xref>]. Exosomes derived from GIPC-deficient cells contain ATP-binding cassette transporter G2 (ABCG2), a molecule associated with resistance to gemcitabine treatment [<xref ref-type="bibr" rid="CR115">115</xref>]. ABCG2, a member of the ABC transporter superfamily, is overexpressed in many tumors and plays a critical role in the efflux of various chemotherapy drugs, contributing to the multidrug resistance (MDR) phenotype [<xref ref-type="bibr" rid="CR227">227</xref>, <xref ref-type="bibr" rid="CR228">228</xref>]. Understanding the relationship between GIPC and ABCG2 in secretory autophagy requires immunohistochemical analysis in clinical samples. Such analysis could elucidate their expression and distribution patterns, aiding the development of more effective targeted therapy strategies. However, the heterogeneity of exosomes must be considered, as alterations in ABCG2 expression may be limited to GIPC-deficient cells. Single EV sequencing provides a potential solution to this challenge, offering higher resolution to analyze exosome characteristics [<xref ref-type="bibr" rid="CR229">229</xref>&#x02013;<xref ref-type="bibr" rid="CR231">231</xref>].</p><p id="Par50">Stromal fibrosis disrupts vasculature, resulting in intratumoral hypoxia and metabolic imbalance. Tumor cells must adapt their nutrient acquisition and utilization strategies to sustain rapid proliferation. Studies have demonstrated that pancreatic stellate cells (PSCs) release significant quantities of alanine to support pancreatic ductal adenocarcinoma (PDAC) cells <italic>via</italic> secretory autophagy [<xref ref-type="bibr" rid="CR232">232</xref>]. Autophagy activation in PSCs is induced by stimulation from PDAC cells, triggering PSCs to catabolize proteins and produce alanine, which is then released into the TME through a secretory autophagy pathway. When shATG5 and shATG7 were used to inhibit autophagy, alanine secretion was significantly reduced [<xref ref-type="bibr" rid="CR232">232</xref>]. PDAC cells actively uptake alanine and utilize it as a carbon source in the tricarboxylic acid (TCA) cycle, converting it into pyruvate. Alanine-derived pyruvate does not equilibrate with cytosolic pyruvate, providing a direct carbon source for mitochondrial metabolism without affecting the intracellular NAD<sup>+/</sup>NADH redox balance [<xref ref-type="bibr" rid="CR232">232</xref>]. This metabolic reprogramming enables the efficient diversion of conventional carbon sources, such as glucose, to other biosynthetic pathways, including serine and glycine production, which are crucial for nucleic acid synthesis [<xref ref-type="bibr" rid="CR232">232</xref>]. This synergistic metabolic adaptation provides essential substrates for tumor growth in nutrient-restricted environments. In highly mesenchymal PDAC, the reciprocal interaction between stromal cells and tumor cells improves the energy acquisition mechanisms of tumor cells under malnourished conditions. This &#x0201c;predatory demand&#x0201d; highlights a survival strategy for tumor cells within extreme microenvironmental constraints.</p></sec><sec id="Sec251"><title>Head and neck squamous cell carcinoma (HNSCC)</title><p id="Par52">HNSCCs are solid malignancies originating from the oral cavity, pharynx, and larynx. Their etiology is often associated with excessive exposure to carcinogens and alcohol consumption [<xref ref-type="bibr" rid="CR233">233</xref>]. The interaction between cancer cells and their microenvironment plays a critical role in tumor survival and malignancy. Over the past decade, the secretory properties of cancer-associated fibroblasts (CAFs) have posed significant challenges in the treatment of tumors. Studies have demonstrated distinct differences between the characteristics of CAFs and normal fibroblasts (NFs) within the same anatomical site. CAFs show a higher abundance of concentrated vesicle structures, indicative of robust secretory activity [<xref ref-type="bibr" rid="CR109">109</xref>]. Knockdown of Beclin-1, ATG7, or treatment with CQ has been shown to significantly reduce the secretion of cytokines such as IL-6 and IL-8 [<xref ref-type="bibr" rid="CR109">109</xref>]. These cytokines are systemically elevated in HNSCC patients and are correlated with resistance to targeted therapies. Moreover, IL-6 and IL-8 are secreted by stromal fibroblasts in various cancer types and are implicated in senescence-related secretory phenotypes [<xref ref-type="bibr" rid="CR234">234</xref>&#x02013;<xref ref-type="bibr" rid="CR237">237</xref>]. Despite the high autophagic activity observed in primary CAF cells, inhibition of autophagy through Beclin-1 knockdown effectively reduces secretory autophagy, thus lowering IL-6 and IL-8 levels [<xref ref-type="bibr" rid="CR109">109</xref>]. Evidence from extensive literature has demonstrated that both chemotherapy and radiotherapy are potent inducers of autophagy in HNSCC cells [<xref ref-type="bibr" rid="CR238">238</xref>, <xref ref-type="bibr" rid="CR239">239</xref>]. While autophagy may act as a protective mechanism for tumor cells, secretory autophagy contributes to clinical resistance to chemotherapy and radiotherapy. However, clinical trials using autophagy inhibitors such as CQ have reported limited efficacy due to insufficient intratumoral concentrations to effectively inhibit autophagy within the tumor microenvironment [<xref ref-type="bibr" rid="CR240">240</xref>]. To address these limitations, the development of novel small-molecule drugs has become a crucial focus. SAR405, a PI3K class III inhibitor, has demonstrated potent autophagy inhibition in HNSCC and CAFs at low doses (1.0 &#x003bc;M), effectively limiting autophagy levels [<xref ref-type="bibr" rid="CR109">109</xref>]. This compound represents a promising alternative to CQ and may offer a viable therapeutic strategy in the clinical setting to overcome resistance associated with secretory autophagy.</p></sec></sec><sec id="Sec153"><title>Secretory autophagy and tumour microenvironment stress</title><sec id="Sec254"><title>Hypoxia</title><p id="Par55">Tumor cell proliferation requires sufficient oxygen supply, and cells located more than 100&#x000a0;&#x003bc;m from an oxygen source are considered hypoxic [<xref ref-type="bibr" rid="CR241">241</xref>]. Hypoxia is one of the most common pathological features of solid tumors, contributing to tumor invasion, metastasis, and resistance to therapy [<xref ref-type="bibr" rid="CR242">242</xref>&#x02013;<xref ref-type="bibr" rid="CR244">244</xref>]. CAFs, key components of the TME, facilitate cancer progression through various mechanisms, particularly <italic>via</italic> their secretome. Secreted factors such as stromal cell-derived factor 1 (SDF-1), interleukin-32 (IL32), and transforming growth factor-beta (TGF-&#x003b2;) are critical mediators of intercellular communication within the TME [<xref ref-type="bibr" rid="CR245">245</xref>, <xref ref-type="bibr" rid="CR246">246</xref>]. Recent studies have demonstrated that ataxia telangiectasia-mutated (ATM) protein is phosphorylated under hypoxic conditions, leading to autophagosome accumulation and lysosomal dysfunction. This process facilitates the fusion of autophagosomes with MVBs through ATG6V1G1, promoting the release of autophagy-dependent exosomes [<xref ref-type="bibr" rid="CR247">247</xref>]. Phosphorylated ATM also induces the phosphorylation of BNIP3, forming the BNIP3-P300-FOXO3 complex, which transcriptionally upregulates ATG5 and ATG16L expression [<xref ref-type="bibr" rid="CR247">247</xref>]. These findings suggest that hypoxia-induced ATM phosphorylation drives secretory autophagy through two distinct mechanisms: enhancing autophagosome formation and modulating MVB acidification. MVB acidification, a critical step in secretory autophagy, is closely associated with the function of V-ATPase. Hypoxic CAFs further promote the secretion of G-protein coupled receptor 64 (GPR64)-enriched exosomes <italic>via</italic> the secretory autophagy pathway, enhancing cancer cell invasion through NF-&#x003ba;B signaling [<xref ref-type="bibr" rid="CR247">247</xref>]. Although the exosomal loading process of GPR64 remains unclear, it is hypothesized that GPR64, as an adhesion receptor [<xref ref-type="bibr" rid="CR248">248</xref>], may be sorted by interactions with other membrane proteins. These findings highlight the importance of hypoxia-driven secretory autophagy in tumor progression and highlight potential therapeutic targets within this pathway.</p></sec><sec id="Sec256"><title>Mechanical stress</title><p id="Par57">The mechanisms underlying tumor metastasis and colonization are complex, with only approximately 0.01% of circulating tumor cells successfully forming secondary lesions due to the challenges of overcoming fluid shear stress [<xref ref-type="bibr" rid="CR249">249</xref>, <xref ref-type="bibr" rid="CR250">250</xref>]. Tumor cells experience acute shear stress (ASS) during growth and metastasis, whether <italic>via</italic> blood or lymphatic dissemination. Under normal physiological conditions, tumor cells exhibit basal levels of autophagy and exosome release. However, changes in the mechanical microenvironment, such as ASS, trigger the remodeling of autophagy-dependent degradation processes, thereby associating autophagy with EV release. Studies have demonstrated that ASS promotes the fusion of autophagosomes with MVBs, resulting in the calcium-dependent exosomal release of LC3II<sup>+</sup> and LAMP1<sup>+</sup> exosomes [<xref ref-type="bibr" rid="CR251">251</xref>]. The presence of autophagy-related proteins in exosomes, including p62, LC3, and LAMP2, highlights the close relationship between autophagy and exosomal pathways [<xref ref-type="bibr" rid="CR252">252</xref>&#x02013;<xref ref-type="bibr" rid="CR256">256</xref>]. Interestingly, the cellular response to mechanical signals is mediated by calcium transporters such as PIEZO1, which helps maintain cellular homeostasis under stress [<xref ref-type="bibr" rid="CR257">257</xref>&#x02013;<xref ref-type="bibr" rid="CR259">259</xref>]. The balance between autophagosomes and MVBs is essential in secretory autophagy, as it determines the fate of transported substances. Blocking exosome release under shear stress conditions leads to the accumulation of autophagosomes and MVBs, ultimately activating Caspase3/PARP-mediated apoptosis [<xref ref-type="bibr" rid="CR251">251</xref>]. These findings suggest that exosomes serve as a complementary pathway to maintain cellular homeostasis, particularly when autophagy is insufficient to degrade large quantities of damaged proteins and prevent cell death. The regulation of exosome release by ASS highlights how tumor cells adapt to mechanical stress and contribute to the formation of a metastatic microenvironment. These insights emphasize the interplay between autophagy, exosomal release, and tumor cell survival under mechanically stressful conditions, providing potential targets for therapeutic intervention.</p></sec></sec><sec id="Sec158"><title>Secretory autophagy and immune regulation</title><p id="Par59">The emergence of tumor cells triggers immune system activation, leading to immune recognition and subsequent elimination through immune-mediated killing processes. However, malignant cells accumulate oncogenic mutations to escape immune surveillance, downregulate tumor antigens, upregulate pro-survival genes, and reshape the immune microenvironment, enabling evasion of immune detection and elimination [<xref ref-type="bibr" rid="CR260">260</xref>&#x02013;<xref ref-type="bibr" rid="CR262">262</xref>]. Autophagy inhibitors are currently among the key strategies for overcoming resistance to clinical treatments. However, they also contribute to immune tolerance in certain contexts. Exosomes have been identified as crucial mediators in enhancing the tumor immunosuppressive microenvironment in this complex landscape. Tumor-derived exosomes can create a tolerant microenvironment, facilitating interactions with the immune system [<xref ref-type="bibr" rid="CR263">263</xref>, <xref ref-type="bibr" rid="CR264">264</xref>]. Understanding the malignant potential of tumor cells and their interplay with exosomes is critical for advancing therapeutic strategies. Studies have shown that tumor cells with high metastatic capacity show elevated basal autophagy levels accompanied by increased secretion activity (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Inhibition of autophagy results in the accumulation of damaged mitochondria and increased reactive oxygen species (ROS), which then enhance secretory autophagy of macrophage migration inhibitory factor (MIF) [<xref ref-type="bibr" rid="CR265">265</xref>, <xref ref-type="bibr" rid="CR266">266</xref>]. MIF is a key immune regulatory molecule with essential roles in both innate and adaptive immunity [<xref ref-type="bibr" rid="CR267">267</xref>, <xref ref-type="bibr" rid="CR268">268</xref>]. It is secreted by various cells, including epithelial and endothelial cells [<xref ref-type="bibr" rid="CR268">268</xref>]. Interestingly, MIF lacks an ER localization motif in its structure and is, therefore, not secreted through the classical ER/Golgi pathway [<xref ref-type="bibr" rid="CR269">269</xref>]. Instead, MIF is secreted <italic>via</italic> an unconventional protein secretion pathway, which has been implicated in cancer progression [<xref ref-type="bibr" rid="CR270">270</xref>, <xref ref-type="bibr" rid="CR271">271</xref>]. MIF promotes target cell signaling through multiple receptors. For instance, MIF activates the MAPK/ERK pathway <italic>via</italic> the CD74/CD44 ligand, resulting in the increased production of proinflammatory cytokines such as TNF, IL-1&#x003b2;, IL-6, nitric oxide (NO), cyclooxygenase-2 (COX2), and IFN-&#x003b3;, thereby triggering immune responses through autocrine and paracrine signaling [<xref ref-type="bibr" rid="CR268">268</xref>]. Furthermore, MIF binds to chemokine receptors CXCR2 and CXCR4, recruiting monocytes, lymphocytes, and neutrophils by promoting IL-8 release [<xref ref-type="bibr" rid="CR268">268</xref>]. In addition to the knockdown of ATG7 and treatment with CQ, the use of antioxidants has been shown to block MIF-induced secretory autophagy. Thus, the combined use of autophagy inhibitors and MIF inhibitors, such as ISO-1, may provide novel insights into enhancing anti-tumor immunity. The effectors released <italic>via</italic> the secretory autophagy pathway significantly contribute to the formation of an immunosuppressive microenvironment by recruiting immune cells and releasing inflammatory factors. This highlights the critical need for therapeutic strategies targeting both secretory autophagy and its downstream effectors to disrupt the tumor-promoting immune landscape and improve clinical outcomes.</p><p id="Par60"><italic>KRAS</italic>, one of the most frequently mutated oncogenes in human solid tumors, plays a critical role in immunomodulation associated with secretory autophagy. Aberrant <italic>KRAS</italic> mutations are prevalent in various solid tumors, including pancreatic, lung, and colorectal cancers [<xref ref-type="bibr" rid="CR272">272</xref>]. Activation of oncogenic <italic>KRAS</italic> signaling leads to immunosuppression through alterations in the TME. PDAC, primarily driven by <italic>KRAS</italic> mutations, remains a highly lethal malignancy despite advances in clinical trials. The survival rate of PDAC patients has shown minimal improvement, highlighting the need for novel therapeutic approaches. Macrophages, quiescent in their basal state, can differentiate into two subtypes upon external stimulation: the M1 phenotype, which shows anti-tumor properties, and the M2 phenotype, which supports tumor progression [<xref ref-type="bibr" rid="CR273">273</xref>]. Recent studies have focused on preventing the transformation of macrophages into the tumor-promoting M2 phenotype. In PDAC, the G12D mutation in <italic>KRAS</italic> (<italic>KRAS</italic><sup>G12D</sup>) is the most common alteration. Emerging evidence indicates that autophagy activation facilitates the release of exosomal <italic>KRAS</italic><sup>G12D</sup> from PDAC cells, which, upon uptake by macrophages through advanced glycation end-product receptor (AGER), induces M2 polarization. This process is mediated by activation of STAT3-dependent fatty acid oxidation [<xref ref-type="bibr" rid="CR274">274</xref>]. AGER plays a pivotal role in the malignant progression of PDAC and its resistance to therapy [<xref ref-type="bibr" rid="CR275">275</xref>&#x02013;<xref ref-type="bibr" rid="CR277">277</xref>]. Depletion of AGER has been shown to limit <italic>KRAS</italic><sup>G12D</sup>-driven PDAC progression and enhance chemotherapy sensitivity [<xref ref-type="bibr" rid="CR275">275</xref>&#x02013;<xref ref-type="bibr" rid="CR277">277</xref>]. Targeting the AGER-mediated polarization pathway through molecular drug design could serve as a promising approach to inhibiting tumor progression. Preliminary in vitro studies have validated measures such as using AGER antibodies, STAT3 signaling inhibitors, CQ, shATG5 and shRAB27 to block secretory autophagy-related signaling pathways of <italic>KRAS</italic><sup>G12D</sup> [<xref ref-type="bibr" rid="CR274">274</xref>]. The development of innovative strategies targeting the delivery of <italic>KRAS</italic><sup>G12D</sup> protein offers a viable avenue for therapeutic intervention. However, exosomes, which play a key role in this process, share mechanistic features with other types of EVs, complicating their precise isolation and identification. Addressing this challenge is essential for advancing the application of exosome-targeted therapies in clinical settings. Further research into purification methods and high-precision identification of exosomes is important to refine and optimize these therapeutic strategies.</p><p id="Par61">
<fig id="Fig6"><label>Fig. 6</label><caption><p>Immune regulation of secretory autophagy molecules from tumour cells</p></caption><graphic xlink:href="40164_2025_603_Fig6_HTML" id="d33e1635"/></fig>
</p></sec><sec id="Sec162"><title>Secretory autophagy and therapy resistance</title><p id="Par63">Secretory autophagy, particularly involving HMGB1, plays a key role in mediating the crosstalk between tumor cells and clinical treatments, affecting tumor sensitivity to therapeutic agents such as TMZ. Extracellular HMGB1, released <italic>via</italic> secretory autophagy, has been identified as a key regulator in this process [<xref ref-type="bibr" rid="CR118">118</xref>]. Studies have shown that autophagy inhibitors like LY294002 and 3-MA significantly block TMZ-induced autophagosome formation and suppress the autophagy-dependent secretion of HMGB1 [<xref ref-type="bibr" rid="CR118">118</xref>]. These findings provide a strong rationale for the combination of autophagy inhibitors with TMZ to enhance therapeutic outcomes. Furthermore, the loss of ATG5 or GORASP2 in GB cells significantly reduces HMGB1 secretion during TMZ treatment [<xref ref-type="bibr" rid="CR118">118</xref>]. ATG5-mediated activation of classical autophagy and GORASP2-dependent unconventional secretion pathways are essential for cytoplasmic protein efflux [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR278">278</xref>, <xref ref-type="bibr" rid="CR279">279</xref>]. This suggests that HMGB1 is located within autophagosomes in GB cells, though the precise mechanism of its loading into autophagosomes warrants further investigation. HMGB1 primarily resides in the nucleus, where it functions as a DNA chaperone. Loss of HMGB1 can lead to excessive DNA damage and reduced DNA repair efficiency during chemotherapy [<xref ref-type="bibr" rid="CR280">280</xref>]. Targeting ATG5 or inhibiting autophagosome formation may provide a viable therapeutic strategy to improve treatment outcomes. However, such approaches may lack selectivity due to the diverse nature of autophagic cargo. A deeper understanding of the HMGB1 loading process could enhance therapeutic precision and efficacy. ATG7 is another crucial regulator of cargo release during secretory autophagy. Its interaction with ATG5 has been shown to facilitate the translocation of CFTR to MVBs, triggering autophagy-dependent CFTR release <italic>via</italic> the ESCRT pathway [<xref ref-type="bibr" rid="CR281">281</xref>]. This process requires SEC16 homolog A (SEC16A) (ER export factor) to disengage CFTR from the ER during unconventional autophagy [<xref ref-type="bibr" rid="CR282">282</xref>]. Furthermore, the coupling of ATG3 and ATG12 is critical for secretory autophagy [<xref ref-type="bibr" rid="CR283">283</xref>, <xref ref-type="bibr" rid="CR284">284</xref>]. The secretion of cytokines such as IL-1&#x003b2; and leukemia inhibitory factor (LIF) is significantly correlated with ATG7 expression, highlighting the interplay between autophagy-dependent secretion and immune modulation [<xref ref-type="bibr" rid="CR285">285</xref>&#x02013;<xref ref-type="bibr" rid="CR288">288</xref>]. IL-1&#x003b2; regulates tumor therapeutic responses and immune activation [<xref ref-type="bibr" rid="CR289">289</xref>, <xref ref-type="bibr" rid="CR290">290</xref>], while the LIF-mediated secretory pathway contributes to drug resistance in tumor cells [<xref ref-type="bibr" rid="CR291">291</xref>, <xref ref-type="bibr" rid="CR292">292</xref>]. These findings suggest an indirect link between autophagy-dependent cargo secretion and tumor resistance to treatment, emphasizing the need for targeted interventions to mitigate drug resistance mechanisms.</p></sec><sec id="Sec164"><title>Treatment strategies on secretory autophagy</title><p id="Par65">Targeting secretory autophagy still lack of sufficient clinical evidences to promote its clinical transformation. Therefore, this part mainly proposes new strategies for targeted therapy based on the aforementioned secretory autophagy mechanism of tumour cells, in order to better promote clinical transformation. At present, the approaches to target secretory autophagy are still in explorational stage, and the main way targeting secretory autophagy is still rely on the traditional signal shared with autophagy. For example, the using of inhibitors of PI3KC3/VPS34 [<xref ref-type="bibr" rid="CR293">293</xref>], targeting ATG4 [<xref ref-type="bibr" rid="CR294">294</xref>, <xref ref-type="bibr" rid="CR295">295</xref>], ATG7 [<xref ref-type="bibr" rid="CR296">296</xref>], ATG5 [<xref ref-type="bibr" rid="CR297">297</xref>], and ULK1-ULK2 complex [<xref ref-type="bibr" rid="CR298">298</xref>], these small molecule drugs have shown good anti-tumour activity and high safety profile. However, these drugs are all based on targets related to classical autophagy signaling and thus lack specificity. In addition, there are drugs that target lysosomal acidification to promote secretory autophagy by blocking the conventional autophagy pathway. For example, targeting ATG5 [<xref ref-type="bibr" rid="CR297">297</xref>, <xref ref-type="bibr" rid="CR299">299</xref>], ATP6V1E [<xref ref-type="bibr" rid="CR300">300</xref>, <xref ref-type="bibr" rid="CR301">301</xref>], ATP6V1G [<xref ref-type="bibr" rid="CR247">247</xref>, <xref ref-type="bibr" rid="CR302">302</xref>], TFEB [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR303">303</xref>, <xref ref-type="bibr" rid="CR304">304</xref>], ATG6V1G [<xref ref-type="bibr" rid="CR247">247</xref>, <xref ref-type="bibr" rid="CR305">305</xref>] could block the fusion of autophagosomes with lysosomes and promote autophagy-dependent secretion. Some classical autophagy inhibitors have also shown good anti-tumour effects and can act on the secretory autophagy pathway. Currently, the only drug that target autophagy in clinical practice is CQ/HCQ. These drugs can inhibit autophagic flux by deacidification of lysosomes and blocking the fusion of autophagosomes and lysosomes. CQ can also enhance the sensitivity of chemotherapy drugs independent of autophagy pathway [<xref ref-type="bibr" rid="CR306">306</xref>&#x02013;<xref ref-type="bibr" rid="CR308">308</xref>]. Clinical trials have found that inhibition of autophagy can improve the prognosis of patients with glioblastoma. Compared with the control group, CQ combined with radiotherapy and the alkylating agent temozolomide could significantly improve the median survival time of patients (33 months vs. 11 months) [<xref ref-type="bibr" rid="CR309">309</xref>]. Phase I clinical trial results also demonstrated that the combination of HCQ and temsilimus can improve the prognosis of patients with advanced solid tumours and melanoma [<xref ref-type="bibr" rid="CR310">310</xref>]. Preliminary application in other tumours and combined therapy trials are gradually carried out, and preliminary results have been achieved. These small molecule drugs around the common pathway of classical autophagy and secretory autophagy have shown good therapeutic effects, but they lack specificity. These small molecule drugs around the common pathway of classical autophagy and secretory autophagy have shown good therapeutic effects, but they lack specificity. The targeted research on secretory autophagy is in the exploratory stage, and further research is needed. However, the targeting of secreted autophagy-related cargo has provided new insights. For example, to prevent cargo loading or targeting molecules itself, we launched discussion.</p></sec><sec id="Sec166"><title>Strategy 1: targeting releasing agents</title><sec id="Sec267"><title>Targeting HMGB1</title><p id="Par68">Salicylates and glycyrrhizic acid are key HMGB1 inhibitors, and it has been widely used in clinical practice, and its safety is worth to be confirmed [<xref ref-type="bibr" rid="CR311">311</xref>, <xref ref-type="bibr" rid="CR312">312</xref>]. The key step is to analyze the correlation between salicylates/glycyrrhizic acid and tumour occurrence and progression in the long-term treatment of tumour. Another study showed that ethyl pyruvate could inhibit the phosphorylation and release of HMGB1, thereby inhibiting the biological function of HMGB1 [<xref ref-type="bibr" rid="CR313">313</xref>]. Metformin, another drug commonly used in clinical practice, was also found to bind HMGB1 and interfere with its function [<xref ref-type="bibr" rid="CR314">314</xref>]. Although several drugs have been found to interfere with HMGB1 expression, it should be of concern that the function of HMGB1 is differentiated between intracellular and extracellular.</p></sec><sec id="Sec269"><title>Targeting KRAS</title><p id="Par70">KRAS, as one of the key mutated genes in solid tumours, provides a lot of hope for the field of tumour targeted therapy. The mechanism of secretory autophagy regulation of KRAS<sup>G12D</sup> has been described previously, and new therapeutic approaches targeting KRAS<sup>G12D</sup> have emerged. TH-Z827 (IC50:4.4&#x000a0;&#x003bc;m) and TH-Z835 (IC50:2.5&#x000a0;&#x003bc;m), as newly developed KRAS<sup>G12D</sup> inhibitors, have lower pharmacological concentrations and certain safety profiles, and significantly improve the efficacy of immunotherapy in animal experiments in vivo [<xref ref-type="bibr" rid="CR315">315</xref>]. A noncovalent, potent, and selective KRAS<sup>G12D</sup> inhibitor, MRTX1133(IC50:5&#x000a0;&#x003bc;m), was also identified in another study [<xref ref-type="bibr" rid="CR316">316</xref>, <xref ref-type="bibr" rid="CR317">317</xref>]. MRTX1133 shows an excellent tumour suppressor effect in pancreatic cancer. MRTX1133 can reprogram the tumour immune microenvironment and enhance the immune killing effect of FAS-mediated CD8<sup>+</sup>T cells [<xref ref-type="bibr" rid="CR318">318</xref>]. In addition to KRAS<sup>G12D</sup>, hot spot mutations such as G12C also widely exist and play a role in carcinogenesis. Although whether the secretion of KRAS G12C depends on secretory autophagy is not known, its application value has also been clarified in the treatment of KRAS<sup>G12C</sup>. Data from sotorasib, a KRAS<sup>G12C</sup> inhibitor, in KRAS<sup>G12C</sup>-mutated advanced lung cancer showed that 88.1% (52 patients) of the patients had disease control [<xref ref-type="bibr" rid="CR319">319</xref>]. These results suggest that KRAS targeted inhibitors may play an anti-cancer/immuno-synergistic role in blocking the secretory autophagy signaling process of KRAS.</p></sec><sec id="Sec271"><title>Targeting ADAM10</title><p id="Par72">ADAM10 inhibitors LT4 and MN8 have been found to inhibit cell metabolism and energy production, as well as cell malignancy in Hodgkin&#x02019;s lymphoma [<xref ref-type="bibr" rid="CR320">320</xref>]. ADAM10 inhibitors LT4 and CAM29 were also reported in another study, both of which could enhance the anti-tumour immunity of targeted drugs by increasing the expression of CD30 [<xref ref-type="bibr" rid="CR321">321</xref>]. LT4 and MN8 may have higher biological activity than GI254023X, another commercial drug, which also exerts anti-tumour effect through ADAM10 [<xref ref-type="bibr" rid="CR322">322</xref>]. However, the safety and pharmacological parameters evaluation data need to be further analyzed.</p></sec><sec id="Sec273"><title>Targeting CAV1</title><p id="Par74">At present, targeted drugs/small molecule inhibitors of CAV1 have not yet entered the clinic, and there is a lack of specific drugs to interfere with its function. Studies have found that chrysotobibenzyl can inhibit CAV-1, inhibit the EMT process of lung cancer cells, prevent cell metastasis and promote the efficacy of cisplatin [<xref ref-type="bibr" rid="CR323">323</xref>]. An interesting phenomenon also exists during the maintenance of cancer stem cells, nitric oxide (NO) is a bioactive substance that abnormally accumulates in tumours and is associated with tumour progression. In CSCs, NO can inhibit the binding of OCT4 to CAV1, thereby inhibiting the degradation of OCT4 and promoting its stemness [<xref ref-type="bibr" rid="CR324">324</xref>]. Thus, blocking the NO transduction pathway may provide a feasible option for targeting CAV1. Similarly, Triptolide can also regulate the malignant ability of prostate cancer cells through CAV1 [<xref ref-type="bibr" rid="CR325">325</xref>]. However, the IC50 and specificity of triptolide are still unclear and need to be further improved in the future. Similarly, Simvastatin can inhibit castration-resistant prostate cancer metastasis and enhance the efficacy of androgen receptor antagonist therapy by inhibiting CAV1 expression [<xref ref-type="bibr" rid="CR326">326</xref>]. The emergence of traditional medicine may provide guidance for the development of small molecule drugs. However, the pharmacological evaluation of different drugs is still lack of research, and the bioavailability and effective pharmacological concentration of drugs are still unclear.</p></sec><sec id="Sec275"><title>Targeting MIF</title><p id="Par76">MIF inhibitors have been extensively studied. At present, the most commonly used MIF inhibitors are isoxazolines (ISO-1), which were first discovered in 2002, ISO-1 inhibits MIF function through dose-dependent regulation with an IC50 of about 7 &#x003bc;M [<xref ref-type="bibr" rid="CR327">327</xref>]. Another study showed that ISO-1 (10&#x000a0;&#x003bc;m) inhibited MIF expression by up to 40%, indicating a large regulatory network [<xref ref-type="bibr" rid="CR328">328</xref>]. The in vivo study demonstrated that ISO-1 significantly reduced the malignant potential of prostate cancer, colon cancer and melanoma [<xref ref-type="bibr" rid="CR329">329</xref>&#x02013;<xref ref-type="bibr" rid="CR331">331</xref>]. Another ISO-1 derived compound, CPSI-1306, lacks the characteristic phenolic function, thus making the drug less susceptible to bioconjugation reactions and inhibiting its inactivation and excretion in vivo [<xref ref-type="bibr" rid="CR332">332</xref>]. In the subsequent development process, Alam-4b (IC50:7.3&#x000a0;&#x003bc;m) and ISO-66 (IC50:1.5&#x000a0;&#x003bc;m) have also been gradually found, ISO-66 can significantly inhibit tumour growth with low/no toxicity in melanoma and colon cancer [<xref ref-type="bibr" rid="CR333">333</xref>, <xref ref-type="bibr" rid="CR334">334</xref>]. The above MIF inhibitors are all isoxazoline derivatives, and the development and application of small molecule MIF inhibitors targeting these molecules have the potential to be new therapeutic methods. With the further development of basic research, 1,2,3-triazole derivatives Jorgensen-3&#x000a0;g and Jorgensen-3&#x000a0;h were found to have an IC50 of only 1&#x000a0;&#x003bc;m, based on which Dziedzic-3bb was more biocompatible [<xref ref-type="bibr" rid="CR335">335</xref>, <xref ref-type="bibr" rid="CR336">336</xref>]. However, in vitro and in vivo studies on these small molecules are still lacking.</p></sec></sec><sec id="Sec177"><title>Strategy 2: changing the cargo loading</title><p id="Par78">At present, the cargo selectivity of secretory autophagy still needs to be explored, and the targeted therapy for sorting proteins also needs to be explored in depth, which requires multidisciplinary progress and a deep understanding of protein structure. Few studies have revealed modulators of secreted autophagy-related sorting proteins, for example, TRIM16 is a secreted autophagy sorting protein. Although highly effective drugs targeting TRIM16 have not been reported, study have found that a natural compound may affect its function. Withaferin A, a steroid ester extracted from ashwagandha, has been found to act as a TRIM16 regulatory drug to block tumour progression [<xref ref-type="bibr" rid="CR337">337</xref>]. However, the targeted research of TRIM16 still needs multidisciplinary integration and common development.</p></sec><sec id="Sec179"><title>Limitations: thorny issues in secretory autophagy</title><p id="Par80">Secretory autophagy is a critical process in tumor progression. The metabolic remodeling of tumor cells often results in the abnormal accumulation of intermediate metabolites. While some of these substances are broken down and recycled through degradation pathways such as autophagy, a significant proportion is transported outward <italic>via</italic> secretory pathways. These substances, whether actively or passively transported, supply energy and substrates to nutrient-deficient cells and redistribute essential resources. As signaling molecules, they also deliver critical information to nearby and distant cells, enabling tumors to adapt synergistically to various adverse environments. Thus, secretory autophagy plays a key role in maintaining the balance between degradation and secretion within tumors. Disruption of this balance often leads to compensatory changes, such as altered expression or post-transcriptional modifications of key regulatory molecules, to re-establish equilibrium. Several unresolved issues remain regarding secretory autophagy: (1) Tumor cells appear to coordinate autophagy and secretion through the expression or modification of key mediators such as ATG5 and ATG7. However, the precise mechanisms underlying these changes remain unknown. (2) The process of cargo selection suggests the presence of specialized carriers. The mechanisms by which cells select specific substances for secretion and the rationale behind these decisions are not yet fully understood. (3) Under stress, cells typically rely on autophagy to recycle materials and generate energy. Yet, in extreme environments, cells paradoxically secrete large quantities of substances, including glucose metabolism intermediates and various lipids, rather than using them internally [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR171">171</xref>, <xref ref-type="bibr" rid="CR338">338</xref>]. This phenomenon raises questions about the factors driving the choice between self-utilization and secretion. Emerging technologies offer promising tools to address these challenges [<xref ref-type="bibr" rid="CR339">339</xref>, <xref ref-type="bibr" rid="CR340">340</xref>]. Single-cell sequencing provides insights into the heterogeneity of secretory preferences among different cell populations, helping identify which subgroups prioritize secretion [<xref ref-type="bibr" rid="CR341">341</xref>, <xref ref-type="bibr" rid="CR342">342</xref>]. Similarly, organoid technology offers realistic and feasible models for in vitro studies, enabling detailed exploration of the regulatory mechanisms underlying secretory autophagy [<xref ref-type="bibr" rid="CR343">343</xref>&#x02013;<xref ref-type="bibr" rid="CR345">345</xref>]. These advancements could pave the way for a deeper understanding of secretory autophagy and its role in tumor progression, potentially leading to novel therapeutic strategies.</p></sec><sec id="Sec181"><title>Can secretory autophagy improve adverse reactions?</title><p id="Par82">Targeting autophagy presents new therapeutic options for clinical cancer treatment. Although low basal autophagy is a metabolic mechanism that helps cells maintain internal homeostasis, tumor cells exploit this process. Adaptive responses triggered by hypoxia and therapeutic stress can lead to excessive autophagy activation, enhancing tumor resistance to treatment. Sustained high autophagy levels in advanced tumors, coupled with the induction or inhibition effects of chemotherapy drugs, suggest that autophagy acts as a key resistance mechanism. Excessive autophagy activation is often the primary means by which cells counteract drug stress. While autophagy inhibitors, such as CQ, have shown potential in preventing autophagy by targeting lysosomes, they are associated with significant side effects. For instance, long-term CQ use has been linked to blurred vision, prolonged QT intervals on ECG, nausea, and abdominal cramps [<xref ref-type="bibr" rid="CR346">346</xref>]. The secretory autophagy pathway offers an explanation for some of these adverse effects. When autophagy is blocked, secretory activity may increase, releasing large quantities of substances that may promote tumor evolution under drug stress. This adaptation enables tumors to accumulate mutations and refine metabolic characteristics, further complicating treatment. Understanding the regulatory mechanisms of secretory autophagy may help mitigate these side effects and improve clinical outcomes. For example, CQ has been shown to trigger the secretion of autophagy-related protein ATG8 [<xref ref-type="bibr" rid="CR347">347</xref>], which can be taken up by neighboring cells, potentially initiating autophagy in those cells. Combining CQ with secretion-associated dynein inhibitors could achieve better efficacy [<xref ref-type="bibr" rid="CR348">348</xref>&#x02013;<xref ref-type="bibr" rid="CR350">350</xref>]. Furthermore, more specific drugs with minimal off-target effects need to be developed. Targeted drugs with single pharmacological mechanisms may represent a future direction for treatment strategies. Cell-penetrating peptide (CPP)-based delivery systems offer a promising approach for delivering membrane-impermeable drugs, peptides, proteins, and nucleic acids. CPPs, containing 4&#x02013;40 amino acids, can modify mRNA to enhance delivery to cells and tissues [<xref ref-type="bibr" rid="CR351">351</xref>, <xref ref-type="bibr" rid="CR352">352</xref>]. Therefore, molecular peptide modification targeting key molecules involved in the secretory autophagy process could improve bioavailability and intracellular delivery, providing valuable insights for future targeted therapies.</p></sec><sec id="Sec183"><title>Perspective and future application</title><p id="Par84">The dynamic balance between cancer cells and the TME is a critical driver of cancer progression. Over the past decade, the regulatory mechanisms of secretory autophagy have revealed significant connections between autophagy and secretory pathways. Secretory autophagy facilitates the release of numerous inflammatory factors, which are crucial for tumor development. For instance, excessive secretion of IL-6 and IL-8 has been observed in various cancers and is associated with resistance to targeted therapies and poor prognosis [<xref ref-type="bibr" rid="CR234">234</xref>, <xref ref-type="bibr" rid="CR235">235</xref>, <xref ref-type="bibr" rid="CR353">353</xref>&#x02013;<xref ref-type="bibr" rid="CR357">357</xref>]. Extensive literature indicates that chemotherapy and radiotherapy can induce cytoprotective autophagy in tumor cells. Despite studies on multiple cancer cell types, the clinical application of autophagy-targeted therapies remains challenging. High doses of CQ are required to achieve effective intratumoral concentrations, which may not be feasible in clinical settings. Moreover, CQ has been shown to activate secretory autophagy, leading to the secretion of IL-6 and IL-8, thereby contributing to treatment resistance [<xref ref-type="bibr" rid="CR109">109</xref>]. Inhibiting the onset of autophagy represents a viable therapeutic strategy, but it is considerable that single inhibitor of autophagy not possess specificity. Therefore, based on the current research basis, we propose some theoretical directions.</p><sec id="Sec211"><title>Establishing targeted therapy strategies for secretory autophagy</title><p id="Par85">Novel targeted therapies for secretory autophagy require gradual establishment while considering the interplay of autophagy pathways. Bypassing cellular feedback and regulatory mechanisms is critical. Monoclonal antibodies targeting secretion-related proteins may provide effective options, though the cellular availability of monoclonal antibodies needs further evaluation. This challenge could be addressed by employing engineered nanotechnologies.</p></sec><sec id="Sec221"><title>Improvement of existing therapeutic drugs</title><p id="Par86">Developing derivatives of existing drugs with enhanced bioavailability remains a key focus. A novel drug-loading strategy, the co-incubation method, involves incubating drugs with donor cells to induce new biological properties in exosomes by altering the culture conditions and incubation environment [<xref ref-type="bibr" rid="CR358">358</xref>]. Engineered exosomes also offer promising potential for drug delivery [<xref ref-type="bibr" rid="CR359">359</xref>]. For instance, exosomes derived from murine immature dendritic cells (IMDCs) have been used to mitigate immunogenicity and toxicity. Tumor-targeting capability was enhanced by binding the exosome membrane protein LAMP2B to an &#x003b1;v-integrin-specific iRGD peptide, creating a highly specific fusion peptide [<xref ref-type="bibr" rid="CR360">360</xref>]. Furthermore, recent studies have demonstrated the feasibility of using mPEG-PLGA nanoparticles (DCV-NPs) for dehydrocurvularin drug delivery in breast cancer [<xref ref-type="bibr" rid="CR361">361</xref>]. Advances in nanoengineering and cell engineering have also led to the development of hyaluronic acid (HA) nanogels co-loaded with CQ, facilitating intracellular delivery of cisplatin by targeting lysosomes [<xref ref-type="bibr" rid="CR362">362</xref>].</p><p id="Par87">Therapeutic strategies targeting secretory autophagy should be systematically evaluated both in vitro and in vivo. The advent of organoid and single-cell sequencing technologies offers a robust foundation for these efforts. Organoids, with their three-dimensional structures and preservation of in vivo molecular properties, provide new opportunities to assess molecular dynamics, pharmacokinetics, and pharmacodynamics [<xref ref-type="bibr" rid="CR363">363</xref>&#x02013;<xref ref-type="bibr" rid="CR365">365</xref>]. Similarly, high-resolution single-cell sequencing enables precise experimental analyses, further advancing the field [<xref ref-type="bibr" rid="CR366">366</xref>, <xref ref-type="bibr" rid="CR367">367</xref>].</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>X.L. conceived and supervised the project. X.L. summarized the literature and drafted the manuscript. X.L. and H.Z. drew the figures and tables and review the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Basic scientific research project of Education Department of Liaoning Province (LJ212410159084).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par95">not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par96">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>3-MA</term><def><p id="Par301">3-methyladenine</p></def></def-item><def-item><term>ABCG2</term><def><p id="Par302">ATP-binding cassette transporter G2</p></def></def-item><def-item><term>ACRs</term><def><p id="Par303">Autophagy cargo receptors</p></def></def-item><def-item><term>ADAM10</term><def><p id="Par304">A disintegrin and metalloprotease-10</p></def></def-item><def-item><term>ASS</term><def><p id="Par305">Acute shear stress</p></def></def-item><def-item><term>ATGs</term><def><p id="Par306">Autophagy related genes</p></def></def-item><def-item><term>ATM</term><def><p id="Par307">Ataxia telangiectasia-mutated gene</p></def></def-item><def-item><term>BafA1</term><def><p id="Par308">Bafilomycin A1</p></def></def-item><def-item><term>CAFs</term><def><p id="Par309">Cancer associated fibroblasts</p></def></def-item><def-item><term>CASM</term><def><p id="Par310">Conjugation of ATG8s to single membranes</p></def></def-item><def-item><term>CAV-1</term><def><p id="Par311">Caveolin-1</p></def></def-item><def-item><term>CCA</term><def><p id="Par312">Cholangiocarcinoma</p></def></def-item><def-item><term>CLEAR</term><def><p id="Par313">Coordinated lysosomal expression and regulation</p></def></def-item><def-item><term>CRC</term><def><p id="Par314">Colorectal cancer</p></def></def-item><def-item><term>CSC</term><def><p id="Par315">Cancer stem cell</p></def></def-item><def-item><term>DFCP1</term><def><p id="Par316">Double FYVE-containing protein 1</p></def></def-item><def-item><term>ER</term><def><p id="Par317">Endoplasmic reticulum</p></def></def-item><def-item><term>ERK</term><def><p id="Par318">Extracellular signal-regulated kinase</p></def></def-item><def-item><term>ESCC</term><def><p id="Par319">Esophageal squamous cell carcinoma</p></def></def-item><def-item><term>EV</term><def><p id="Par320">Extracellular vesicle</p></def></def-item><def-item><term>FAN</term><def><p id="Par321">Fanconi anemia-associated nuclease</p></def></def-item><def-item><term>FIP200</term><def><p id="Par322">Focal adhesion kinase family interacting protein of 200&#x000a0;kDa</p></def></def-item><def-item><term>GABARAP</term><def><p id="Par323">GABA(A) receptor associated protein</p></def></def-item><def-item><term>GB</term><def><p id="Par324">Glioblastoma</p></def></def-item><def-item><term>GIPC</term><def><p id="Par325">GAIP-interacting protein C-terminus</p></def></def-item><def-item><term>GPR64</term><def><p id="Par326">G-protein coupled receptor 64</p></def></def-item><def-item><term>GRASP</term><def><p id="Par327">Golgi reassembly and stacking protein</p></def></def-item><def-item><term>HCC</term><def><p id="Par328">Hepatocellular carcinoma</p></def></def-item><def-item><term>HDAC6</term><def><p id="Par329">Histone deacetylase&#x000a0;6</p></def></def-item><def-item><term>HNSCC</term><def><p id="Par330">Head and neck squamous cell carcinoma</p></def></def-item><def-item><term>HSP90AA1</term><def><p id="Par331">Heat shock protein 90&#x003b1; family class A member 1</p></def></def-item><def-item><term>IKB</term><def><p id="Par332">Inhibitor-kB</p></def></def-item><def-item><term>LC3</term><def><p id="Par333">Microtubule-associated proteins 1&#x000a0;A/1B-light chain 3</p></def></def-item><def-item><term>LDELS</term><def><p id="Par334">LC3-Dependent&#x000a0;EV&#x000a0;Loading and&#x000a0;Secretion</p></def></def-item><def-item><term>LDHB</term><def><p id="Par335">Lactate dehydrogenase B</p></def></def-item><def-item><term>MDR</term><def><p id="Par336">Multidrug resistance</p></def></def-item><def-item><term>MIF</term><def><p id="Par337">Migration inhibitory factor</p></def></def-item><def-item><term>mTORC1</term><def><p id="Par338">Rapamycin complex 1</p></def></def-item><def-item><term>MVB</term><def><p id="Par339">Multivesicular body</p></def></def-item><def-item><term>NF-kB</term><def><p id="Par340">Nuclear factor kB</p></def></def-item><def-item><term>NFs</term><def><p id="Par341">Normal fibroblasts</p></def></def-item><def-item><term>PDAC</term><def><p id="Par342">Pancreatic ductal adenocarcinoma</p></def></def-item><def-item><term>PE</term><def><p id="Par343">Phosphatidylethanolamine</p></def></def-item><def-item><term>PI3P</term><def><p id="Par344">Phosphatidylinositol-3-phosphate</p></def></def-item><def-item><term>PSCs</term><def><p id="Par345">Pancreatic stellate cells</p></def></def-item><def-item><term>PTEN</term><def><p id="Par346">Phosphatase and tensin homolog</p></def></def-item><def-item><term>RAGE</term><def><p id="Par347">Receptor for advanced glycation endproducts</p></def></def-item><def-item><term>RBP</term><def><p id="Par348">RNA binding protein</p></def></def-item><def-item><term>SASP</term><def><p id="Par349">Senescence-associated secretory phenotype</p></def></def-item><def-item><term>SCF</term><def><p id="Par350">SKP1-Cullin 1-F-box protein</p></def></def-item><def-item><term>SFN</term><def><p id="Par351">Sulforaphane</p></def></def-item><def-item><term>SKP1</term><def><p id="Par352">S-phase Kinase-Associated Protein 1</p></def></def-item><def-item><term>SNARE</term><def><p id="Par353">Soluble n-ethylmaleimide-sensitive factor attachment protein receptor</p></def></def-item><def-item><term>TCA</term><def><p id="Par354">Tricarboxylic acid cycle</p></def></def-item><def-item><term>TFE3</term><def><p id="Par355">Transcription factor that binds IGHM enhancer 3</p></def></def-item><def-item><term>TFEB</term><def><p id="Par356">Transcription factor EB</p></def></def-item><def-item><term>THD</term><def><p id="Par357">Thioridazine</p></def></def-item><def-item><term>TIMP1</term><def><p id="Par358">Tissue inhibitor of metalloproteinase-1</p></def></def-item><def-item><term>TME</term><def><p id="Par359">Tumour microenvironment</p></def></def-item><def-item><term>TMZ</term><def><p id="Par360">Temozolomide</p></def></def-item><def-item><term>TRIM16</term><def><p id="Par361">Tripartite motif-containing protein 16</p></def></def-item><def-item><term>ULK</term><def><p id="Par362">Unc-51-like kinase</p></def></def-item><def-item><term>VAM</term><def><p id="Par363">Vesicle associated membrane protein</p></def></def-item><def-item><term>VPS34</term><def><p id="Par364">Vacuolar protein sorting 34</p></def></def-item><def-item><term>VPS34</term><def><p id="Par365">Vacuolar protein-sorting 34</p></def></def-item><def-item><term>ZFYVE</term><def><p id="Par366">Zinc finger containing FYVE domain</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname><given-names>DJ</given-names></name><name><surname>Petroni</surname><given-names>G</given-names></name><name><surname>Amaravadi</surname><given-names>RK</given-names></name><name><surname>Baehrecke</surname><given-names>EH</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name><name><surname>Boya</surname><given-names>P</given-names></name><etal/></person-group><article-title>Autophagy in major human diseases</article-title><source>EMBO J</source><year>2021</year><volume>40</volume><issue>19</issue><fpage>e108863</fpage><pub-id pub-id-type="doi">10.15252/embj.2021108863</pub-id><pub-id pub-id-type="pmid">34459017</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. EMBO J. 2021;40(19):e108863. 10.15252/embj.2021108863<pub-id pub-id-type="pmid">34459017</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Litwiniuk</surname><given-names>A</given-names></name><name><surname>Juszczak</surname><given-names>GR</given-names></name><name><surname>Stankiewicz</surname><given-names>AM</given-names></name><name><surname>Urbanska</surname><given-names>K</given-names></name></person-group><article-title>The role of glial autophagy in Alzheimer&#x02019;s disease</article-title><source>Mol Psychiatry</source><year>2023</year><pub-id pub-id-type="doi">10.1038/s41380-023-02242-5</pub-id><pub-id pub-id-type="pmid">37679471</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Litwiniuk A, Juszczak GR, Stankiewicz AM, Urbanska K. The role of glial autophagy in Alzheimer&#x02019;s disease. Mol Psychiatry. 2023. 10.1038/s41380-023-02242-5<pub-id pub-id-type="pmid">37679471</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Debnath</surname><given-names>J</given-names></name><name><surname>Gammoh</surname><given-names>N</given-names></name><name><surname>Ryan</surname><given-names>KM</given-names></name></person-group><article-title>Autophagy and autophagy-related pathways in cancer</article-title><source>Nat Rev Mol Cell Biol</source><year>2023</year><volume>24</volume><issue>8</issue><fpage>560</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1038/s41580-023-00585-z</pub-id><pub-id pub-id-type="pmid">36864290</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560&#x02013;75. 10.1038/s41580-023-00585-z<pub-id pub-id-type="pmid">36864290</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Tooze</surname><given-names>SA</given-names></name></person-group><article-title>Emerging roles of ATG proteins and membrane lipids in autophagosome formation</article-title><source>Cell Discov</source><year>2020</year><volume>6</volume><issue>1</issue><fpage>32</fpage><pub-id pub-id-type="doi">10.1038/s41421-020-0161-3</pub-id><pub-id pub-id-type="pmid">32509328</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Nishimura T, Tooze SA. Emerging roles of ATG proteins and membrane lipids in autophagosome formation. Cell Discov. 2020;6(1):32. 10.1038/s41421-020-0161-3<pub-id pub-id-type="pmid">32509328</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>MG</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><article-title>Structure and function of the ULK1 complex in autophagy</article-title><source>Curr Opin Cell Biol</source><year>2016</year><volume>39</volume><fpage>61</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2016.02.010</pub-id><pub-id pub-id-type="pmid">26921696</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Lin MG, Hurley JH. Structure and function of the ULK1 complex in autophagy. Curr Opin Cell Biol. 2016;39:61&#x02013;8. 10.1016/j.ceb.2016.02.010<pub-id pub-id-type="pmid">26921696</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Wirth</surname><given-names>M</given-names></name><name><surname>Joachim</surname><given-names>J</given-names></name><name><surname>Tooze</surname><given-names>SA</given-names></name></person-group><article-title>Autophagosome formation&#x02013;the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage</article-title><source>Semin Cancer Biol</source><year>2013</year><volume>23</volume><issue>5</issue><fpage>301</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2013.05.007</pub-id><pub-id pub-id-type="pmid">23727157</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Wirth M, Joachim J, Tooze SA. Autophagosome formation&#x02013;the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol. 2013;23(5):301&#x02013;9. 10.1016/j.semcancer.2013.05.007<pub-id pub-id-type="pmid">23727157</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>RH</given-names></name></person-group><article-title>KLHL20 links the ubiquitin-proteasome system to autophagy termination</article-title><source>Autophagy</source><year>2016</year><volume>12</volume><issue>5</issue><fpage>890</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.1080/15548627.2016.1157243</pub-id><pub-id pub-id-type="pmid">26985984</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Liu CC, Chen RH. KLHL20 links the ubiquitin-proteasome system to autophagy termination. Autophagy. 2016;12(5):890&#x02013;1. 10.1080/15548627.2016.1157243<pub-id pub-id-type="pmid">26985984</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>TJ</given-names></name><name><surname>Gubas</surname><given-names>A</given-names></name><name><surname>Tooze</surname><given-names>SA</given-names></name></person-group><article-title>A molecular perspective of mammalian autophagosome biogenesis</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><issue>15</issue><fpage>5386</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1074/jbc.R117.810366</pub-id><pub-id pub-id-type="pmid">29371398</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Mercer TJ, Gubas A, Tooze SA. A molecular perspective of mammalian autophagosome biogenesis. J Biol Chem. 2018;293(15):5386&#x02013;95. 10.1074/jbc.R117.810366<pub-id pub-id-type="pmid">29371398</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatogawa</surname><given-names>H</given-names></name></person-group><article-title>Mechanisms governing autophagosome biogenesis</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><issue>8</issue><fpage>439</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0241-0</pub-id><pub-id pub-id-type="pmid">32372019</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Nakatogawa H. Mechanisms governing autophagosome biogenesis. Nat Rev Mol Cell Biol. 2020;21(8):439&#x02013;58. 10.1038/s41580-020-0241-0<pub-id pub-id-type="pmid">32372019</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>YG</given-names></name><name><surname>Codogno</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Machinery, regulation and pathophysiological implications of autophagosome maturation</article-title><source>Nat Rev Mol Cell Biol</source><year>2021</year><volume>22</volume><issue>11</issue><fpage>733</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/s41580-021-00392-4</pub-id><pub-id pub-id-type="pmid">34302147</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol. 2021;22(11):733&#x02013;50. 10.1038/s41580-021-00392-4<pub-id pub-id-type="pmid">34302147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Grumati</surname><given-names>P</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name></person-group><article-title>Ubiquitin signaling and autophagy</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><issue>15</issue><fpage>5404</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1074/jbc.TM117.000117</pub-id><pub-id pub-id-type="pmid">29187595</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Grumati P, Dikic I. Ubiquitin signaling and autophagy. J Biol Chem. 2018;293(15):5404&#x02013;13. 10.1074/jbc.TM117.000117<pub-id pub-id-type="pmid">29187595</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>Autophagy-independent functions of the Autophagy Machinery</article-title><source>Cell</source><year>2019</year><volume>177</volume><issue>7</issue><fpage>1682</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.026</pub-id><pub-id pub-id-type="pmid">31199916</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Galluzzi L, Green DR. Autophagy-independent functions of the Autophagy Machinery. Cell. 2019;177(7):1682&#x02013;99. 10.1016/j.cell.2019.05.026<pub-id pub-id-type="pmid">31199916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Henault</surname><given-names>J</given-names></name><name><surname>Martinez</surname><given-names>J</given-names></name><name><surname>Riggs</surname><given-names>JM</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><etal/></person-group><article-title>Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes</article-title><source>Immunity</source><year>2012</year><volume>37</volume><issue>6</issue><fpage>986</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.014</pub-id><pub-id pub-id-type="pmid">23219390</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Henault J, Martinez J, Riggs JM, Tian J, Mehta P, Clarke L, et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity. 2012;37(6):986&#x02013;97. 10.1016/j.immuni.2012.09.014<pub-id pub-id-type="pmid">23219390</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Lindblad</surname><given-names>JL</given-names></name><name><surname>Perez</surname><given-names>E</given-names></name><name><surname>Bergmann</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name></person-group><article-title>Autophagy-independent function of Atg1 for apoptosis-induced compensatory proliferation</article-title><source>BMC Biol</source><year>2016</year><volume>14</volume><fpage>70</fpage><pub-id pub-id-type="doi">10.1186/s12915-016-0293-y</pub-id><pub-id pub-id-type="pmid">27542914</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Li M, Lindblad JL, Perez E, Bergmann A, Fan Y. Autophagy-independent function of Atg1 for apoptosis-induced compensatory proliferation. BMC Biol. 2016;14:70. 10.1186/s12915-016-0293-y<pub-id pub-id-type="pmid">27542914</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Tung</surname><given-names>SM</given-names></name><name><surname>Unal</surname><given-names>C</given-names></name><name><surname>Ley</surname><given-names>A</given-names></name><name><surname>Pena</surname><given-names>C</given-names></name><name><surname>Tunggal</surname><given-names>B</given-names></name><name><surname>Noegel</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Loss of Dictyostelium ATG9 results in a pleiotropic phenotype affecting growth, development, phagocytosis and clearance and replication of Legionella pneumophila</article-title><source>Cell Microbiol</source><year>2010</year><volume>12</volume><issue>6</issue><fpage>765</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01432.x</pub-id><pub-id pub-id-type="pmid">20070309</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Tung SM, Unal C, Ley A, Pena C, Tunggal B, Noegel AA, et al. Loss of Dictyostelium ATG9 results in a pleiotropic phenotype affecting growth, development, phagocytosis and clearance and replication of Legionella pneumophila. Cell Microbiol. 2010;12(6):765&#x02013;80. 10.1111/j.1462-5822.2010.01432.x<pub-id pub-id-type="pmid">20070309</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Q</given-names></name><name><surname>Unal</surname><given-names>C</given-names></name><name><surname>Matthias</surname><given-names>J</given-names></name><name><surname>Steinert</surname><given-names>M</given-names></name><name><surname>Eichinger</surname><given-names>L</given-names></name></person-group><article-title>The phenotypes of ATG9, ATG16 and ATG9/16 knock-out mutants imply autophagy-dependent and -independent functions</article-title><source>Open Biol</source><year>2015</year><volume>5</volume><issue>4</issue><fpage>150008</fpage><pub-id pub-id-type="doi">10.1098/rsob.150008</pub-id><pub-id pub-id-type="pmid">25878144</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Xiong Q, Unal C, Matthias J, Steinert M, Eichinger L. The phenotypes of ATG9, ATG16 and ATG9/16 knock-out mutants imply autophagy-dependent and -independent functions. Open Biol. 2015;5(4):150008. 10.1098/rsob.150008<pub-id pub-id-type="pmid">25878144</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Ghozalli</surname><given-names>I</given-names></name><etal/></person-group><article-title>PtdIns(3)P-bound UVRAG coordinates Golgi-ER retrograde and Atg9 transport by differential interactions with the ER tether and the beclin 1 complex</article-title><source>Nat Cell Biol</source><year>2013</year><volume>15</volume><issue>10</issue><fpage>1206</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1038/ncb2848</pub-id><pub-id pub-id-type="pmid">24056303</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">He S, Ni D, Ma B, Lee JH, Zhang T, Ghozalli I, et al. PtdIns(3)P-bound UVRAG coordinates Golgi-ER retrograde and Atg9 transport by differential interactions with the ER tether and the beclin 1 complex. Nat Cell Biol. 2013;15(10):1206&#x02013;19. 10.1038/ncb2848<pub-id pub-id-type="pmid">24056303</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Frankel</surname><given-names>E</given-names></name><name><surname>Ge</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Iyengar</surname><given-names>R</given-names></name><etal/></person-group><article-title>The noncanonical role of ULK/ATG1 in ER-to-golgi trafficking is essential for Cellular Homeostasis</article-title><source>Mol Cell</source><year>2016</year><volume>62</volume><issue>4</issue><fpage>491</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.04.020</pub-id><pub-id pub-id-type="pmid">27203176</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Joo JH, Wang B, Frankel E, Ge L, Xu L, Iyengar R, et al. The noncanonical role of ULK/ATG1 in ER-to-golgi trafficking is essential for Cellular Homeostasis. Mol Cell. 2016;62(4):491&#x02013;506. 10.1016/j.molcel.2016.04.020<pub-id pub-id-type="pmid">27203176</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Iyengar</surname><given-names>R</given-names></name><name><surname>Li-Harms</surname><given-names>X</given-names></name><name><surname>Joo</surname><given-names>JH</given-names></name><name><surname>Wright</surname><given-names>C</given-names></name><name><surname>Lavado</surname><given-names>A</given-names></name><etal/></person-group><article-title>The autophagy-inducing kinases, ULK1 and ULK2, regulate axon guidance in the developing mouse forebrain via a noncanonical pathway</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><issue>5</issue><fpage>796</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1386820</pub-id><pub-id pub-id-type="pmid">29099309</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Wang B, Iyengar R, Li-Harms X, Joo JH, Wright C, Lavado A, et al. The autophagy-inducing kinases, ULK1 and ULK2, regulate axon guidance in the developing mouse forebrain via a noncanonical pathway. Autophagy. 2018;14(5):796&#x02013;811. 10.1080/15548627.2017.1386820<pub-id pub-id-type="pmid">29099309</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Chitiprolu</surname><given-names>M</given-names></name><name><surname>Roncevic</surname><given-names>L</given-names></name><name><surname>Javalet</surname><given-names>C</given-names></name><name><surname>Hemming</surname><given-names>FJ</given-names></name><name><surname>Trung</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Atg5 disassociates the V(1)V(0)-ATPase to promote Exosome Production and Tumor Metastasis Independent of Canonical Macroautophagy</article-title><source>Dev Cell</source><year>2017</year><volume>43</volume><issue>6</issue><fpage>716</fpage><lpage>e307</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.11.018</pub-id><pub-id pub-id-type="pmid">29257951</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Guo H, Chitiprolu M, Roncevic L, Javalet C, Hemming FJ, Trung MT, et al. Atg5 disassociates the V(1)V(0)-ATPase to promote Exosome Production and Tumor Metastasis Independent of Canonical Macroautophagy. Dev Cell. 2017;43(6):716&#x02013;e307. 10.1016/j.devcel.2017.11.018<pub-id pub-id-type="pmid">29257951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Jae</surname><given-names>N</given-names></name><name><surname>McEwan</surname><given-names>DG</given-names></name><name><surname>Manavski</surname><given-names>Y</given-names></name><name><surname>Boon</surname><given-names>RA</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name></person-group><article-title>Rab7a and Rab27b control secretion of endothelial microRNA through extracellular vesicles</article-title><source>FEBS Lett</source><year>2015</year><volume>589</volume><issue>20 Pt B</issue><fpage>3182</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2015.08.040</pub-id><pub-id pub-id-type="pmid">26348397</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Jae N, McEwan DG, Manavski Y, Boon RA, Dimmeler S. Rab7a and Rab27b control secretion of endothelial microRNA through extracellular vesicles. FEBS Lett. 2015;589(20 Pt B):3182&#x02013;8. 10.1016/j.febslet.2015.08.040<pub-id pub-id-type="pmid">26348397</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>S</given-names></name><name><surname>Devhare</surname><given-names>P</given-names></name><name><surname>Sujijantarat</surname><given-names>N</given-names></name><name><surname>Steele</surname><given-names>R</given-names></name><name><surname>Kwon</surname><given-names>YC</given-names></name><name><surname>Ray</surname><given-names>R</given-names></name><etal/></person-group><article-title>Knockdown of Autophagy inhibits infectious Hepatitis C Virus Release by the Exosomal Pathway</article-title><source>J Virol</source><year>2016</year><volume>90</volume><issue>3</issue><fpage>1387</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1128/JVI.02383-15</pub-id><pub-id pub-id-type="pmid">26581990</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Shrivastava S, Devhare P, Sujijantarat N, Steele R, Kwon YC, Ray R, et al. Knockdown of Autophagy inhibits infectious Hepatitis C Virus Release by the Exosomal Pathway. J Virol. 2016;90(3):1387&#x02013;96. 10.1128/JVI.02383-15<pub-id pub-id-type="pmid">26581990</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Claude-Taupin</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cellular and molecular mechanism for secretory autophagy</article-title><source>Autophagy</source><year>2017</year><volume>13</volume><issue>6</issue><fpage>1084</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1307486</pub-id><pub-id pub-id-type="pmid">28368721</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kimura T, Jia J, Claude-Taupin A, Kumar S, Choi SW, Gu Y, et al. Cellular and molecular mechanism for secretory autophagy. Autophagy. 2017;13(6):1084&#x02013;5. 10.1080/15548627.2017.1307486<pub-id pub-id-type="pmid">28368721</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Ponpuak</surname><given-names>M</given-names></name><name><surname>Mandell</surname><given-names>MA</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Cleyrat</surname><given-names>C</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><article-title>Secretory autophagy</article-title><source>Curr Opin Cell Biol</source><year>2015</year><volume>35</volume><fpage>106</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2015.04.016</pub-id><pub-id pub-id-type="pmid">25988755</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Ponpuak M, Mandell MA, Kimura T, Chauhan S, Cleyrat C, Deretic V. Secretory autophagy. Curr Opin Cell Biol. 2015;35:106&#x02013;16. 10.1016/j.ceb.2015.04.016<pub-id pub-id-type="pmid">25988755</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Duran</surname><given-names>JM</given-names></name><name><surname>Anjard</surname><given-names>C</given-names></name><name><surname>Stefan</surname><given-names>C</given-names></name><name><surname>Loomis</surname><given-names>WF</given-names></name><name><surname>Malhotra</surname><given-names>V</given-names></name></person-group><article-title>Unconventional secretion of Acb1 is mediated by autophagosomes</article-title><source>J Cell Biol</source><year>2010</year><volume>188</volume><issue>4</issue><fpage>527</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1083/jcb.200911154</pub-id><pub-id pub-id-type="pmid">20156967</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Duran JM, Anjard C, Stefan C, Loomis WF, Malhotra V. Unconventional secretion of Acb1 is mediated by autophagosomes. J Cell Biol. 2010;188(4):527&#x02013;36. 10.1083/jcb.200911154<pub-id pub-id-type="pmid">20156967</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Pilli</surname><given-names>M</given-names></name><name><surname>Ornatowski</surname><given-names>W</given-names></name><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><article-title>Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta</article-title><source>EMBO J</source><year>2011</year><volume>30</volume><issue>23</issue><fpage>4701</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.398</pub-id><pub-id pub-id-type="pmid">22068051</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011;30(23):4701&#x02013;11. 10.1038/emboj.2011.398<pub-id pub-id-type="pmid">22068051</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Ejlerskov</surname><given-names>P</given-names></name><name><surname>Rasmussen</surname><given-names>I</given-names></name><name><surname>Nielsen</surname><given-names>TT</given-names></name><name><surname>Bergstrom</surname><given-names>AL</given-names></name><name><surname>Tohyama</surname><given-names>Y</given-names></name><name><surname>Jensen</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Tubulin polymerization-promoting protein (TPPP/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>24</issue><fpage>17313</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.401174</pub-id><pub-id pub-id-type="pmid">23629650</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Ejlerskov P, Rasmussen I, Nielsen TT, Bergstrom AL, Tohyama Y, Jensen PH, et al. Tubulin polymerization-promoting protein (TPPP/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem. 2013;288(24):17313&#x02013;35. 10.1074/jbc.M112.401174<pub-id pub-id-type="pmid">23629650</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Manjithaya</surname><given-names>R</given-names></name><name><surname>Anjard</surname><given-names>C</given-names></name><name><surname>Loomis</surname><given-names>WF</given-names></name><name><surname>Subramani</surname><given-names>S</given-names></name></person-group><article-title>Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation</article-title><source>J Cell Biol</source><year>2010</year><volume>188</volume><issue>4</issue><fpage>537</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1083/jcb.200911149</pub-id><pub-id pub-id-type="pmid">20156962</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Manjithaya R, Anjard C, Loomis WF, Subramani S. Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. J Cell Biol. 2010;188(4):537&#x02013;46. 10.1083/jcb.200911149<pub-id pub-id-type="pmid">20156962</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Pilli</surname><given-names>M</given-names></name><name><surname>Arko-Mensah</surname><given-names>J</given-names></name><name><surname>Ponpuak</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Master</surname><given-names>S</given-names></name><name><surname>Mandell</surname><given-names>MA</given-names></name><etal/></person-group><article-title>TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation</article-title><source>Immunity</source><year>2012</year><volume>37</volume><issue>2</issue><fpage>223</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.04.015</pub-id><pub-id pub-id-type="pmid">22921120</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37(2):223&#x02013;34. 10.1016/j.immuni.2012.04.015<pub-id pub-id-type="pmid">22921120</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Durgan</surname><given-names>J</given-names></name><name><surname>Florey</surname><given-names>O</given-names></name></person-group><article-title>Many roads lead to CASM: diverse stimuli of noncanonical autophagy share a unifying molecular mechanism</article-title><source>Sci Adv</source><year>2022</year><volume>8</volume><issue>43</issue><fpage>eabo1274</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abo1274</pub-id><pub-id pub-id-type="pmid">36288315</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Durgan J, Florey O. Many roads lead to CASM: diverse stimuli of noncanonical autophagy share a unifying molecular mechanism. Sci Adv. 2022;8(43):eabo1274. 10.1126/sciadv.abo1274<pub-id pub-id-type="pmid">36288315</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Raudenska</surname><given-names>M</given-names></name><name><surname>Balvan</surname><given-names>J</given-names></name><name><surname>Masarik</surname><given-names>M</given-names></name></person-group><article-title>Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers</article-title><source>Mol Cancer</source><year>2021</year><volume>20</volume><issue>1</issue><fpage>140</fpage><pub-id pub-id-type="doi">10.1186/s12943-021-01423-6</pub-id><pub-id pub-id-type="pmid">34706732</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Raudenska M, Balvan J, Masarik M. Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers. Mol Cancer. 2021;20(1):140. 10.1186/s12943-021-01423-6<pub-id pub-id-type="pmid">34706732</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Leidal</surname><given-names>AM</given-names></name><name><surname>Huang</surname><given-names>HH</given-names></name><name><surname>Marsh</surname><given-names>T</given-names></name><name><surname>Solvik</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><etal/></person-group><article-title>The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles</article-title><source>Nat Cell Biol</source><year>2020</year><volume>22</volume><issue>2</issue><fpage>187</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0450-y</pub-id><pub-id pub-id-type="pmid">31932738</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Leidal AM, Huang HH, Marsh T, Solvik T, Zhang D, Ye J, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020;22(2):187&#x02013;99. 10.1038/s41556-019-0450-y<pub-id pub-id-type="pmid">31932738</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Nahse V, Schink KO, Stenmark H. ATPase-regulated autophagosome biogenesis. Autophagy. 2023;1&#x02013;2. 10.1080/15548627.2023.2255967</mixed-citation></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Axe</surname><given-names>EL</given-names></name><name><surname>Walker</surname><given-names>SA</given-names></name><name><surname>Manifava</surname><given-names>M</given-names></name><name><surname>Chandra</surname><given-names>P</given-names></name><name><surname>Roderick</surname><given-names>HL</given-names></name><name><surname>Habermann</surname><given-names>A</given-names></name><etal/></person-group><article-title>Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum</article-title><source>J Cell Biol</source><year>2008</year><volume>182</volume><issue>4</issue><fpage>685</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1083/jcb.200803137</pub-id><pub-id pub-id-type="pmid">18725538</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685&#x02013;701. 10.1083/jcb.200803137<pub-id pub-id-type="pmid">18725538</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Bruns</surname><given-names>C</given-names></name><name><surname>McCaffery</surname><given-names>JM</given-names></name><name><surname>Curwin</surname><given-names>AJ</given-names></name><name><surname>Duran</surname><given-names>JM</given-names></name><name><surname>Malhotra</surname><given-names>V</given-names></name></person-group><article-title>Biogenesis of a novel compartment for autophagosome-mediated unconventional protein secretion</article-title><source>J Cell Biol</source><year>2011</year><volume>195</volume><issue>6</issue><fpage>979</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1083/jcb.201106098</pub-id><pub-id pub-id-type="pmid">22144692</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Bruns C, McCaffery JM, Curwin AJ, Duran JM, Malhotra V. Biogenesis of a novel compartment for autophagosome-mediated unconventional protein secretion. J Cell Biol. 2011;195(6):979&#x02013;92. 10.1083/jcb.201106098<pub-id pub-id-type="pmid">22144692</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Karanasios</surname><given-names>E</given-names></name><name><surname>Stapleton</surname><given-names>E</given-names></name><name><surname>Manifava</surname><given-names>M</given-names></name><name><surname>Kaizuka</surname><given-names>T</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Walker</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Dynamic association of the ULK1 complex with omegasomes during autophagy induction</article-title><source>J Cell Sci</source><year>2013</year><volume>126</volume><issue>Pt 22</issue><fpage>5224</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1242/jcs.132415</pub-id><pub-id pub-id-type="pmid">24013547</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Karanasios E, Stapleton E, Manifava M, Kaizuka T, Mizushima N, Walker SA, et al. Dynamic association of the ULK1 complex with omegasomes during autophagy induction. J Cell Sci. 2013;126(Pt 22):5224&#x02013;38. 10.1242/jcs.132415<pub-id pub-id-type="pmid">24013547</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Karanasios</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>SA</given-names></name><name><surname>Okkenhaug</surname><given-names>H</given-names></name><name><surname>Manifava</surname><given-names>M</given-names></name><name><surname>Hummel</surname><given-names>E</given-names></name><name><surname>Zimmermann</surname><given-names>H</given-names></name><etal/></person-group><article-title>Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 vesicles</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>12420</fpage><pub-id pub-id-type="doi">10.1038/ncomms12420</pub-id><pub-id pub-id-type="pmid">27510922</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Karanasios E, Walker SA, Okkenhaug H, Manifava M, Hummel E, Zimmermann H, et al. Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 vesicles. Nat Commun. 2016;7:12420. 10.1038/ncomms12420<pub-id pub-id-type="pmid">27510922</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Nahse</surname><given-names>V</given-names></name><name><surname>Raiborg</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>KW</given-names></name><name><surname>Mork</surname><given-names>S</given-names></name><name><surname>Torgersen</surname><given-names>ML</given-names></name><name><surname>Wenzel</surname><given-names>EM</given-names></name><etal/></person-group><article-title>ATPase activity of DFCP1 controls selective autophagy</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><issue>1</issue><fpage>4051</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-39641-9</pub-id><pub-id pub-id-type="pmid">37422481</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Nahse V, Raiborg C, Tan KW, Mork S, Torgersen ML, Wenzel EM, et al. ATPase activity of DFCP1 controls selective autophagy. Nat Commun. 2023;14(1):4051. 10.1038/s41467-023-39641-9<pub-id pub-id-type="pmid">37422481</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Garcia</surname><given-names>D</given-names></name><name><surname>Curwin</surname><given-names>AJ</given-names></name><name><surname>Popoff</surname><given-names>JF</given-names></name><name><surname>Bruns</surname><given-names>C</given-names></name><name><surname>Duran</surname><given-names>JM</given-names></name><name><surname>Malhotra</surname><given-names>V</given-names></name></person-group><article-title>Remodeling of secretory compartments creates CUPS during nutrient starvation</article-title><source>J Cell Biol</source><year>2014</year><volume>207</volume><issue>6</issue><fpage>695</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1083/jcb.201407119</pub-id><pub-id pub-id-type="pmid">25512390</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Cruz-Garcia D, Curwin AJ, Popoff JF, Bruns C, Duran JM, Malhotra V. Remodeling of secretory compartments creates CUPS during nutrient starvation. J Cell Biol. 2014;207(6):695&#x02013;703. 10.1083/jcb.201407119<pub-id pub-id-type="pmid">25512390</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Gan</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name></person-group><article-title>Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion</article-title><source>J Extracell Vesicles</source><year>2023</year><volume>12</volume><issue>9</issue><fpage>e12356</fpage><pub-id pub-id-type="doi">10.1002/jev2.12356</pub-id><pub-id pub-id-type="pmid">37700095</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Liu C, Liu D, Wang S, Gan L, Yang X, Ma C. Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion. J Extracell Vesicles. 2023;12(9):e12356. 10.1002/jev2.12356<pub-id pub-id-type="pmid">37700095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>AM</given-names></name><name><surname>Di Paolo</surname><given-names>G</given-names></name></person-group><article-title>Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders</article-title><source>Cell Stress</source><year>2018</year><volume>2</volume><issue>5</issue><fpage>115</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.15698/cst2018.05.136</pub-id><pub-id pub-id-type="pmid">31225476</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Miranda AM, Di Paolo G. Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders. Cell Stress. 2018;2(5):115&#x02013;8. 10.15698/cst2018.05.136<pub-id pub-id-type="pmid">31225476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>AM</given-names></name><name><surname>Lasiecka</surname><given-names>ZM</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Neufeld</surname><given-names>J</given-names></name><name><surname>Shahriar</surname><given-names>S</given-names></name><name><surname>Simoes</surname><given-names>S</given-names></name><etal/></person-group><article-title>Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>291</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-02533-w</pub-id><pub-id pub-id-type="pmid">29348617</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Miranda AM, Lasiecka ZM, Xu Y, Neufeld J, Shahriar S, Simoes S, et al. Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures. Nat Commun. 2018;9(1):291. 10.1038/s41467-017-02533-w<pub-id pub-id-type="pmid">29348617</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name></person-group><article-title>Panobinostat inhibits breast cancer progression via Vps34-mediated exosomal pathway</article-title><source>Hum Cell</source><year>2023</year><volume>36</volume><issue>1</issue><fpage>366</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/s13577-022-00812-3</pub-id><pub-id pub-id-type="pmid">36329365</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Wang X, Yin X. Panobinostat inhibits breast cancer progression via Vps34-mediated exosomal pathway. Hum Cell. 2023;36(1):366&#x02013;76. 10.1007/s13577-022-00812-3<pub-id pub-id-type="pmid">36329365</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Xu P, Hankins HM, MacDonald C, Erlinger SJ, Frazier MN, Diab NS, et al. COPI mediates recycling of an exocytic SNARE by recognition of a ubiquitin sorting signal. Elife. 2017;6. 10.7554/eLife.28342</mixed-citation></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Gaikwad</surname><given-names>S</given-names></name><name><surname>Puangmalai</surname><given-names>N</given-names></name><name><surname>Bittar</surname><given-names>A</given-names></name><name><surname>Montalbano</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>S</given-names></name><name><surname>McAllen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer&#x02019;s disease and frontotemporal dementia</article-title><source>Cell Rep</source><year>2021</year><volume>36</volume><issue>3</issue><fpage>109419doi</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109419</pub-id><pub-id pub-id-type="pmid">34289368</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Gaikwad S, Puangmalai N, Bittar A, Montalbano M, Garcia S, McAllen S, et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer&#x02019;s disease and frontotemporal dementia. Cell Rep. 2021;36(3):10941910.1016/j.celrep.2021.109419<pub-id pub-id-type="pmid">34289368</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez</surname><given-names>JS</given-names></name><name><surname>Novelli</surname><given-names>F</given-names></name><name><surname>Goto</surname><given-names>K</given-names></name><name><surname>Ehara</surname><given-names>M</given-names></name><name><surname>Steele</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><etal/></person-group><article-title>HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma</article-title><source>Proc Natl Acad Sci U S A</source><year>2023</year><volume>120</volume><issue>39</issue><fpage>e2307999120</fpage><pub-id pub-id-type="doi">10.1073/pnas.2307999120</pub-id><pub-id pub-id-type="pmid">37729199</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Suarez JS, Novelli F, Goto K, Ehara M, Steele M, Kim JH, et al. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma. Proc Natl Acad Sci U S A. 2023;120(39):e2307999120. 10.1073/pnas.2307999120<pub-id pub-id-type="pmid">37729199</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Tu</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Posttranslational S-nitrosylation modification regulates HMGB1 secretion and promotes its proinflammatory and neurodegenerative effects</article-title><source>Cell Rep</source><year>2022</year><volume>40</volume><issue>11</issue><fpage>111330</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111330</pub-id><pub-id pub-id-type="pmid">36103834</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Yang R, Gao Y, Li H, Huang W, Tu D, Yang M, et al. Posttranslational S-nitrosylation modification regulates HMGB1 secretion and promotes its proinflammatory and neurodegenerative effects. Cell Rep. 2022;40(11):111330. 10.1016/j.celrep.2022.111330<pub-id pub-id-type="pmid">36103834</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Rabouille</surname><given-names>C</given-names></name></person-group><article-title>Pathways of unconventional protein secretion</article-title><source>Trends Cell Biol</source><year>2017</year><volume>27</volume><issue>3</issue><fpage>230</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2016.11.007</pub-id><pub-id pub-id-type="pmid">27989656</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Rabouille C. Pathways of unconventional protein secretion. Trends Cell Biol. 2017;27(3):230&#x02013;40. 10.1016/j.tcb.2016.11.007<pub-id pub-id-type="pmid">27989656</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Rabouille</surname><given-names>C</given-names></name><name><surname>Malhotra</surname><given-names>V</given-names></name><name><surname>Nickel</surname><given-names>W</given-names></name></person-group><article-title>Diversity in unconventional protein secretion</article-title><source>J Cell Sci</source><year>2012</year><volume>125</volume><issue>Pt 22</issue><fpage>5251</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1242/jcs.103630</pub-id><pub-id pub-id-type="pmid">23377655</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Rabouille C, Malhotra V, Nickel W. Diversity in unconventional protein secretion. J Cell Sci. 2012;125(Pt 22):5251&#x02013;5. 10.1242/jcs.103630<pub-id pub-id-type="pmid">23377655</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Schekman</surname><given-names>R</given-names></name></person-group><article-title>Cell biology. Unconventional secretion, unconventional solutions</article-title><source>Science</source><year>2013</year><volume>340</volume><issue>6132</issue><fpage>559</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1126/science.1234740</pub-id><pub-id pub-id-type="pmid">23641104</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Zhang M, Schekman R. Cell biology. Unconventional secretion, unconventional solutions. Science. 2013;340(6132):559&#x02013;61. 10.1126/science.1234740<pub-id pub-id-type="pmid">23641104</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kwak</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Shin</surname><given-names>JM</given-names></name><name><surname>Aum</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>IH</given-names></name><etal/></person-group><article-title>Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><issue>9</issue><fpage>2345</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1826690</pub-id><pub-id pub-id-type="pmid">33017561</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Kim YH, Kwak MS, Lee B, Shin JM, Aum S, Park IH, et al. Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion. Autophagy. 2021;17(9):2345&#x02013;62. 10.1080/15548627.2020.1826690<pub-id pub-id-type="pmid">33017561</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>van der Grein</surname><given-names>SG</given-names></name><name><surname>Defourny</surname><given-names>KAY</given-names></name><name><surname>Rabouw</surname><given-names>HH</given-names></name><name><surname>Goerdayal</surname><given-names>SS</given-names></name><name><surname>van Herwijnen</surname><given-names>MJC</given-names></name><name><surname>Wubbolts</surname><given-names>RW</given-names></name><etal/></person-group><article-title>The encephalomyocarditis virus leader promotes the release of virions inside extracellular vesicles via the induction of secretory autophagy</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>3625</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-31181-y</pub-id><pub-id pub-id-type="pmid">35750662</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">van der Grein SG, Defourny KAY, Rabouw HH, Goerdayal SS, van Herwijnen MJC, Wubbolts RW, et al. The encephalomyocarditis virus leader promotes the release of virions inside extracellular vesicles via the induction of secretory autophagy. Nat Commun. 2022;13(1):3625. 10.1038/s41467-022-31181-y<pub-id pub-id-type="pmid">35750662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>SY</given-names></name><name><surname>Wu</surname><given-names>HT</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>CJ</given-names></name><name><surname>Shan</surname><given-names>YS</given-names></name><name><surname>Wu</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Secretory autophagy promotes RAB37-mediated insulin secretion under glucose stimulation both in vitro and in vivo</article-title><source>Autophagy</source><year>2023</year><volume>19</volume><issue>4</issue><fpage>1239</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1080/15548627.2022.2123098</pub-id><pub-id pub-id-type="pmid">36109708</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Wu SY, Wu HT, Wang YC, Chang CJ, Shan YS, Wu SR, et al. Secretory autophagy promotes RAB37-mediated insulin secretion under glucose stimulation both in vitro and in vivo. Autophagy. 2023;19(4):1239&#x02013;57. 10.1080/15548627.2022.2123098<pub-id pub-id-type="pmid">36109708</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Gerstenmaier</surname><given-names>L</given-names></name><name><surname>Pilla</surname><given-names>R</given-names></name><name><surname>Herrmann</surname><given-names>L</given-names></name><name><surname>Herrmann</surname><given-names>H</given-names></name><name><surname>Prado</surname><given-names>M</given-names></name><name><surname>Villafano</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>The autophagic machinery ensures nonlytic transmission of mycobacteria</article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><issue>7</issue><fpage>E687</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1073/pnas.1423318112</pub-id><pub-id pub-id-type="pmid">25646440</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Gerstenmaier L, Pilla R, Herrmann L, Herrmann H, Prado M, Villafano GJ, et al. The autophagic machinery ensures nonlytic transmission of mycobacteria. Proc Natl Acad Sci U S A. 2015;112(7):E687&#x02013;92. 10.1073/pnas.1423318112<pub-id pub-id-type="pmid">25646440</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Mandell</surname><given-names>MA</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Arko-Mensah</surname><given-names>J</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Dinkins</surname><given-names>C</given-names></name><etal/></person-group><article-title>TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition</article-title><source>Dev Cell</source><year>2014</year><volume>30</volume><issue>4</issue><fpage>394</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.06.013</pub-id><pub-id pub-id-type="pmid">25127057</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Mandell MA, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C, et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell. 2014;30(4):394&#x02013;409. 10.1016/j.devcel.2014.06.013<pub-id pub-id-type="pmid">25127057</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Munding</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Niklaus</surname><given-names>G</given-names></name><name><surname>Papin</surname><given-names>S</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><etal/></person-group><article-title>The estrogen-responsive B box protein: a novel enhancer of interleukin-1beta secretion</article-title><source>Cell Death Differ</source><year>2006</year><volume>13</volume><issue>11</issue><fpage>1938</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401896</pub-id><pub-id pub-id-type="pmid">16575408</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Munding C, Keller M, Niklaus G, Papin S, Tschopp J, Werner S, et al. The estrogen-responsive B box protein: a novel enhancer of interleukin-1beta secretion. Cell Death Differ. 2006;13(11):1938&#x02013;49. 10.1038/sj.cdd.4401896<pub-id pub-id-type="pmid">16575408</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Mudd</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy</article-title><source>EMBO J</source><year>2017</year><volume>36</volume><issue>1</issue><fpage>42</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.15252/embj.201695081</pub-id><pub-id pub-id-type="pmid">27932448</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Kimura T, Jia J, Kumar S, Choi SW, Gu Y, Mudd M, et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J. 2017;36(1):42&#x02013;60. 10.15252/embj.201695081<pub-id pub-id-type="pmid">27932448</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>N</given-names></name><name><surname>Morita</surname><given-names>E</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Nakaoka</surname><given-names>M</given-names></name><name><surname>Osada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin</article-title><source>J Cell Biol</source><year>2013</year><volume>203</volume><issue>1</issue><fpage>115</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1083/jcb.201304188</pub-id><pub-id pub-id-type="pmid">24100292</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Fujita N, Morita E, Itoh T, Tanaka A, Nakaoka M, Osada Y, et al. Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J Cell Biol. 2013;203(1):115&#x02013;28. 10.1083/jcb.201304188<pub-id pub-id-type="pmid">24100292</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Maejima</surname><given-names>I</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Omori</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Takabatake</surname><given-names>Y</given-names></name><name><surname>Saitoh</surname><given-names>T</given-names></name><etal/></person-group><article-title>Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury</article-title><source>EMBO J</source><year>2013</year><volume>32</volume><issue>17</issue><fpage>2336</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.171</pub-id><pub-id pub-id-type="pmid">23921551</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 2013;32(17):2336&#x02013;47. 10.1038/emboj.2013.171<pub-id pub-id-type="pmid">23921551</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Nabi</surname><given-names>IR</given-names></name><name><surname>Shankar</surname><given-names>J</given-names></name><name><surname>Dennis</surname><given-names>JW</given-names></name></person-group><article-title>The galectin lattice at a glance</article-title><source>J Cell Sci</source><year>2015</year><volume>128</volume><issue>13</issue><fpage>2213</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1242/jcs.151159</pub-id><pub-id pub-id-type="pmid">26092931</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Nabi IR, Shankar J, Dennis JW. The galectin lattice at a glance. J Cell Sci. 2015;128(13):2213&#x02013;9. 10.1242/jcs.151159<pub-id pub-id-type="pmid">26092931</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Thurston</surname><given-names>TL</given-names></name><name><surname>Wandel</surname><given-names>MP</given-names></name><name><surname>von Muhlinen</surname><given-names>N</given-names></name><name><surname>Foeglein</surname><given-names>A</given-names></name><name><surname>Randow</surname><given-names>F</given-names></name></person-group><article-title>Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion</article-title><source>Nature</source><year>2012</year><volume>482</volume><issue>7385</issue><fpage>414</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nature10744</pub-id><pub-id pub-id-type="pmid">22246324</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature. 2012;482(7385):414&#x02013;8. 10.1038/nature10744<pub-id pub-id-type="pmid">22246324</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>LA</given-names></name><name><surname>Gutierrez</surname><given-names>L</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Leichtmann-Bardoogo</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>DL</given-names></name><name><surname>Crooks</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway</article-title><source>Blood</source><year>2010</year><volume>116</volume><issue>9</issue><fpage>1574</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-11-253815</pub-id><pub-id pub-id-type="pmid">20472835</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010;116(9):1574&#x02013;84. 10.1182/blood-2009-11-253815<pub-id pub-id-type="pmid">20472835</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Jena KK, Kolapalli SP, Mehto S, Nath P, Das B, Sahoo PK, et al. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy. EMBO J. 2018;37(18). 10.15252/embj.201798358</mixed-citation></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Progida</surname><given-names>C</given-names></name><name><surname>Bakke</surname><given-names>O</given-names></name></person-group><article-title>Bidirectional traffic between the Golgi and the endosomes - machineries and regulation</article-title><source>J Cell Sci</source><year>2016</year><volume>129</volume><issue>21</issue><fpage>3971</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1242/jcs.185702</pub-id><pub-id pub-id-type="pmid">27802132</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Progida C, Bakke O. Bidirectional traffic between the Golgi and the endosomes - machineries and regulation. J Cell Sci. 2016;129(21):3971&#x02013;82. 10.1242/jcs.185702<pub-id pub-id-type="pmid">27802132</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Raiborg</surname><given-names>C</given-names></name><name><surname>Wenzel</surname><given-names>EM</given-names></name><name><surname>Stenmark</surname><given-names>H</given-names></name></person-group><article-title>ER-endosome contact sites: molecular compositions and functions</article-title><source>EMBO J</source><year>2015</year><volume>34</volume><issue>14</issue><fpage>1848</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.15252/embj.201591481</pub-id><pub-id pub-id-type="pmid">26041457</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Raiborg C, Wenzel EM, Stenmark H. ER-endosome contact sites: molecular compositions and functions. EMBO J. 2015;34(14):1848&#x02013;58. 10.15252/embj.201591481<pub-id pub-id-type="pmid">26041457</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Haubert</surname><given-names>D</given-names></name><name><surname>Gharib</surname><given-names>N</given-names></name><name><surname>Rivero</surname><given-names>F</given-names></name><name><surname>Wiegmann</surname><given-names>K</given-names></name><name><surname>Hosel</surname><given-names>M</given-names></name><name><surname>Kronke</surname><given-names>M</given-names></name><etal/></person-group><article-title>PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-induced actin reorganization</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><issue>14</issue><fpage>3308</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601778</pub-id><pub-id pub-id-type="pmid">17599063</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Haubert D, Gharib N, Rivero F, Wiegmann K, Hosel M, Kronke M, et al. PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-induced actin reorganization. EMBO J. 2007;26(14):3308&#x02013;21. 10.1038/sj.emboj.7601778<pub-id pub-id-type="pmid">17599063</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>T</given-names></name><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Selective Autophagy</surname></name></person-group><article-title>ATG8 family proteins, LIR motifs and Cargo receptors</article-title><source>J Mol Biol</source><year>2020</year><volume>432</volume><issue>1</issue><fpage>80</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.07.016</pub-id><pub-id pub-id-type="pmid">31310766</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Johansen T, Lamark T, Selective Autophagy. ATG8 family proteins, LIR motifs and Cargo receptors. J Mol Biol. 2020;432(1):80&#x02013;103. 10.1016/j.jmb.2019.07.016<pub-id pub-id-type="pmid">31310766</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Hubstenberger</surname><given-names>A</given-names></name><name><surname>Courel</surname><given-names>M</given-names></name><name><surname>Benard</surname><given-names>M</given-names></name><name><surname>Souquere</surname><given-names>S</given-names></name><name><surname>Ernoult-Lange</surname><given-names>M</given-names></name><name><surname>Chouaib</surname><given-names>R</given-names></name><etal/></person-group><article-title>P-Body purification reveals the condensation of repressed mRNA regulons</article-title><source>Mol Cell</source><year>2017</year><volume>68</volume><issue>1</issue><fpage>144</fpage><lpage>e575</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.003</pub-id><pub-id pub-id-type="pmid">28965817</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Hubstenberger A, Courel M, Benard M, Souquere S, Ernoult-Lange M, Chouaib R, et al. P-Body purification reveals the condensation of repressed mRNA regulons. Mol Cell. 2017;68(1):144&#x02013;e575. 10.1016/j.molcel.2017.09.003<pub-id pub-id-type="pmid">28965817</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Wheeler</surname><given-names>JR</given-names></name><name><surname>Walters</surname><given-names>RW</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Barsic</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name></person-group><article-title>ATPase-Modulated stress granules contain a diverse proteome and substructure</article-title><source>Cell</source><year>2016</year><volume>164</volume><issue>3</issue><fpage>487</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.12.038</pub-id><pub-id pub-id-type="pmid">26777405</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. ATPase-Modulated stress granules contain a diverse proteome and substructure. Cell. 2016;164(3):487&#x02013;98. 10.1016/j.cell.2015.12.038<pub-id pub-id-type="pmid">26777405</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>JO</given-names></name><name><surname>Leidal</surname><given-names>AM</given-names></name><name><surname>Nguyen</surname><given-names>TA</given-names></name><name><surname>Debnath</surname><given-names>J</given-names></name></person-group><article-title>LC3-dependent EV loading and secretion (LDELS) promotes TFRC (transferrin receptor) secretion via extracellular vesicles</article-title><source>Autophagy</source><year>2023</year><volume>19</volume><issue>5</issue><fpage>1551</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1080/15548627.2022.2140557</pub-id><pub-id pub-id-type="pmid">36286616</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Gardner JO, Leidal AM, Nguyen TA, Debnath J. LC3-dependent EV loading and secretion (LDELS) promotes TFRC (transferrin receptor) secretion via extracellular vesicles. Autophagy. 2023;19(5):1551&#x02013;61. 10.1080/15548627.2022.2140557<pub-id pub-id-type="pmid">36286616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Bobrie</surname><given-names>A</given-names></name><name><surname>Krumeich</surname><given-names>S</given-names></name><name><surname>Reyal</surname><given-names>F</given-names></name><name><surname>Recchi</surname><given-names>C</given-names></name><name><surname>Moita</surname><given-names>LF</given-names></name><name><surname>Seabra</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression</article-title><source>Cancer Res</source><year>2012</year><volume>72</volume><issue>19</issue><fpage>4920</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-0925</pub-id><pub-id pub-id-type="pmid">22865453</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012;72(19):4920&#x02013;30. 10.1158/0008-5472.CAN-12-0925<pub-id pub-id-type="pmid">22865453</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Shin</surname><given-names>KJ</given-names></name><name><surname>Jang</surname><given-names>HJ</given-names></name><name><surname>Ryu</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>CY</given-names></name><name><surname>Yoon</surname><given-names>JH</given-names></name><etal/></person-group><article-title>GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis</article-title><source>Dev Cell</source><year>2023</year><volume>58</volume><issue>4</issue><fpage>320</fpage><lpage>e348</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2023.01.006</pub-id><pub-id pub-id-type="pmid">36800996</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Lee YJ, Shin KJ, Jang HJ, Ryu JS, Lee CY, Yoon JH, et al. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Dev Cell. 2023;58(4):320&#x02013;e348. 10.1016/j.devcel.2023.01.006<pub-id pub-id-type="pmid">36800996</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Ostrowski</surname><given-names>M</given-names></name><name><surname>Carmo</surname><given-names>NB</given-names></name><name><surname>Krumeich</surname><given-names>S</given-names></name><name><surname>Fanget</surname><given-names>I</given-names></name><name><surname>Raposo</surname><given-names>G</given-names></name><name><surname>Savina</surname><given-names>A</given-names></name><etal/></person-group><article-title>Rab27a and Rab27b control different steps of the exosome secretion pathway</article-title><source>Nat Cell Biol</source><year>2010</year><volume>12</volume><issue>1</issue><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/ncb2000</pub-id><pub-id pub-id-type="pmid">19966785</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19&#x02013;30. 10.1038/ncb2000. sup pp 1-13.<pub-id pub-id-type="pmid">19966785</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Vietri</surname><given-names>M</given-names></name><name><surname>Radulovic</surname><given-names>M</given-names></name><name><surname>Stenmark</surname><given-names>H</given-names></name></person-group><article-title>The many functions of ESCRTs</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><issue>1</issue><fpage>25</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0177-4</pub-id><pub-id pub-id-type="pmid">31705132</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Vietri M, Radulovic M, Stenmark H. The many functions of ESCRTs. Nat Rev Mol Cell Biol. 2020;21(1):25&#x02013;42. 10.1038/s41580-019-0177-4<pub-id pub-id-type="pmid">31705132</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Yue</surname><given-names>J</given-names></name><etal/></person-group><article-title>Manipulation of PD-L1 endosomal trafficking promotes anticancer immunity</article-title><source>Adv Sci (Weinh)</source><year>2023</year><volume>10</volume><issue>6</issue><fpage>e2206411</fpage><pub-id pub-id-type="doi">10.1002/advs.202206411</pub-id><pub-id pub-id-type="pmid">36567273</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Ye Z, Xiong Y, Peng W, Wei W, Huang L, Yue J, et al. Manipulation of PD-L1 endosomal trafficking promotes anticancer immunity. Adv Sci (Weinh). 2023;10(6):e2206411. 10.1002/advs.202206411<pub-id pub-id-type="pmid">36567273</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="other">Wu SY, Wang YC, Zuchini R, Lan KY, Liu HS, Lan SH. Secretory autophagy-promoted cargo exocytosis requires active RAB37. Autophagy. 2023;1&#x02013;2. 10.1080/15548627.2023.2210446</mixed-citation></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name><name><surname>Liu</surname><given-names>HY</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Chu</surname><given-names>YS</given-names></name><name><surname>Huang</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Secretory autophagy promotes Rab37-mediated exocytosis of tissue inhibitor of metalloproteinase 1</article-title><source>J Biomed Sci</source><year>2022</year><volume>29</volume><issue>1</issue><fpage>103</fpage><pub-id pub-id-type="doi">10.1186/s12929-022-00886-z</pub-id><pub-id pub-id-type="pmid">36457117</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Wu SY, Chen JW, Liu HY, Wang YC, Chu YS, Huang CY, et al. Secretory autophagy promotes Rab37-mediated exocytosis of tissue inhibitor of metalloproteinase 1. J Biomed Sci. 2022;29(1):103. 10.1186/s12929-022-00886-z<pub-id pub-id-type="pmid">36457117</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi-Itakura</surname><given-names>C</given-names></name><name><surname>Koyama-Honda</surname><given-names>I</given-names></name><name><surname>Itakura</surname><given-names>E</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><article-title>Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells</article-title><source>J Cell Sci</source><year>2014</year><volume>127</volume><issue>Pt 18</issue><fpage>4089</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1242/jcs.156034</pub-id><pub-id pub-id-type="pmid">25052093</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Kishi-Itakura C, Koyama-Honda I, Itakura E, Mizushima N. Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells. J Cell Sci. 2014;127(Pt 18):4089&#x02013;102. 10.1242/jcs.156034<pub-id pub-id-type="pmid">25052093</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Padman</surname><given-names>BS</given-names></name><name><surname>Usher</surname><given-names>J</given-names></name><name><surname>Oorschot</surname><given-names>V</given-names></name><name><surname>Ramm</surname><given-names>G</given-names></name><name><surname>Lazarou</surname><given-names>M</given-names></name></person-group><article-title>Atg8 family LC3/GABARAP proteins are crucial for autophagosome-lysosome fusion but not autophagosome formation during PINK1/Parkin mitophagy and starvation</article-title><source>J Cell Biol</source><year>2016</year><volume>215</volume><issue>6</issue><fpage>857</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1083/jcb.201607039</pub-id><pub-id pub-id-type="pmid">27864321</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Nguyen TN, Padman BS, Usher J, Oorschot V, Ramm G, Lazarou M. Atg8 family LC3/GABARAP proteins are crucial for autophagosome-lysosome fusion but not autophagosome formation during PINK1/Parkin mitophagy and starvation. J Cell Biol. 2016;215(6):857&#x02013;74. 10.1083/jcb.201607039<pub-id pub-id-type="pmid">27864321</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>E</given-names></name><name><surname>Schafer</surname><given-names>JH</given-names></name><name><surname>Wilmes</surname><given-names>S</given-names></name><name><surname>Ungermann</surname><given-names>C</given-names></name><name><surname>Moeller</surname><given-names>A</given-names></name><name><surname>Kummel</surname><given-names>D</given-names></name></person-group><article-title>Structure of the metazoan Rab7 GEF complex Mon1-Ccz1-Bulli</article-title><source>Proc Natl Acad Sci U S A</source><year>2023</year><volume>120</volume><issue>20</issue><fpage>e2301908120</fpage><pub-id pub-id-type="doi">10.1073/pnas.2301908120</pub-id><pub-id pub-id-type="pmid">37155863</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Herrmann E, Schafer JH, Wilmes S, Ungermann C, Moeller A, Kummel D. Structure of the metazoan Rab7 GEF complex Mon1-Ccz1-Bulli. Proc Natl Acad Sci U S A. 2023;120(20):e2301908120. 10.1073/pnas.2301908120<pub-id pub-id-type="pmid">37155863</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name></person-group><article-title>Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis</article-title><source>Pharm Biol</source><year>2023</year><volume>61</volume><issue>1</issue><fpage>1120</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1080/13880209.2023.2233998</pub-id><pub-id pub-id-type="pmid">37477949</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Qin X, Chen H, Zhu X, Xu X, Gao J. Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis. Pharm Biol. 2023;61(1):1120&#x02013;34. 10.1080/13880209.2023.2233998<pub-id pub-id-type="pmid">37477949</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>HWS</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Cho</surname><given-names>YL</given-names></name><name><surname>Natalia</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>3720</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-31213-7</pub-id><pub-id pub-id-type="pmid">35764633</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Tan HWS, Lu G, Dong H, Cho YL, Natalia A, Wang L, et al. A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery. Nat Commun. 2022;13(1):3720. 10.1038/s41467-022-31213-7<pub-id pub-id-type="pmid">35764633</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reduced O-GlcNAcylation of SNAP-23 promotes cisplatin resistance by inducing exosome secretion in ovarian cancer</article-title><source>Cell Death Discov</source><year>2021</year><volume>7</volume><issue>1</issue><fpage>112</fpage><pub-id pub-id-type="doi">10.1038/s41420-021-00489-x</pub-id><pub-id pub-id-type="pmid">34001861</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Qian L, Yang X, Li S, Zhao H, Gao Y, Zhao S, et al. Reduced O-GlcNAcylation of SNAP-23 promotes cisplatin resistance by inducing exosome secretion in ovarian cancer. Cell Death Discov. 2021;7(1):112. 10.1038/s41420-021-00489-x<pub-id pub-id-type="pmid">34001861</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Krzystek</surname><given-names>TJ</given-names></name><name><surname>White</surname><given-names>JA</given-names></name><name><surname>Rathnayake</surname><given-names>R</given-names></name><name><surname>Thurston</surname><given-names>L</given-names></name><name><surname>Hoffmar-Glennon</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>HTT (huntingtin) and RAB7 co-migrate retrogradely on a signaling LAMP1-containing late endosome during axonal injury</article-title><source>Autophagy</source><year>2023</year><volume>19</volume><issue>4</issue><fpage>1199</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1080/15548627.2022.2119351</pub-id><pub-id pub-id-type="pmid">36048753</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Krzystek TJ, White JA, Rathnayake R, Thurston L, Hoffmar-Glennon H, Li Y, et al. HTT (huntingtin) and RAB7 co-migrate retrogradely on a signaling LAMP1-containing late endosome during axonal injury. Autophagy. 2023;19(4):1199&#x02013;220. 10.1080/15548627.2022.2119351<pub-id pub-id-type="pmid">36048753</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname><given-names>PP</given-names></name><name><surname>Fan</surname><given-names>SJ</given-names></name><name><surname>Mason</surname><given-names>J</given-names></name><name><surname>Wells</surname><given-names>A</given-names></name><name><surname>Mendes</surname><given-names>CC</given-names></name><name><surname>Wainwright</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formation</article-title><source>J Extracell Vesicles</source><year>2023</year><volume>12</volume><issue>3</issue><fpage>e12311</fpage><pub-id pub-id-type="doi">10.1002/jev2.12311</pub-id><pub-id pub-id-type="pmid">36872252</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Marie PP, Fan SJ, Mason J, Wells A, Mendes CC, Wainwright SM, et al. Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formation. J Extracell Vesicles. 2023;12(3):e12311. 10.1002/jev2.12311<pub-id pub-id-type="pmid">36872252</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>MF</given-names></name><name><surname>Rappa</surname><given-names>G</given-names></name><name><surname>Karbanova</surname><given-names>J</given-names></name><name><surname>Fontana</surname><given-names>S</given-names></name><name><surname>Bella</surname><given-names>MAD</given-names></name><name><surname>Pope</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Itraconazole inhibits nuclear delivery of extracellular vesicle cargo by disrupting the entry of late endosomes into the nucleoplasmic reticulum</article-title><source>J Extracell Vesicles</source><year>2021</year><volume>10</volume><issue>10</issue><fpage>e12132</fpage><pub-id pub-id-type="doi">10.1002/jev2.12132</pub-id><pub-id pub-id-type="pmid">34429859</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Santos MF, Rappa G, Karbanova J, Fontana S, Bella MAD, Pope MR, et al. Itraconazole inhibits nuclear delivery of extracellular vesicle cargo by disrupting the entry of late endosomes into the nucleoplasmic reticulum. J Extracell Vesicles. 2021;10(10):e12132. 10.1002/jev2.12132<pub-id pub-id-type="pmid">34429859</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Schleinitz</surname><given-names>A</given-names></name><name><surname>Pottgen</surname><given-names>LA</given-names></name><name><surname>Keren-Kaplan</surname><given-names>T</given-names></name><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><name><surname>Bonifacino</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Consecutive functions of small GTPases guide HOPS-mediated tethering of late endosomes and lysosomes</article-title><source>Cell Rep</source><year>2023</year><volume>42</volume><issue>1</issue><fpage>111969doi</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111969</pub-id><pub-id pub-id-type="pmid">36640308</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Schleinitz A, Pottgen LA, Keren-Kaplan T, Pu J, Saftig P, Bonifacino JS, et al. Consecutive functions of small GTPases guide HOPS-mediated tethering of late endosomes and lysosomes. Cell Rep. 2023;42(1):11196910.1016/j.celrep.2022.111969<pub-id pub-id-type="pmid">36640308</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="other">Deretic V, Lazarou M. A guide to membrane atg8ylation and autophagy with reflections on immunity. J Cell Biol. 2022;221(7). 10.1083/jcb.202203083</mixed-citation></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><article-title>The ATG conjugation systems in autophagy</article-title><source>Curr Opin Cell Biol</source><year>2020</year><volume>63</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2019.12.001</pub-id><pub-id pub-id-type="pmid">31901645</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Mizushima N. The ATG conjugation systems in autophagy. Curr Opin Cell Biol. 2020;63:1&#x02013;10. 10.1016/j.ceb.2019.12.001<pub-id pub-id-type="pmid">31901645</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Lamark</surname><given-names>T</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name></person-group><article-title>Mechanisms of selective autophagy</article-title><source>Annu Rev Cell Dev Biol</source><year>2021</year><volume>37</volume><fpage>143</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-120219-035530</pub-id><pub-id pub-id-type="pmid">34152791</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Lamark T, Johansen T. Mechanisms of selective autophagy. Annu Rev Cell Dev Biol. 2021;37:143&#x02013;69. 10.1146/annurev-cellbio-120219-035530<pub-id pub-id-type="pmid">34152791</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Weidberg</surname><given-names>H</given-names></name><name><surname>Shpilka</surname><given-names>T</given-names></name><name><surname>Shvets</surname><given-names>E</given-names></name><name><surname>Abada</surname><given-names>A</given-names></name><name><surname>Shimron</surname><given-names>F</given-names></name><name><surname>Elazar</surname><given-names>Z</given-names></name></person-group><article-title>LC3 and GATE-16&#x000a0;N termini mediate membrane fusion processes required for autophagosome biogenesis</article-title><source>Dev Cell</source><year>2011</year><volume>20</volume><issue>4</issue><fpage>444</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.02.006</pub-id><pub-id pub-id-type="pmid">21497758</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Weidberg H, Shpilka T, Shvets E, Abada A, Shimron F, Elazar Z. LC3 and GATE-16&#x000a0;N termini mediate membrane fusion processes required for autophagosome biogenesis. Dev Cell. 2011;20(4):444&#x02013;54. 10.1016/j.devcel.2011.02.006<pub-id pub-id-type="pmid">21497758</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>T</given-names></name><name><surname>Alam</surname><given-names>JM</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Kageyama</surname><given-names>S</given-names></name><name><surname>Kirisako</surname><given-names>H</given-names></name><name><surname>Ishii</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Membrane perturbation by lipidated Atg8 underlies autophagosome biogenesis</article-title><source>Nat Struct Mol Biol</source><year>2021</year><volume>28</volume><issue>7</issue><fpage>583</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/s41594-021-00614-5</pub-id><pub-id pub-id-type="pmid">34239122</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Maruyama T, Alam JM, Fukuda T, Kageyama S, Kirisako H, Ishii Y, et al. Membrane perturbation by lipidated Atg8 underlies autophagosome biogenesis. Nat Struct Mol Biol. 2021;28(7):583&#x02013;93. 10.1038/s41594-021-00614-5<pub-id pub-id-type="pmid">34239122</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><mixed-citation publication-type="other">Krylova SV, Feng D. The Machinery of exosomes: Biogenesis, Release, and Uptake. Int J Mol Sci. 2023;24(2). 10.3390/ijms24021337</mixed-citation></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Bharti</surname><given-names>PS</given-names></name><name><surname>Rani</surname><given-names>N</given-names></name><name><surname>Nikolajeff</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>A tale of exosomes and their implication in cancer</article-title><source>Biochim Biophys Acta Rev Cancer</source><year>2023</year><volume>1878</volume><issue>4</issue><fpage>188908</fpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2023.188908</pub-id><pub-id pub-id-type="pmid">37172650</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Mishra A, Bharti PS, Rani N, Nikolajeff F, Kumar S. A tale of exosomes and their implication in cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(4):188908. 10.1016/j.bbcan.2023.188908<pub-id pub-id-type="pmid">37172650</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name></person-group><article-title>Exosomal circRNA: emerging insights into cancer progression and clinical application potential</article-title><source>J Hematol Oncol</source><year>2023</year><volume>16</volume><issue>1</issue><fpage>67</fpage><pub-id pub-id-type="doi">10.1186/s13045-023-01452-2</pub-id><pub-id pub-id-type="pmid">37365670</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Zhang F, Jiang J, Qian H, Yan Y, Xu W. Exosomal circRNA: emerging insights into cancer progression and clinical application potential. J Hematol Oncol. 2023;16(1):67. 10.1186/s13045-023-01452-2<pub-id pub-id-type="pmid">37365670</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Dang</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Engineered exosomes from different sources for cancer-targeted therapy</article-title><source>Signal Transduct Target Ther</source><year>2023</year><volume>8</volume><issue>1</issue><fpage>124</fpage><pub-id pub-id-type="doi">10.1038/s41392-023-01382-y</pub-id><pub-id pub-id-type="pmid">36922504</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z, et al. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023;8(1):124. 10.1038/s41392-023-01382-y<pub-id pub-id-type="pmid">36922504</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Exosomes: key players in cancer and potential therapeutic strategy</article-title><source>Signal Transduct Target Ther</source><year>2020</year><volume>5</volume><issue>1</issue><fpage>145</fpage><pub-id pub-id-type="doi">10.1038/s41392-020-00261-0</pub-id><pub-id pub-id-type="pmid">32759948</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145. 10.1038/s41392-020-00261-0<pub-id pub-id-type="pmid">32759948</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Mashouri</surname><given-names>L</given-names></name><name><surname>Yousefi</surname><given-names>H</given-names></name><name><surname>Aref</surname><given-names>AR</given-names></name><name><surname>Ahadi</surname><given-names>AM</given-names></name><name><surname>Molaei</surname><given-names>F</given-names></name><name><surname>Alahari</surname><given-names>SK</given-names></name></person-group><article-title>Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance</article-title><source>Mol Cancer</source><year>2019</year><volume>18</volume><issue>1</issue><fpage>75</fpage><pub-id pub-id-type="doi">10.1186/s12943-019-0991-5</pub-id><pub-id pub-id-type="pmid">30940145</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75. 10.1186/s12943-019-0991-5<pub-id pub-id-type="pmid">30940145</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Vlaeminck-Guillem</surname><given-names>V</given-names></name></person-group><article-title>Exosomes and prostate cancer management</article-title><source>Semin Cancer Biol</source><year>2022</year><volume>86</volume><issue>Pt 1</issue><fpage>101</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2021.08.004</pub-id><pub-id pub-id-type="pmid">34384877</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Vlaeminck-Guillem V. Exosomes and prostate cancer management. Semin Cancer Biol. 2022;86(Pt 1):101&#x02013;11. 10.1016/j.semcancer.2021.08.004<pub-id pub-id-type="pmid">34384877</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name></person-group><article-title>Autophagy and autophagy-related proteins in cancer</article-title><source>Mol Cancer</source><year>2020</year><volume>19</volume><issue>1</issue><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/s12943-020-1138-4</pub-id><pub-id pub-id-type="pmid">31969156</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12. 10.1186/s12943-020-1138-4<pub-id pub-id-type="pmid">31969156</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Thorburn</surname><given-names>A</given-names></name></person-group><article-title>Autophagy and organelle homeostasis in cancer</article-title><source>Dev Cell</source><year>2021</year><volume>56</volume><issue>7</issue><fpage>906</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.02.010</pub-id><pub-id pub-id-type="pmid">33689692</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Miller DR, Thorburn A. Autophagy and organelle homeostasis in cancer. Dev Cell. 2021;56(7):906&#x02013;18. 10.1016/j.devcel.2021.02.010<pub-id pub-id-type="pmid">33689692</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>JMM</given-names></name><name><surname>Towers</surname><given-names>CG</given-names></name><name><surname>Thorburn</surname><given-names>A</given-names></name></person-group><article-title>Targeting autophagy in cancer</article-title><source>Nat Rev Cancer</source><year>2017</year><volume>17</volume><issue>9</issue><fpage>528</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/nrc.2017.53</pub-id><pub-id pub-id-type="pmid">28751651</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528&#x02013;42. 10.1038/nrc.2017.53<pub-id pub-id-type="pmid">28751651</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Hou</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><etal/></person-group><article-title>PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment</article-title><source>Autophagy</source><year>2017</year><volume>13</volume><issue>3</issue><fpage>579</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1080/15548627.2016.1272742</pub-id><pub-id pub-id-type="pmid">28103122</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Ma K, Fu W, Tang M, Zhang C, Hou T, Li R, et al. PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment. Autophagy. 2017;13(3):579&#x02013;91. 10.1080/15548627.2016.1272742<pub-id pub-id-type="pmid">28103122</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies</article-title><source>Cancer Commun (Lond)</source><year>2024</year><volume>44</volume><issue>3</issue><fpage>408</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1002/cac2.12525</pub-id><pub-id pub-id-type="pmid">38407943</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Tang L, Zhang H, Zhou F, Wei Q, Du M, Wu J, et al. Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies. Cancer Commun (Lond). 2024;44(3):408&#x02013;32. 10.1002/cac2.12525<pub-id pub-id-type="pmid">38407943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><etal/></person-group><article-title>A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3</article-title><source>Cell Death Differ</source><year>2023</year><volume>30</volume><issue>1</issue><fpage>111</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-01049-1</pub-id><pub-id pub-id-type="pmid">35978049</pub-id>
</element-citation><mixed-citation id="mc-CR105" publication-type="journal">Zhou Y, Shao Y, Hu W, Zhang J, Shi Y, Kong X, et al. A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3. Cell Death Differ. 2023;30(1):111&#x02013;24. 10.1038/s41418-022-01049-1<pub-id pub-id-type="pmid">35978049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>KW</given-names></name><name><surname>Lahad</surname><given-names>JP</given-names></name><name><surname>Gray</surname><given-names>JW</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name></person-group><article-title>Emerging role of RAB GTPases in cancer and human disease</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><issue>7</issue><fpage>2516</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0573</pub-id><pub-id pub-id-type="pmid">15805241</pub-id>
</element-citation><mixed-citation id="mc-CR106" publication-type="journal">Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res. 2005;65(7):2516&#x02013;9. 10.1158/0008-5472.CAN-05-0573<pub-id pub-id-type="pmid">15805241</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy</article-title><source>Autophagy</source><year>2023</year><volume>19</volume><issue>3</issue><fpage>873</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1080/15548627.2022.2107314</pub-id><pub-id pub-id-type="pmid">35900990</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Di Q, Zhao X, Tang H, Li X, Xiao Y, Wu H, et al. USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy. Autophagy. 2023;19(3):873&#x02013;85. 10.1080/15548627.2022.2107314<pub-id pub-id-type="pmid">35900990</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Bi</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>M(6)a mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7</article-title><source>Autophagy</source><year>2020</year><volume>16</volume><issue>7</issue><fpage>1221</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1080/15548627.2019.1659617</pub-id><pub-id pub-id-type="pmid">31451060</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">Wang X, Wu R, Liu Y, Zhao Y, Bi Z, Yao Y, et al. M(6)a mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7. Autophagy. 2020;16(7):1221&#x02013;35. 10.1080/15548627.2019.1659617<pub-id pub-id-type="pmid">31451060</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name><surname>New</surname><given-names>J</given-names></name><name><surname>Arnold</surname><given-names>L</given-names></name><name><surname>Ananth</surname><given-names>M</given-names></name><name><surname>Alvi</surname><given-names>S</given-names></name><name><surname>Thornton</surname><given-names>M</given-names></name><name><surname>Werner</surname><given-names>L</given-names></name><etal/></person-group><article-title>Secretory autophagy in Cancer-Associated fibroblasts promotes Head and Neck Cancer Progression and offers a Novel Therapeutic Target</article-title><source>Cancer Res</source><year>2017</year><volume>77</volume><issue>23</issue><fpage>6679</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-1077</pub-id><pub-id pub-id-type="pmid">28972076</pub-id>
</element-citation><mixed-citation id="mc-CR109" publication-type="journal">New J, Arnold L, Ananth M, Alvi S, Thornton M, Werner L, et al. Secretory autophagy in Cancer-Associated fibroblasts promotes Head and Neck Cancer Progression and offers a Novel Therapeutic Target. Cancer Res. 2017;77(23):6679&#x02013;91. 10.1158/0008-5472.CAN-17-1077<pub-id pub-id-type="pmid">28972076</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>YM</given-names></name><name><surname>Tzeng</surname><given-names>SF</given-names></name><name><surname>Ho</surname><given-names>PC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name></person-group><article-title>Immunosurveillance encounters cancer metabolism</article-title><source>EMBO Rep</source><year>2024</year><volume>25</volume><issue>2</issue><fpage>471</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/s44319-023-00038-w</pub-id><pub-id pub-id-type="pmid">38216787</pub-id>
</element-citation><mixed-citation id="mc-CR110" publication-type="journal">Chuang YM, Tzeng SF, Ho PC, Tsai CH. Immunosurveillance encounters cancer metabolism. EMBO Rep. 2024;25(2):471&#x02013;88. 10.1038/s44319-023-00038-w<pub-id pub-id-type="pmid">38216787</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="other">Dussold C, Zilinger K, Turunen J, Heimberger AB, Miska J. Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer. J Clin Invest. 2024;134(2). 10.1172/JCI175445</mixed-citation></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Frigo</surname><given-names>DE</given-names></name></person-group><article-title>Diet and Tumor Genetics Conspire to promote prostate Cancer metabolism and shape the Tumor Microenvironment</article-title><source>Cancer Res</source><year>2024</year><volume>84</volume><issue>11</issue><fpage>1742</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-24-0302</pub-id><pub-id pub-id-type="pmid">38831750</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Frigo DE. Diet and Tumor Genetics Conspire to promote prostate Cancer metabolism and shape the Tumor Microenvironment. Cancer Res. 2024;84(11):1742&#x02013;4. 10.1158/0008-5472.CAN-24-0302<pub-id pub-id-type="pmid">38831750</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>FCE</given-names></name><name><surname>Chaves-Filho</surname><given-names>AB</given-names></name><name><surname>Schulze</surname><given-names>A</given-names></name></person-group><article-title>Lipids as mediators of cancer progression and metastasis</article-title><source>Nat Cancer</source><year>2024</year><volume>5</volume><issue>1</issue><fpage>16</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/s43018-023-00702-z</pub-id><pub-id pub-id-type="pmid">38273023</pub-id>
</element-citation><mixed-citation id="mc-CR113" publication-type="journal">Vogel FCE, Chaves-Filho AB, Schulze A. Lipids as mediators of cancer progression and metastasis. Nat Cancer. 2024;5(1):16&#x02013;29. 10.1038/s43018-023-00702-z<pub-id pub-id-type="pmid">38273023</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name><surname>Ariotti</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Okano</surname><given-names>S</given-names></name><name><surname>Gambin</surname><given-names>Y</given-names></name><name><surname>Follett</surname><given-names>J</given-names></name><name><surname>Rae</surname><given-names>J</given-names></name><etal/></person-group><article-title>An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><issue>9</issue><fpage>2200</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1820787</pub-id><pub-id pub-id-type="pmid">32897127</pub-id>
</element-citation><mixed-citation id="mc-CR114" publication-type="journal">Ariotti N, Wu Y, Okano S, Gambin Y, Follett J, Rae J, et al. An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells. Autophagy. 2021;17(9):2200&#x02013;16. 10.1080/15548627.2020.1820787<pub-id pub-id-type="pmid">32897127</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Pal</surname><given-names>K</given-names></name><name><surname>Sharma</surname><given-names>AK</given-names></name><name><surname>Dutta</surname><given-names>SK</given-names></name><name><surname>Lau</surname><given-names>JS</given-names></name><name><surname>Yan</surname><given-names>IK</given-names></name><etal/></person-group><article-title>GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>12</issue><fpage>e114409</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0114409</pub-id><pub-id pub-id-type="pmid">25469510</pub-id>
</element-citation><mixed-citation id="mc-CR115" publication-type="journal">Bhattacharya S, Pal K, Sharma AK, Dutta SK, Lau JS, Yan IK, et al. GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PLoS ONE. 2014;9(12):e114409. 10.1371/journal.pone.0114409<pub-id pub-id-type="pmid">25469510</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>TY</given-names></name><name><surname>Shi</surname><given-names>YY</given-names></name><name><surname>Cui</surname><given-names>XW</given-names></name><name><surname>Pan</surname><given-names>YF</given-names></name><name><surname>Lin</surname><given-names>YK</given-names></name><name><surname>Feng</surname><given-names>XF</given-names></name><etal/></person-group><article-title>PTEN Deficiency facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis</article-title><source>Gastroenterology</source><year>2023</year><volume>164</volume><issue>3</issue><fpage>424</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2022.11.025</pub-id><pub-id pub-id-type="pmid">36436593</pub-id>
</element-citation><mixed-citation id="mc-CR116" publication-type="journal">Jiang TY, Shi YY, Cui XW, Pan YF, Lin YK, Feng XF, et al. PTEN Deficiency facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis. Gastroenterology. 2023;164(3):424&#x02013;38. 10.1053/j.gastro.2022.11.025<pub-id pub-id-type="pmid">36436593</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Krause</surname><given-names>GJ</given-names></name><name><surname>Gui</surname><given-names>Q</given-names></name><name><surname>Kaushik</surname><given-names>S</given-names></name><name><surname>Rona</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>A noncanonical function of SKP1 regulates the switch between autophagy and unconventional secretion</article-title><source>Sci Adv</source><year>2023</year><volume>9</volume><issue>41</issue><fpage>eadh1134</fpage><pub-id pub-id-type="doi">10.1126/sciadv.adh1134</pub-id><pub-id pub-id-type="pmid">37831778</pub-id>
</element-citation><mixed-citation id="mc-CR117" publication-type="journal">Li J, Krause GJ, Gui Q, Kaushik S, Rona G, Zhang Q, et al. A noncanonical function of SKP1 regulates the switch between autophagy and unconventional secretion. Sci Adv. 2023;9(41):eadh1134. 10.1126/sciadv.adh1134<pub-id pub-id-type="pmid">37831778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Fu</surname><given-names>WJ</given-names></name><name><surname>Chen</surname><given-names>XQ</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Deng</surname><given-names>RS</given-names></name><name><surname>Tang</surname><given-names>XP</given-names></name><etal/></person-group><article-title>Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization</article-title><source>J Exp Clin Cancer Res</source><year>2022</year><volume>41</volume><issue>1</issue><fpage>74</fpage><pub-id pub-id-type="doi">10.1186/s13046-022-02291-8</pub-id><pub-id pub-id-type="pmid">35193644</pub-id>
</element-citation><mixed-citation id="mc-CR118" publication-type="journal">Li Z, Fu WJ, Chen XQ, Wang S, Deng RS, Tang XP, et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res. 2022;41(1):74. 10.1186/s13046-022-02291-8<pub-id pub-id-type="pmid">35193644</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>TH</given-names></name><name><surname>Kao</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>HS</given-names></name><name><surname>Hong</surname><given-names>YR</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>CF</given-names></name></person-group><article-title>Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2alpha/ATF4/CHOP and secretory autophagy pathways</article-title><source>Cell Commun Signal</source><year>2023</year><volume>21</volume><issue>1</issue><fpage>184</fpage><pub-id pub-id-type="doi">10.1186/s12964-023-01190-5</pub-id><pub-id pub-id-type="pmid">37488534</pub-id>
</element-citation><mixed-citation id="mc-CR119" publication-type="journal">Tran TH, Kao M, Liu HS, Hong YR, Su Y, Huang CF. Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2alpha/ATF4/CHOP and secretory autophagy pathways. Cell Commun Signal. 2023;21(1):184. 10.1186/s12964-023-01190-5<pub-id pub-id-type="pmid">37488534</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>K</given-names></name></person-group><article-title>Sulforaphane inhibits autophagy and induces exosome-mediated paracrine senescence via regulating mTOR/TFE3</article-title><source>Mol Nutr Food Res</source><year>2020</year><volume>64</volume><issue>14</issue><fpage>e1901231</fpage><pub-id pub-id-type="doi">10.1002/mnfr.201901231</pub-id><pub-id pub-id-type="pmid">32476238</pub-id>
</element-citation><mixed-citation id="mc-CR120" publication-type="journal">Zheng K, Ma J, Wang Y, He Z, Deng K. Sulforaphane inhibits autophagy and induces exosome-mediated paracrine senescence via regulating mTOR/TFE3. Mol Nutr Food Res. 2020;64(14):e1901231. 10.1002/mnfr.201901231<pub-id pub-id-type="pmid">32476238</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>MH</given-names></name><name><surname>Gerlach</surname><given-names>D</given-names></name><name><surname>Misale</surname><given-names>S</given-names></name><name><surname>Petronczki</surname><given-names>M</given-names></name><name><surname>Kraut</surname><given-names>N</given-names></name></person-group><article-title>Expanding the Reach of Precision Oncology by drugging all KRAS mutants</article-title><source>Cancer Discov</source><year>2022</year><volume>12</volume><issue>4</issue><fpage>924</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-21-1331</pub-id><pub-id pub-id-type="pmid">35046095</pub-id>
</element-citation><mixed-citation id="mc-CR121" publication-type="journal">Hofmann MH, Gerlach D, Misale S, Petronczki M, Kraut N. Expanding the Reach of Precision Oncology by drugging all KRAS mutants. Cancer Discov. 2022;12(4):924&#x02013;37. 10.1158/2159-8290.CD-21-1331<pub-id pub-id-type="pmid">35046095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name></person-group><article-title>KRAS mutation: from undruggable to druggable in cancer</article-title><source>Signal Transduct Target Ther</source><year>2021</year><volume>6</volume><issue>1</issue><fpage>386</fpage><pub-id pub-id-type="doi">10.1038/s41392-021-00780-4</pub-id><pub-id pub-id-type="pmid">34776511</pub-id>
</element-citation><mixed-citation id="mc-CR122" publication-type="journal">Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther. 2021;6(1):386. 10.1038/s41392-021-00780-4<pub-id pub-id-type="pmid">34776511</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>MC</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><article-title>Mutant p53: it&#x02019;s not all one and the same</article-title><source>Cell Death Differ</source><year>2022</year><volume>29</volume><issue>5</issue><fpage>983</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-00989-y</pub-id><pub-id pub-id-type="pmid">35361963</pub-id>
</element-citation><mixed-citation id="mc-CR123" publication-type="journal">Kennedy MC, Lowe SW. Mutant p53: it&#x02019;s not all one and the same. Cell Death Differ. 2022;29(5):983&#x02013;7. 10.1038/s41418-022-00989-y<pub-id pub-id-type="pmid">35361963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Tavana</surname><given-names>O</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name></person-group><article-title>Understanding the complexity of p53 in a new era of tumor suppression</article-title><source>Cancer Cell</source><year>2024</year><volume>42</volume><issue>6</issue><fpage>946</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2024.04.009</pub-id><pub-id pub-id-type="pmid">38729160</pub-id>
</element-citation><mixed-citation id="mc-CR124" publication-type="journal">Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42(6):946&#x02013;67. 10.1016/j.ccell.2024.04.009<pub-id pub-id-type="pmid">38729160</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Laversanne</surname><given-names>M</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><year>2021</year><volume>71</volume><issue>3</issue><fpage>209</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><pub-id pub-id-type="pmid">33538338</pub-id>
</element-citation><mixed-citation id="mc-CR125" publication-type="journal">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209&#x02013;49. 10.3322/caac.21660<pub-id pub-id-type="pmid">33538338</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name></person-group><article-title>A genetic model for colorectal tumorigenesis</article-title><source>Cell</source><year>1990</year><volume>61</volume><issue>5</issue><fpage>759</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(90)90186-i</pub-id><pub-id pub-id-type="pmid">2188735</pub-id>
</element-citation><mixed-citation id="mc-CR126" publication-type="journal">Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759&#x02013;67. 10.1016/0092-8674(90)90186-i<pub-id pub-id-type="pmid">2188735</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>C</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Bozic</surname><given-names>I</given-names></name></person-group><article-title>Mathematical model of colorectal cancer initiation</article-title><source>Proc Natl Acad Sci U S A</source><year>2020</year><volume>117</volume><issue>34</issue><fpage>20681</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.2003771117</pub-id><pub-id pub-id-type="pmid">32788368</pub-id>
</element-citation><mixed-citation id="mc-CR127" publication-type="journal">Paterson C, Clevers H, Bozic I. Mathematical model of colorectal cancer initiation. Proc Natl Acad Sci U S A. 2020;117(34):20681&#x02013;8. 10.1073/pnas.2003771117<pub-id pub-id-type="pmid">32788368</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name><surname>Bettencourt</surname><given-names>MV</given-names></name><name><surname>Bosne-David</surname><given-names>S</given-names></name><name><surname>Amaral</surname><given-names>L</given-names></name></person-group><article-title>Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis</article-title><source>Int J Antimicrob Agents</source><year>2000</year><volume>16</volume><issue>1</issue><fpage>69</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/s0924-8579(00)00199-0</pub-id><pub-id pub-id-type="pmid">11185417</pub-id>
</element-citation><mixed-citation id="mc-CR128" publication-type="journal">Bettencourt MV, Bosne-David S, Amaral L. Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis. Int J Antimicrob Agents. 2000;16(1):69&#x02013;71. 10.1016/s0924-8579(00)00199-0<pub-id pub-id-type="pmid">11185417</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>BR</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name><name><surname>Trink</surname><given-names>B</given-names></name><name><surname>Byun</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells</article-title><source>Apoptosis</source><year>2012</year><volume>17</volume><issue>9</issue><fpage>989</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1007/s10495-012-0717-2</pub-id><pub-id pub-id-type="pmid">22460505</pub-id>
</element-citation><mixed-citation id="mc-CR129" publication-type="journal">Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ, et al. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells. Apoptosis. 2012;17(9):989&#x02013;97. 10.1007/s10495-012-0717-2<pub-id pub-id-type="pmid">22460505</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR130"><label>130.</label><mixed-citation publication-type="other">van Soolingen D, Hernandez-Pando R, Orozco H, Aguilar D, Magis-Escurra C, Amaral L, et al. The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis. PLoS ONE. 2010;5(9). 10.1371/journal.pone.0012640</mixed-citation></ref><ref id="CR131"><label>131.</label><citation-alternatives><element-citation id="ec-CR131" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhelev</surname><given-names>Z</given-names></name><name><surname>Ohba</surname><given-names>H</given-names></name><name><surname>Bakalova</surname><given-names>R</given-names></name><name><surname>Hadjimitova</surname><given-names>V</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Shinohara</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia</article-title><source>Cancer Chemother Pharmacol</source><year>2004</year><volume>53</volume><issue>3</issue><fpage>267</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/s00280-003-0738-1</pub-id><pub-id pub-id-type="pmid">14663628</pub-id>
</element-citation><mixed-citation id="mc-CR131" publication-type="journal">Zhelev Z, Ohba H, Bakalova R, Hadjimitova V, Ishikawa M, Shinohara Y, et al. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Cancer Chemother Pharmacol. 2004;53(3):267&#x02013;75. 10.1007/s00280-003-0738-1<pub-id pub-id-type="pmid">14663628</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR132"><label>132.</label><citation-alternatives><element-citation id="ec-CR132" publication-type="journal"><person-group person-group-type="author"><name><surname>Byun</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>BR</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>SM</given-names></name><name><surname>Park</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway</article-title><source>Microvasc Res</source><year>2012</year><volume>84</volume><issue>3</issue><fpage>227</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.mvr.2012.09.006</pub-id><pub-id pub-id-type="pmid">23022044</pub-id>
</element-citation><mixed-citation id="mc-CR132" publication-type="journal">Byun HJ, Lee JH, Kim BR, Kang S, Dong SM, Park MS, et al. Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway. Microvasc Res. 2012;84(3):227&#x02013;34. 10.1016/j.mvr.2012.09.006<pub-id pub-id-type="pmid">23022044</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR133"><label>133.</label><citation-alternatives><element-citation id="ec-CR133" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>F</given-names></name><name><surname>She</surname><given-names>J</given-names></name></person-group><article-title>The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer</article-title><source>Stem Cell Res Ther</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>138</fpage><pub-id pub-id-type="doi">10.1186/s13287-022-02811-5</pub-id><pub-id pub-id-type="pmid">35365226</pub-id>
</element-citation><mixed-citation id="mc-CR133" publication-type="journal">Guo G, Tan Z, Liu Y, Shi F, She J. The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Stem Cell Res Ther. 2022;13(1):138. 10.1186/s13287-022-02811-5<pub-id pub-id-type="pmid">35365226</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR134"><label>134.</label><citation-alternatives><element-citation id="ec-CR134" publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>M</given-names></name><name><surname>Berral-Gonzalez</surname><given-names>A</given-names></name><name><surname>Lopez-Cade</surname><given-names>I</given-names></name><name><surname>Galindo-Pumarino</surname><given-names>C</given-names></name><name><surname>Bueno-Fortes</surname><given-names>S</given-names></name><name><surname>Martin-Merino</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients</article-title><source>Mol Cancer</source><year>2021</year><volume>20</volume><issue>1</issue><fpage>73</fpage><pub-id pub-id-type="doi">10.1186/s12943-021-01367-x</pub-id><pub-id pub-id-type="pmid">33926453</pub-id>
</element-citation><mixed-citation id="mc-CR134" publication-type="journal">Herrera M, Berral-Gonzalez A, Lopez-Cade I, Galindo-Pumarino C, Bueno-Fortes S, Martin-Merino M, et al. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients. Mol Cancer. 2021;20(1):73. 10.1186/s12943-021-01367-x<pub-id pub-id-type="pmid">33926453</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR135"><label>135.</label><citation-alternatives><element-citation id="ec-CR135" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Tu</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>YM</given-names></name><etal/></person-group><article-title>Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment</article-title><source>Cell Metab</source><year>2023</year><volume>35</volume><issue>7</issue><fpage>1209</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2023.04.013</pub-id><pub-id pub-id-type="pmid">37172577</pub-id>
</element-citation><mixed-citation id="mc-CR135" publication-type="journal">Wang Z, Kim SY, Tu W, Kim J, Xu A, Yang YM, et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab. 2023;35(7):1209&#x02013;26. 10.1016/j.cmet.2023.04.013<pub-id pub-id-type="pmid">37172577</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR136"><label>136.</label><citation-alternatives><element-citation id="ec-CR136" publication-type="journal"><person-group person-group-type="author"><name><surname>Munz</surname><given-names>C</given-names></name></person-group><article-title>The Macroautophagy Machinery in Endo- and exocytosis</article-title><source>J Mol Biol</source><year>2017</year><volume>429</volume><issue>4</issue><fpage>473</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.11.028</pub-id><pub-id pub-id-type="pmid">27932293</pub-id>
</element-citation><mixed-citation id="mc-CR136" publication-type="journal">Munz C. The Macroautophagy Machinery in Endo- and exocytosis. J Mol Biol. 2017;429(4):473&#x02013;85. 10.1016/j.jmb.2016.11.028<pub-id pub-id-type="pmid">27932293</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR137"><label>137.</label><citation-alternatives><element-citation id="ec-CR137" publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>RC</given-names></name><name><surname>Yuan</surname><given-names>HX</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>Autophagy regulation by nutrient signaling</article-title><source>Cell Res</source><year>2014</year><volume>24</volume><issue>1</issue><fpage>42</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/cr.2013.166</pub-id><pub-id pub-id-type="pmid">24343578</pub-id>
</element-citation><mixed-citation id="mc-CR137" publication-type="journal">Russell RC, Yuan HX, Guan KL. Autophagy regulation by nutrient signaling. Cell Res. 2014;24(1):42&#x02013;57. 10.1038/cr.2013.166<pub-id pub-id-type="pmid">24343578</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR138"><label>138.</label><citation-alternatives><element-citation id="ec-CR138" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Crosstalk between lysine methylation and phosphorylation of ATG16L1 dictates the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><issue>5</issue><fpage>825</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1080/15548627.2017.1389357</pub-id><pub-id pub-id-type="pmid">29634390</pub-id>
</element-citation><mixed-citation id="mc-CR138" publication-type="journal">Song H, Feng X, Zhang M, Jin X, Xu X, Wang L, et al. Crosstalk between lysine methylation and phosphorylation of ATG16L1 dictates the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes. Autophagy. 2018;14(5):825&#x02013;44. 10.1080/15548627.2017.1389357<pub-id pub-id-type="pmid">29634390</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR139"><label>139.</label><citation-alternatives><element-citation id="ec-CR139" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenation</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><issue>8</issue><fpage>1308</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1060386</pub-id><pub-id pub-id-type="pmid">26083323</pub-id>
</element-citation><mixed-citation id="mc-CR139" publication-type="journal">Song H, Pu J, Wang L, Wu L, Xiao J, Liu Q, et al. ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenation. Autophagy. 2015;11(8):1308&#x02013;25. 10.1080/15548627.2015.1060386<pub-id pub-id-type="pmid">26083323</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR140"><label>140.</label><citation-alternatives><element-citation id="ec-CR140" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1</article-title><source>Autophagy</source><year>2019</year><volume>15</volume><issue>3</issue><fpage>478</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1522467</pub-id><pub-id pub-id-type="pmid">30208760</pub-id>
</element-citation><mixed-citation id="mc-CR140" publication-type="journal">Li Y, Zhou D, Ren Y, Zhang Z, Guo X, Ma M, et al. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. Autophagy. 2019;15(3):478&#x02013;92. 10.1080/15548627.2018.1522467<pub-id pub-id-type="pmid">30208760</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR141"><label>141.</label><citation-alternatives><element-citation id="ec-CR141" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>HG</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>YL</given-names></name><etal/></person-group><article-title>MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy</article-title><source>Gastroenterology</source><year>2014</year><volume>146</volume><issue>1</issue><fpage>188</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.09.006</pub-id><pub-id pub-id-type="pmid">24036151</pub-id>
</element-citation><mixed-citation id="mc-CR141" publication-type="journal">Lu C, Chen J, Xu HG, Zhou X, He Q, Li YL, et al. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology. 2014;146(1):188&#x02013;99. 10.1053/j.gastro.2013.09.006<pub-id pub-id-type="pmid">24036151</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR142"><label>142.</label><citation-alternatives><element-citation id="ec-CR142" publication-type="journal"><person-group person-group-type="author"><name><surname>Pantoom</surname><given-names>S</given-names></name><name><surname>Konstantinidis</surname><given-names>G</given-names></name><name><surname>Voss</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Hofnagel</surname><given-names>O</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>RAB33B recruits the ATG16L1 complex to the phagophore via a noncanonical RAB binding protein</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><issue>9</issue><fpage>2290</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1822629</pub-id><pub-id pub-id-type="pmid">32960676</pub-id>
</element-citation><mixed-citation id="mc-CR142" publication-type="journal">Pantoom S, Konstantinidis G, Voss S, Han H, Hofnagel O, Li Z, et al. RAB33B recruits the ATG16L1 complex to the phagophore via a noncanonical RAB binding protein. Autophagy. 2021;17(9):2290&#x02013;304. 10.1080/15548627.2020.1822629<pub-id pub-id-type="pmid">32960676</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR143"><label>143.</label><citation-alternatives><element-citation id="ec-CR143" publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>MD</given-names></name><name><surname>Ching</surname><given-names>KL</given-names></name><name><surname>Liang</surname><given-names>FX</given-names></name><name><surname>Dhabaria</surname><given-names>A</given-names></name><name><surname>Tam</surname><given-names>K</given-names></name><name><surname>Ueberheide</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Decoy exosomes provide protection against bacterial toxins</article-title><source>Nature</source><year>2020</year><volume>579</volume><issue>7798</issue><fpage>260</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2066-6</pub-id><pub-id pub-id-type="pmid">32132711</pub-id>
</element-citation><mixed-citation id="mc-CR143" publication-type="journal">Keller MD, Ching KL, Liang FX, Dhabaria A, Tam K, Ueberheide BM, et al. Decoy exosomes provide protection against bacterial toxins. Nature. 2020;579(7798):260&#x02013;4. 10.1038/s41586-020-2066-6<pub-id pub-id-type="pmid">32132711</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR144"><label>144.</label><citation-alternatives><element-citation id="ec-CR144" publication-type="journal"><person-group person-group-type="author"><name><surname>Ostrom</surname><given-names>QT</given-names></name><name><surname>Price</surname><given-names>M</given-names></name><name><surname>Neff</surname><given-names>C</given-names></name><name><surname>Cioffi</surname><given-names>G</given-names></name><name><surname>Waite</surname><given-names>KA</given-names></name><name><surname>Kruchko</surname><given-names>C</given-names></name><etal/></person-group><article-title>CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2016&#x02013;2020</article-title><source>Neuro Oncol</source><year>2023</year><volume>25</volume><issue>12 Suppl 2</issue><fpage>iv1</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1093/neuonc/noad149</pub-id><pub-id pub-id-type="pmid">37793125</pub-id>
</element-citation><mixed-citation id="mc-CR144" publication-type="journal">Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2016&#x02013;2020. Neuro Oncol. 2023;25(12 Suppl 2):iv1&#x02013;99. 10.1093/neuonc/noad149<pub-id pub-id-type="pmid">37793125</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR145"><label>145.</label><citation-alternatives><element-citation id="ec-CR145" publication-type="journal"><person-group person-group-type="author"><name><surname>Stupp</surname><given-names>R</given-names></name><name><surname>Hegi</surname><given-names>ME</given-names></name><name><surname>Mason</surname><given-names>WP</given-names></name><name><surname>van den Bent</surname><given-names>MJ</given-names></name><name><surname>Taphoorn</surname><given-names>MJ</given-names></name><name><surname>Janzer</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial</article-title><source>Lancet Oncol</source><year>2009</year><volume>10</volume><issue>5</issue><fpage>459</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(09)70025-7</pub-id><pub-id pub-id-type="pmid">19269895</pub-id>
</element-citation><mixed-citation id="mc-CR145" publication-type="journal">Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459&#x02013;66. 10.1016/S1470-2045(09)70025-7<pub-id pub-id-type="pmid">19269895</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR146"><label>146.</label><citation-alternatives><element-citation id="ec-CR146" publication-type="journal"><person-group person-group-type="author"><name><surname>Thorburn</surname><given-names>J</given-names></name><name><surname>Horita</surname><given-names>H</given-names></name><name><surname>Redzic</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Frankel</surname><given-names>AE</given-names></name><name><surname>Thorburn</surname><given-names>A</given-names></name></person-group><article-title>Autophagy regulates selective HMGB1 release in tumor cells that are destined to die</article-title><source>Cell Death Differ</source><year>2009</year><volume>16</volume><issue>1</issue><fpage>175</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/cdd.2008.143</pub-id><pub-id pub-id-type="pmid">18846108</pub-id>
</element-citation><mixed-citation id="mc-CR146" publication-type="journal">Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, Thorburn A. Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ. 2009;16(1):175&#x02013;83. 10.1038/cdd.2008.143<pub-id pub-id-type="pmid">18846108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR147"><label>147.</label><citation-alternatives><element-citation id="ec-CR147" publication-type="journal"><person-group person-group-type="author"><name><surname>Apetoh</surname><given-names>L</given-names></name><name><surname>Ghiringhelli</surname><given-names>F</given-names></name><name><surname>Tesniere</surname><given-names>A</given-names></name><name><surname>Obeid</surname><given-names>M</given-names></name><name><surname>Ortiz</surname><given-names>C</given-names></name><name><surname>Criollo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy</article-title><source>Nat Med</source><year>2007</year><volume>13</volume><issue>9</issue><fpage>1050</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nm1622</pub-id><pub-id pub-id-type="pmid">17704786</pub-id>
</element-citation><mixed-citation id="mc-CR147" publication-type="journal">Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050&#x02013;9. 10.1038/nm1622<pub-id pub-id-type="pmid">17704786</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR148"><label>148.</label><citation-alternatives><element-citation id="ec-CR148" publication-type="journal"><person-group person-group-type="author"><name><surname>Rovere-Querini</surname><given-names>P</given-names></name><name><surname>Capobianco</surname><given-names>A</given-names></name><name><surname>Scaffidi</surname><given-names>P</given-names></name><name><surname>Valentinis</surname><given-names>B</given-names></name><name><surname>Catalanotti</surname><given-names>F</given-names></name><name><surname>Giazzon</surname><given-names>M</given-names></name><etal/></person-group><article-title>HMGB1 is an endogenous immune adjuvant released by necrotic cells</article-title><source>EMBO Rep</source><year>2004</year><volume>5</volume><issue>8</issue><fpage>825</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.7400205</pub-id><pub-id pub-id-type="pmid">15272298</pub-id>
</element-citation><mixed-citation id="mc-CR148" publication-type="journal">Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004;5(8):825&#x02013;30. 10.1038/sj.embor.7400205<pub-id pub-id-type="pmid">15272298</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR149"><label>149.</label><citation-alternatives><element-citation id="ec-CR149" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname><given-names>MR</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Supko</surname><given-names>JG</given-names></name><name><surname>Desideri</surname><given-names>S</given-names></name><name><surname>Grossman</surname><given-names>SA</given-names></name><name><surname>Brem</surname><given-names>S</given-names></name><etal/></person-group><article-title>A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme</article-title><source>Autophagy</source><year>2014</year><volume>10</volume><issue>8</issue><fpage>1359</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.4161/auto.28984</pub-id><pub-id pub-id-type="pmid">24991840</pub-id>
</element-citation><mixed-citation id="mc-CR149" publication-type="journal">Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 2014;10(8):1359&#x02013;68. 10.4161/auto.28984<pub-id pub-id-type="pmid">24991840</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR150"><label>150.</label><citation-alternatives><element-citation id="ec-CR150" publication-type="journal"><person-group person-group-type="author"><name><surname>Logsdon</surname><given-names>CD</given-names></name><name><surname>Fuentes</surname><given-names>MK</given-names></name><name><surname>Huang</surname><given-names>EH</given-names></name><name><surname>Arumugam</surname><given-names>T</given-names></name></person-group><article-title>RAGE and RAGE ligands in cancer</article-title><source>Curr Mol Med</source><year>2007</year><volume>7</volume><issue>8</issue><fpage>777</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.2174/156652407783220697</pub-id><pub-id pub-id-type="pmid">18331236</pub-id>
</element-citation><mixed-citation id="mc-CR150" publication-type="journal">Logsdon CD, Fuentes MK, Huang EH, Arumugam T. RAGE and RAGE ligands in cancer. Curr Mol Med. 2007;7(8):777&#x02013;89. 10.2174/156652407783220697<pub-id pub-id-type="pmid">18331236</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR151"><label>151.</label><citation-alternatives><element-citation id="ec-CR151" publication-type="journal"><person-group person-group-type="author"><name><surname>Sparvero</surname><given-names>LJ</given-names></name><name><surname>Asafu-Adjei</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Im</surname><given-names>J</given-names></name><etal/></person-group><article-title>RAGE (receptor for Advanced Glycation endproducts), RAGE ligands, and their role in cancer and inflammation</article-title><source>J Transl Med</source><year>2009</year><volume>7</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-7-17</pub-id><pub-id pub-id-type="pmid">19292913</pub-id>
</element-citation><mixed-citation id="mc-CR151" publication-type="journal">Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, et al. RAGE (receptor for Advanced Glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med. 2009;7:17. 10.1186/1479-5876-7-17<pub-id pub-id-type="pmid">19292913</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR152"><label>152.</label><citation-alternatives><element-citation id="ec-CR152" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Kong</surname><given-names>XH</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>XY</given-names></name><etal/></person-group><article-title>Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma</article-title><source>Cancer Commun (Lond)</source><year>2023</year><volume>43</volume><issue>2</issue><fpage>225</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1002/cac2.12388</pub-id><pub-id pub-id-type="pmid">36346061</pub-id>
</element-citation><mixed-citation id="mc-CR152" publication-type="journal">Zhan X, Wu R, Kong XH, You Y, He K, Sun XY, et al. Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma. Cancer Commun (Lond). 2023;43(2):225&#x02013;45. 10.1002/cac2.12388<pub-id pub-id-type="pmid">36346061</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR153"><label>153.</label><citation-alternatives><element-citation id="ec-CR153" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Duan</surname><given-names>L</given-names></name></person-group><article-title>High mobility Group Box 1 (HMGB1) predicts Invasion and poor prognosis of Glioblastoma Multiforme via activating AKT Signaling in an Autocrine Pathway</article-title><source>Med Sci Monit</source><year>2018</year><volume>24</volume><fpage>8916</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.12659/MSM.912104</pub-id><pub-id pub-id-type="pmid">30531692</pub-id>
</element-citation><mixed-citation id="mc-CR153" publication-type="journal">Cheng P, Ma Y, Gao Z, Duan L. High mobility Group Box 1 (HMGB1) predicts Invasion and poor prognosis of Glioblastoma Multiforme via activating AKT Signaling in an Autocrine Pathway. Med Sci Monit. 2018;24:8916&#x02013;24. 10.12659/MSM.912104<pub-id pub-id-type="pmid">30531692</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR154"><label>154.</label><citation-alternatives><element-citation id="ec-CR154" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Da</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><etal/></person-group><article-title>HMGB1-Induced p62 overexpression promotes snail-mediated epithelial-mesenchymal transition in Glioblastoma Cells via the degradation of GSK-3beta</article-title><source>Theranostics</source><year>2019</year><volume>9</volume><issue>7</issue><fpage>1909</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.7150/thno.30578</pub-id><pub-id pub-id-type="pmid">31037147</pub-id>
</element-citation><mixed-citation id="mc-CR154" publication-type="journal">Li H, Li J, Zhang G, Da Q, Chen L, Yu S, et al. HMGB1-Induced p62 overexpression promotes snail-mediated epithelial-mesenchymal transition in Glioblastoma Cells via the degradation of GSK-3beta. Theranostics. 2019;9(7):1909&#x02013;22. 10.7150/thno.30578<pub-id pub-id-type="pmid">31037147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR155"><label>155.</label><citation-alternatives><element-citation id="ec-CR155" publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Mi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE</article-title><source>iScience</source><year>2022</year><volume>25</volume><issue>9</issue><fpage>104872</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2022.104872</pub-id><pub-id pub-id-type="pmid">36034219</pub-id>
</element-citation><mixed-citation id="mc-CR155" publication-type="journal">Ye C, Li H, Li Y, Zhang Y, Liu G, Mi H, et al. Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE. iScience. 2022;25(9):104872. 10.1016/j.isci.2022.104872<pub-id pub-id-type="pmid">36034219</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR156"><label>156.</label><citation-alternatives><element-citation id="ec-CR156" publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Laversanne</surname><given-names>M</given-names></name><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><etal/></person-group><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><year>2024</year><volume>74</volume><issue>3</issue><fpage>229</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id><pub-id pub-id-type="pmid">38572751</pub-id>
</element-citation><mixed-citation id="mc-CR156" publication-type="journal">Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229&#x02013;63. 10.3322/caac.21834<pub-id pub-id-type="pmid">38572751</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR157"><label>157.</label><citation-alternatives><element-citation id="ec-CR157" publication-type="journal"><person-group person-group-type="author"><name><surname>Karam</surname><given-names>JA</given-names></name><name><surname>Lotan</surname><given-names>Y</given-names></name><name><surname>Roehrborn</surname><given-names>CG</given-names></name><name><surname>Ashfaq</surname><given-names>R</given-names></name><name><surname>Karakiewicz</surname><given-names>PI</given-names></name><name><surname>Shariat</surname><given-names>SF</given-names></name></person-group><article-title>Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence</article-title><source>Prostate</source><year>2007</year><volume>67</volume><issue>6</issue><fpage>614</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1002/pros.20557</pub-id><pub-id pub-id-type="pmid">17299799</pub-id>
</element-citation><mixed-citation id="mc-CR157" publication-type="journal">Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI, Shariat SF. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate. 2007;67(6):614&#x02013;22. 10.1002/pros.20557<pub-id pub-id-type="pmid">17299799</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR158"><label>158.</label><citation-alternatives><element-citation id="ec-CR158" publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Egawa</surname><given-names>S</given-names></name><name><surname>Addai</surname><given-names>J</given-names></name><name><surname>Frolov</surname><given-names>A</given-names></name><name><surname>Kuwao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients</article-title><source>Cancer</source><year>2003</year><volume>97</volume><issue>5</issue><fpage>1225</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1002/cncr.11198</pub-id><pub-id pub-id-type="pmid">12599229</pub-id>
</element-citation><mixed-citation id="mc-CR158" publication-type="journal">Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, et al. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Cancer. 2003;97(5):1225&#x02013;33. 10.1002/cncr.11198<pub-id pub-id-type="pmid">12599229</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR159"><label>159.</label><citation-alternatives><element-citation id="ec-CR159" publication-type="journal"><person-group person-group-type="author"><name><surname>Tahir</surname><given-names>SA</given-names></name><name><surname>Frolov</surname><given-names>A</given-names></name><name><surname>Hayes</surname><given-names>TG</given-names></name><name><surname>Mims</surname><given-names>MP</given-names></name><name><surname>Miles</surname><given-names>BJ</given-names></name><name><surname>Lerner</surname><given-names>SP</given-names></name><etal/></person-group><article-title>Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort</article-title><source>Clin Cancer Res</source><year>2006</year><volume>12</volume><issue>16</issue><fpage>4872</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-0417</pub-id><pub-id pub-id-type="pmid">16914574</pub-id>
</element-citation><mixed-citation id="mc-CR159" publication-type="journal">Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, et al. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006;12(16):4872&#x02013;5. 10.1158/1078-0432.CCR-06-0417<pub-id pub-id-type="pmid">16914574</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR160"><label>160.</label><citation-alternatives><element-citation id="ec-CR160" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Addai</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>TM</given-names></name><name><surname>Frolov</surname><given-names>A</given-names></name><name><surname>Miles</surname><given-names>BJ</given-names></name><name><surname>Kadmon</surname><given-names>D</given-names></name><etal/></person-group><article-title>Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis</article-title><source>Hum Pathol</source><year>2007</year><volume>38</volume><issue>11</issue><fpage>1688</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.humpath.2007.03.024</pub-id><pub-id pub-id-type="pmid">17707459</pub-id>
</element-citation><mixed-citation id="mc-CR160" publication-type="journal">Yang G, Addai J, Wheeler TM, Frolov A, Miles BJ, Kadmon D, et al. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol. 2007;38(11):1688&#x02013;95. 10.1016/j.humpath.2007.03.024<pub-id pub-id-type="pmid">17707459</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR161"><label>161.</label><citation-alternatives><element-citation id="ec-CR161" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Truong</surname><given-names>LD</given-names></name><name><surname>Wheeler</surname><given-names>TM</given-names></name><name><surname>Thompson</surname><given-names>TC</given-names></name></person-group><article-title>Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><issue>22</issue><fpage>5719</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">10582690</pub-id>
</element-citation><mixed-citation id="mc-CR161" publication-type="journal">Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 1999;59(22):5719&#x02013;23.<pub-id pub-id-type="pmid">10582690</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR162"><label>162.</label><mixed-citation publication-type="other">Williams JK, Ngo JM, Lehman IM, Schekman R. Annexin A6 mediates calcium-dependent exosome secretion during plasma membrane repair. Elife. 2023;12. 10.7554/eLife.86556</mixed-citation></ref><ref id="CR163"><label>163.</label><citation-alternatives><element-citation id="ec-CR163" publication-type="journal"><person-group person-group-type="author"><name><surname>Messenger</surname><given-names>SW</given-names></name><name><surname>Woo</surname><given-names>SS</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Martin</surname><given-names>TFJ</given-names></name></person-group><article-title>A ca(2+)-stimulated exosome release pathway in cancer cells is regulated by Munc13-4</article-title><source>J Cell Biol</source><year>2018</year><volume>217</volume><issue>8</issue><fpage>2877</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1083/jcb.201710132</pub-id><pub-id pub-id-type="pmid">29930202</pub-id>
</element-citation><mixed-citation id="mc-CR163" publication-type="journal">Messenger SW, Woo SS, Sun Z, Martin TFJ. A ca(2+)-stimulated exosome release pathway in cancer cells is regulated by Munc13-4. J Cell Biol. 2018;217(8):2877&#x02013;90. 10.1083/jcb.201710132<pub-id pub-id-type="pmid">29930202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR164"><label>164.</label><citation-alternatives><element-citation id="ec-CR164" publication-type="journal"><person-group person-group-type="author"><name><surname>Savina</surname><given-names>A</given-names></name><name><surname>Furlan</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name><name><surname>Colombo</surname><given-names>MI</given-names></name></person-group><article-title>Exosome release is regulated by a calcium-dependent mechanism in K562 cells</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>22</issue><fpage>20083</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1074/jbc.M301642200</pub-id><pub-id pub-id-type="pmid">12639953</pub-id>
</element-citation><mixed-citation id="mc-CR164" publication-type="journal">Savina A, Furlan M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem. 2003;278(22):20083&#x02013;90. 10.1074/jbc.M301642200<pub-id pub-id-type="pmid">12639953</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR165"><label>165.</label><citation-alternatives><element-citation id="ec-CR165" publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>NW</given-names></name><name><surname>Corrotte</surname><given-names>M</given-names></name></person-group><article-title>Plasma membrane repair</article-title><source>Curr Biol</source><year>2018</year><volume>28</volume><issue>8</issue><fpage>R392</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2017.12.034</pub-id><pub-id pub-id-type="pmid">29689221</pub-id>
</element-citation><mixed-citation id="mc-CR165" publication-type="journal">Andrews NW, Corrotte M. Plasma membrane repair. Curr Biol. 2018;28(8):R392&#x02013;7. 10.1016/j.cub.2017.12.034<pub-id pub-id-type="pmid">29689221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR166"><label>166.</label><citation-alternatives><element-citation id="ec-CR166" publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>PMR</given-names></name><name><surname>Mandleywala</surname><given-names>K</given-names></name><name><surname>Monette</surname><given-names>S</given-names></name><name><surname>Lumish</surname><given-names>M</given-names></name><name><surname>Tully</surname><given-names>KM</given-names></name><name><surname>Panikar</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>2526</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-30142-9</pub-id><pub-id pub-id-type="pmid">35534471</pub-id>
</element-citation><mixed-citation id="mc-CR166" publication-type="journal">Pereira PMR, Mandleywala K, Monette S, Lumish M, Tully KM, Panikar SS, et al. Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nat Commun. 2022;13(1):2526. 10.1038/s41467-022-30142-9<pub-id pub-id-type="pmid">35534471</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR167"><label>167.</label><citation-alternatives><element-citation id="ec-CR167" publication-type="journal"><person-group person-group-type="author"><name><surname>Raikar</surname><given-names>LS</given-names></name><name><surname>Vallejo</surname><given-names>J</given-names></name><name><surname>Lloyd</surname><given-names>PG</given-names></name><name><surname>Hardin</surname><given-names>CD</given-names></name></person-group><article-title>Overexpression of caveolin-1 results in increased plasma membrane targeting of glycolytic enzymes: the structural basis for a membrane associated metabolic compartment</article-title><source>J Cell Biochem</source><year>2006</year><volume>98</volume><issue>4</issue><fpage>861</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1002/jcb.20732</pub-id><pub-id pub-id-type="pmid">16453288</pub-id>
</element-citation><mixed-citation id="mc-CR167" publication-type="journal">Raikar LS, Vallejo J, Lloyd PG, Hardin CD. Overexpression of caveolin-1 results in increased plasma membrane targeting of glycolytic enzymes: the structural basis for a membrane associated metabolic compartment. J Cell Biochem. 2006;98(4):861&#x02013;71. 10.1002/jcb.20732<pub-id pub-id-type="pmid">16453288</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR168"><label>168.</label><citation-alternatives><element-citation id="ec-CR168" publication-type="journal"><person-group person-group-type="author"><name><surname>Shiroto</surname><given-names>T</given-names></name><name><surname>Romero</surname><given-names>N</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Sartoretto</surname><given-names>JL</given-names></name><name><surname>Kalwa</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e87871</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0087871</pub-id><pub-id pub-id-type="pmid">24498385</pub-id>
</element-citation><mixed-citation id="mc-CR168" publication-type="journal">Shiroto T, Romero N, Sugiyama T, Sartoretto JL, Kalwa H, Yan Z, et al. Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium. PLoS ONE. 2014;9(2):e87871. 10.1371/journal.pone.0087871<pub-id pub-id-type="pmid">24498385</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR169"><label>169.</label><citation-alternatives><element-citation id="ec-CR169" publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>M</given-names></name><name><surname>Morgan</surname><given-names>E</given-names></name><name><surname>Rumgay</surname><given-names>H</given-names></name><name><surname>Mafra</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Laversanne</surname><given-names>M</given-names></name><etal/></person-group><article-title>Current and future burden of breast cancer: global statistics for 2020 and 2040</article-title><source>Breast</source><year>2022</year><volume>66</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.breast.2022.08.010</pub-id><pub-id pub-id-type="pmid">36084384</pub-id>
</element-citation><mixed-citation id="mc-CR169" publication-type="journal">Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15&#x02013;23. 10.1016/j.breast.2022.08.010<pub-id pub-id-type="pmid">36084384</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="other">Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). 10.1126/science.aau6977</mixed-citation></ref><ref id="CR171"><label>171.</label><citation-alternatives><element-citation id="ec-CR171" publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Deep</surname><given-names>G</given-names></name></person-group><article-title>Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities</article-title><source>Cancer Lett</source><year>2020</year><volume>479</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2020.03.017</pub-id><pub-id pub-id-type="pmid">32201202</pub-id>
</element-citation><mixed-citation id="mc-CR171" publication-type="journal">Kumar A, Deep G. Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities. Cancer Lett. 2020;479:23&#x02013;30. 10.1016/j.canlet.2020.03.017<pub-id pub-id-type="pmid">32201202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR172"><label>172.</label><citation-alternatives><element-citation id="ec-CR172" publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>JJ</given-names></name><name><surname>Chau</surname><given-names>ZL</given-names></name><name><surname>Chen</surname><given-names>SY</given-names></name><name><surname>Hill</surname><given-names>JJ</given-names></name><name><surname>Korpany</surname><given-names>KV</given-names></name><name><surname>Liang</surname><given-names>NW</given-names></name><etal/></person-group><article-title>Exosome Processing and characterization approaches for Research and Technology Development</article-title><source>Adv Sci (Weinh)</source><year>2022</year><volume>9</volume><issue>15</issue><fpage>e2103222</fpage><pub-id pub-id-type="doi">10.1002/advs.202103222</pub-id><pub-id pub-id-type="pmid">35332686</pub-id>
</element-citation><mixed-citation id="mc-CR172" publication-type="journal">Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, et al. Exosome Processing and characterization approaches for Research and Technology Development. Adv Sci (Weinh). 2022;9(15):e2103222. 10.1002/advs.202103222<pub-id pub-id-type="pmid">35332686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR173"><label>173.</label><citation-alternatives><element-citation id="ec-CR173" publication-type="journal"><person-group person-group-type="author"><name><surname>Ichimura</surname><given-names>Y</given-names></name><name><surname>Kirisako</surname><given-names>T</given-names></name><name><surname>Takao</surname><given-names>T</given-names></name><name><surname>Satomi</surname><given-names>Y</given-names></name><name><surname>Shimonishi</surname><given-names>Y</given-names></name><name><surname>Ishihara</surname><given-names>N</given-names></name><etal/></person-group><article-title>A ubiquitin-like system mediates protein lipidation</article-title><source>Nature</source><year>2000</year><volume>408</volume><issue>6811</issue><fpage>488</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/35044114</pub-id><pub-id pub-id-type="pmid">11100732</pub-id>
</element-citation><mixed-citation id="mc-CR173" publication-type="journal">Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, et al. A ubiquitin-like system mediates protein lipidation. Nature. 2000;408(6811):488&#x02013;92. 10.1038/35044114<pub-id pub-id-type="pmid">11100732</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR174"><label>174.</label><citation-alternatives><element-citation id="ec-CR174" publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>George</surname><given-names>MD</given-names></name><etal/></person-group><article-title>A protein conjugation system essential for autophagy</article-title><source>Nature</source><year>1998</year><volume>395</volume><issue>6700</issue><fpage>395</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/26506</pub-id><pub-id pub-id-type="pmid">9759731</pub-id>
</element-citation><mixed-citation id="mc-CR174" publication-type="journal">Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, et al. A protein conjugation system essential for autophagy. Nature. 1998;395(6700):395&#x02013;8. 10.1038/26506<pub-id pub-id-type="pmid">9759731</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR175"><label>175.</label><citation-alternatives><element-citation id="ec-CR175" publication-type="journal"><person-group person-group-type="author"><name><surname>Kabeya</surname><given-names>Y</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Kirisako</surname><given-names>T</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><etal/></person-group><article-title>LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><issue>21</issue><fpage>5720</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.21.5720</pub-id><pub-id pub-id-type="pmid">11060023</pub-id>
</element-citation><mixed-citation id="mc-CR175" publication-type="journal">Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19(21):5720&#x02013;8. 10.1093/emboj/19.21.5720<pub-id pub-id-type="pmid">11060023</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR176"><label>176.</label><citation-alternatives><element-citation id="ec-CR176" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjuan</surname><given-names>MA</given-names></name><name><surname>Dillon</surname><given-names>CP</given-names></name><name><surname>Tait</surname><given-names>SW</given-names></name><name><surname>Moshiach</surname><given-names>S</given-names></name><name><surname>Dorsey</surname><given-names>F</given-names></name><name><surname>Connell</surname><given-names>S</given-names></name><etal/></person-group><article-title>Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis</article-title><source>Nature</source><year>2007</year><volume>450</volume><issue>7173</issue><fpage>1253</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature06421</pub-id><pub-id pub-id-type="pmid">18097414</pub-id>
</element-citation><mixed-citation id="mc-CR176" publication-type="journal">Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, Connell S, et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature. 2007;450(7173):1253&#x02013;7. 10.1038/nature06421<pub-id pub-id-type="pmid">18097414</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR177"><label>177.</label><citation-alternatives><element-citation id="ec-CR177" publication-type="journal"><person-group person-group-type="author"><name><surname>McKnight</surname><given-names>NC</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Wold</surname><given-names>MS</given-names></name><name><surname>Gong</surname><given-names>S</given-names></name><name><surname>Phillips</surname><given-names>GR</given-names></name><name><surname>Dou</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Beclin 1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex</article-title><source>PLoS Genet</source><year>2014</year><volume>10</volume><issue>10</issue><fpage>e1004626</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1004626</pub-id><pub-id pub-id-type="pmid">25275521</pub-id>
</element-citation><mixed-citation id="mc-CR177" publication-type="journal">McKnight NC, Zhong Y, Wold MS, Gong S, Phillips GR, Dou Z, et al. Beclin 1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex. PLoS Genet. 2014;10(10):e1004626. 10.1371/journal.pgen.1004626<pub-id pub-id-type="pmid">25275521</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR178"><label>178.</label><citation-alternatives><element-citation id="ec-CR178" publication-type="journal"><person-group person-group-type="author"><name><surname>Futter</surname><given-names>CE</given-names></name><name><surname>Collinson</surname><given-names>LM</given-names></name><name><surname>Backer</surname><given-names>JM</given-names></name><name><surname>Hopkins</surname><given-names>CR</given-names></name></person-group><article-title>Human VPS34 is required for internal vesicle formation within multivesicular endosomes</article-title><source>J Cell Biol</source><year>2001</year><volume>155</volume><issue>7</issue><fpage>1251</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1083/jcb.200108152</pub-id><pub-id pub-id-type="pmid">11756475</pub-id>
</element-citation><mixed-citation id="mc-CR178" publication-type="journal">Futter CE, Collinson LM, Backer JM, Hopkins CR. Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J Cell Biol. 2001;155(7):1251&#x02013;64. 10.1083/jcb.200108152<pub-id pub-id-type="pmid">11756475</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR179"><label>179.</label><citation-alternatives><element-citation id="ec-CR179" publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Erviti</surname><given-names>L</given-names></name><name><surname>Seow</surname><given-names>Y</given-names></name><name><surname>Schapira</surname><given-names>AH</given-names></name><name><surname>Gardiner</surname><given-names>C</given-names></name><name><surname>Sargent</surname><given-names>IL</given-names></name><name><surname>Wood</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission</article-title><source>Neurobiol Dis</source><year>2011</year><volume>42</volume><issue>3</issue><fpage>360</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2011.01.029</pub-id><pub-id pub-id-type="pmid">21303699</pub-id>
</element-citation><mixed-citation id="mc-CR179" publication-type="journal">Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis. 2011;42(3):360&#x02013;7. 10.1016/j.nbd.2011.01.029<pub-id pub-id-type="pmid">21303699</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR180"><label>180.</label><citation-alternatives><element-citation id="ec-CR180" publication-type="journal"><person-group person-group-type="author"><name><surname>Parolini</surname><given-names>I</given-names></name><name><surname>Federici</surname><given-names>C</given-names></name><name><surname>Raggi</surname><given-names>C</given-names></name><name><surname>Lugini</surname><given-names>L</given-names></name><name><surname>Palleschi</surname><given-names>S</given-names></name><name><surname>De Milito</surname><given-names>A</given-names></name><etal/></person-group><article-title>Microenvironmental pH is a key factor for exosome traffic in tumor cells</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>49</issue><fpage>34211</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.041152</pub-id><pub-id pub-id-type="pmid">19801663</pub-id>
</element-citation><mixed-citation id="mc-CR180" publication-type="journal">Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211&#x02013;22. 10.1074/jbc.M109.041152<pub-id pub-id-type="pmid">19801663</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR181"><label>181.</label><citation-alternatives><element-citation id="ec-CR181" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeldt</surname><given-names>MT</given-names></name><name><surname>O&#x02019;Prey</surname><given-names>J</given-names></name><name><surname>Morton</surname><given-names>JP</given-names></name><name><surname>Nixon</surname><given-names>C</given-names></name><name><surname>MacKay</surname><given-names>G</given-names></name><name><surname>Mrowinska</surname><given-names>A</given-names></name><etal/></person-group><article-title>p53 status determines the role of autophagy in pancreatic tumour development</article-title><source>Nature</source><year>2013</year><volume>504</volume><issue>7479</issue><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1038/nature12865</pub-id><pub-id pub-id-type="pmid">24305049</pub-id>
</element-citation><mixed-citation id="mc-CR181" publication-type="journal">Rosenfeldt MT, O&#x02019;Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature. 2013;504(7479):296&#x02013;300. 10.1038/nature12865<pub-id pub-id-type="pmid">24305049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR182"><label>182.</label><citation-alternatives><element-citation id="ec-CR182" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>JL</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>YG</given-names></name><name><surname>Song</surname><given-names>HX</given-names></name><name><surname>Wu</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Arsenic Trioxide rescues structural p53 mutations through a cryptic allosteric site</article-title><source>Cancer Cell</source><year>2021</year><volume>39</volume><issue>2</issue><fpage>225</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2020.11.013</pub-id><pub-id pub-id-type="pmid">33357454</pub-id>
</element-citation><mixed-citation id="mc-CR182" publication-type="journal">Chen S, Wu JL, Liang Y, Tang YG, Song HX, Wu LL, et al. Arsenic Trioxide rescues structural p53 mutations through a cryptic allosteric site. Cancer Cell. 2021;39(2):225&#x02013;39. 10.1016/j.ccell.2020.11.013<pub-id pub-id-type="pmid">33357454</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR183"><label>183.</label><citation-alternatives><element-citation id="ec-CR183" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties</article-title><source>Sci Transl Med</source><year>2023</year><volume>15</volume><issue>690</issue><fpage>eabn9155</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abn9155</pub-id><pub-id pub-id-type="pmid">37018419</pub-id>
</element-citation><mixed-citation id="mc-CR183" publication-type="journal">Song H, Wu J, Tang Y, Dai Y, Xiang X, Li Y, et al. Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties. Sci Transl Med. 2023;15(690):eabn9155. 10.1126/scitranslmed.abn9155<pub-id pub-id-type="pmid">37018419</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR184"><label>184.</label><citation-alternatives><element-citation id="ec-CR184" publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>Z</given-names></name><name><surname>White</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><article-title>Cancer stem cells in TNBC</article-title><source>Semin Cancer Biol</source><year>2022</year><volume>82</volume><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2021.06.015</pub-id><pub-id pub-id-type="pmid">34147641</pub-id>
</element-citation><mixed-citation id="mc-CR184" publication-type="journal">Hua Z, White J, Zhou J. Cancer stem cells in TNBC. Semin Cancer Biol. 2022;82:26&#x02013;34. 10.1016/j.semcancer.2021.06.015<pub-id pub-id-type="pmid">34147641</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR185"><label>185.</label><citation-alternatives><element-citation id="ec-CR185" publication-type="journal"><person-group person-group-type="author"><name><surname>Quaglino</surname><given-names>E</given-names></name><name><surname>Conti</surname><given-names>L</given-names></name><name><surname>Cavallo</surname><given-names>F</given-names></name></person-group><article-title>Breast cancer stem cell antigens as targets for immunotherapy</article-title><source>Semin Immunol</source><year>2020</year><volume>47</volume><fpage>101386</fpage><pub-id pub-id-type="doi">10.1016/j.smim.2020.101386</pub-id><pub-id pub-id-type="pmid">31932198</pub-id>
</element-citation><mixed-citation id="mc-CR185" publication-type="journal">Quaglino E, Conti L, Cavallo F. Breast cancer stem cell antigens as targets for immunotherapy. Semin Immunol. 2020;47:101386. 10.1016/j.smim.2020.101386<pub-id pub-id-type="pmid">31932198</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR186"><label>186.</label><citation-alternatives><element-citation id="ec-CR186" publication-type="journal"><person-group person-group-type="author"><name><surname>Maycotte</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>KL</given-names></name><name><surname>Goodall</surname><given-names>ML</given-names></name><name><surname>Thorburn</surname><given-names>J</given-names></name><name><surname>Thorburn</surname><given-names>A</given-names></name></person-group><article-title>Autophagy supports breast Cancer stem cell maintenance by regulating IL6 secretion</article-title><source>Mol Cancer Res</source><year>2015</year><volume>13</volume><issue>4</issue><fpage>651</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-14-0487</pub-id><pub-id pub-id-type="pmid">25573951</pub-id>
</element-citation><mixed-citation id="mc-CR186" publication-type="journal">Maycotte P, Jones KL, Goodall ML, Thorburn J, Thorburn A. Autophagy supports breast Cancer stem cell maintenance by regulating IL6 secretion. Mol Cancer Res. 2015;13(4):651&#x02013;8. 10.1158/1541-7786.MCR-14-0487<pub-id pub-id-type="pmid">25573951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR187"><label>187.</label><mixed-citation publication-type="other">Felcher CM, Bogni ES, Kordon EC. IL-6 Cytokine Family: a putative target for breast Cancer Prevention and Treatment. Int J Mol Sci. 2022;23(3). 10.3390/ijms23031809</mixed-citation></ref><ref id="CR188"><label>188.</label><citation-alternatives><element-citation id="ec-CR188" publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>SC</given-names></name><name><surname>Adhikari</surname><given-names>S</given-names></name><name><surname>Brownell</surname><given-names>JE</given-names></name><name><surname>Calderwood</surname><given-names>EF</given-names></name><name><surname>Chouitar</surname><given-names>J</given-names></name><name><surname>D&#x02019;Amore</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors</article-title><source>Bioorg Med Chem</source><year>2020</year><volume>28</volume><issue>19</issue><fpage>115681</fpage><pub-id pub-id-type="doi">10.1016/j.bmc.2020.115681</pub-id><pub-id pub-id-type="pmid">32912429</pub-id>
</element-citation><mixed-citation id="mc-CR188" publication-type="journal">Huang SC, Adhikari S, Brownell JE, Calderwood EF, Chouitar J, D&#x02019;Amore NR, et al. Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors. Bioorg Med Chem. 2020;28(19):115681. 10.1016/j.bmc.2020.115681<pub-id pub-id-type="pmid">32912429</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR189"><label>189.</label><citation-alternatives><element-citation id="ec-CR189" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>LT</given-names></name><name><surname>Kjaer</surname><given-names>SK</given-names></name></person-group><article-title>Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China</article-title><source>BMC Med</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>165</fpage><pub-id pub-id-type="doi">10.1186/s12916-021-02051-z</pub-id><pub-id pub-id-type="pmid">34261466</pub-id>
</element-citation><mixed-citation id="mc-CR189" publication-type="journal">Thomsen LT, Kjaer SK. Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China. BMC Med. 2021;19(1):165. 10.1186/s12916-021-02051-z<pub-id pub-id-type="pmid">34261466</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR190"><label>190.</label><mixed-citation publication-type="other">Bouyahya A, El Allam A, Aboulaghras S, Bakrim S, El Menyiy N, Alshahrani MM, et al. Targeting mTOR as a Cancer Therapy: recent advances in Natural Bioactive compounds and Immunotherapy. Cancers (Basel). 2022;14(22). 10.3390/cancers14225520</mixed-citation></ref><ref id="CR191"><label>191.</label><citation-alternatives><element-citation id="ec-CR191" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Zen</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway</article-title><source>J Exp Clin Cancer Res</source><year>2020</year><volume>39</volume><issue>1</issue><fpage>197</fpage><pub-id pub-id-type="doi">10.1186/s13046-020-01701-z</pub-id><pub-id pub-id-type="pmid">32962728</pub-id>
</element-citation><mixed-citation id="mc-CR191" publication-type="journal">Yang Y, Wang Q, Song D, Zen R, Zhang L, Wang Y, et al. Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway. J Exp Clin Cancer Res. 2020;39(1):197. 10.1186/s13046-020-01701-z<pub-id pub-id-type="pmid">32962728</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR192"><label>192.</label><citation-alternatives><element-citation id="ec-CR192" publication-type="journal"><person-group person-group-type="author"><name><surname>Glaviano</surname><given-names>A</given-names></name><name><surname>Foo</surname><given-names>ASC</given-names></name><name><surname>Lam</surname><given-names>HY</given-names></name><name><surname>Yap</surname><given-names>KCH</given-names></name><name><surname>Jacot</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>RH</given-names></name><etal/></person-group><article-title>PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer</article-title><source>Mol Cancer</source><year>2023</year><volume>22</volume><issue>1</issue><fpage>138</fpage><pub-id pub-id-type="doi">10.1186/s12943-023-01827-6</pub-id><pub-id pub-id-type="pmid">37596643</pub-id>
</element-citation><mixed-citation id="mc-CR192" publication-type="journal">Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138. 10.1186/s12943-023-01827-6<pub-id pub-id-type="pmid">37596643</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR193"><label>193.</label><citation-alternatives><element-citation id="ec-CR193" publication-type="journal"><person-group person-group-type="author"><name><surname>Panwar</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Bhatt</surname><given-names>M</given-names></name><name><surname>Tonk</surname><given-names>RK</given-names></name><name><surname>Azizov</surname><given-names>S</given-names></name><name><surname>Raza</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease</article-title><source>Signal Transduct Target Ther</source><year>2023</year><volume>8</volume><issue>1</issue><fpage>375</fpage><pub-id pub-id-type="doi">10.1038/s41392-023-01608-z</pub-id><pub-id pub-id-type="pmid">37779156</pub-id>
</element-citation><mixed-citation id="mc-CR193" publication-type="journal">Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023;8(1):375. 10.1038/s41392-023-01608-z<pub-id pub-id-type="pmid">37779156</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR194"><label>194.</label><citation-alternatives><element-citation id="ec-CR194" publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Lai</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><etal/></person-group><article-title>Exosome Release is regulated by mTORC1</article-title><source>Adv Sci (Weinh)</source><year>2019</year><volume>6</volume><issue>3</issue><fpage>1801313</fpage><pub-id pub-id-type="doi">10.1002/advs.201801313</pub-id><pub-id pub-id-type="pmid">30775228</pub-id>
</element-citation><mixed-citation id="mc-CR194" publication-type="journal">Zou W, Lai M, Zhang Y, Zheng L, Xing Z, Li T, et al. Exosome Release is regulated by mTORC1. Adv Sci (Weinh). 2019;6(3):1801313. 10.1002/advs.201801313<pub-id pub-id-type="pmid">30775228</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR195"><label>195.</label><citation-alternatives><element-citation id="ec-CR195" publication-type="journal"><person-group person-group-type="author"><name><surname>Blundon</surname><given-names>JM</given-names></name><name><surname>Cesar</surname><given-names>BI</given-names></name><name><surname>Bae</surname><given-names>JW</given-names></name><name><surname>Cavka</surname><given-names>I</given-names></name><name><surname>Haversat</surname><given-names>J</given-names></name><name><surname>Ries</surname><given-names>J</given-names></name><etal/></person-group><article-title>Skp1 proteins are structural components of the synaptonemal complex in C. Elegans</article-title><source>Sci Adv</source><year>2024</year><volume>10</volume><issue>7</issue><fpage>eadl4876</fpage><pub-id pub-id-type="doi">10.1126/sciadv.adl4876</pub-id><pub-id pub-id-type="pmid">38354250</pub-id>
</element-citation><mixed-citation id="mc-CR195" publication-type="journal">Blundon JM, Cesar BI, Bae JW, Cavka I, Haversat J, Ries J, et al. Skp1 proteins are structural components of the synaptonemal complex in C. Elegans. Sci Adv. 2024;10(7):eadl4876. 10.1126/sciadv.adl4876<pub-id pub-id-type="pmid">38354250</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR196"><label>196.</label><citation-alternatives><element-citation id="ec-CR196" publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Leu</surname><given-names>NA</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Chmatal</surname><given-names>L</given-names></name><name><surname>Ruthel</surname><given-names>G</given-names></name><name><surname>Bloom</surname><given-names>JC</given-names></name><etal/></person-group><article-title>SKP1 drives the prophase I to metaphase I transition during male meiosis</article-title><source>Sci Adv</source><year>2020</year><volume>6</volume><issue>13</issue><fpage>eaaz2129</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aaz2129</pub-id><pub-id pub-id-type="pmid">32232159</pub-id>
</element-citation><mixed-citation id="mc-CR196" publication-type="journal">Guan Y, Leu NA, Ma J, Chmatal L, Ruthel G, Bloom JC, et al. SKP1 drives the prophase I to metaphase I transition during male meiosis. Sci Adv. 2020;6(13):eaaz2129. 10.1126/sciadv.aaz2129<pub-id pub-id-type="pmid">32232159</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR197"><label>197.</label><citation-alternatives><element-citation id="ec-CR197" publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name></person-group><article-title>Autophagy in the cellular energetic balance</article-title><source>Cell Metab</source><year>2011</year><volume>13</volume><issue>5</issue><fpage>495</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.04.004</pub-id><pub-id pub-id-type="pmid">21531332</pub-id>
</element-citation><mixed-citation id="mc-CR197" publication-type="journal">Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab. 2011;13(5):495&#x02013;504. 10.1016/j.cmet.2011.04.004<pub-id pub-id-type="pmid">21531332</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR198"><label>198.</label><citation-alternatives><element-citation id="ec-CR198" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Peters</surname><given-names>R</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Mudd</surname><given-names>M</given-names></name><name><surname>Salemi</surname><given-names>M</given-names></name><name><surname>Allers</surname><given-names>L</given-names></name><etal/></person-group><article-title>ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion</article-title><source>Dev Cell</source><year>2023</year><volume>58</volume><issue>10</issue><fpage>866</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2023.03.014</pub-id><pub-id pub-id-type="pmid">37054706</pub-id>
</element-citation><mixed-citation id="mc-CR198" publication-type="journal">Wang F, Peters R, Jia J, Mudd M, Salemi M, Allers L, et al. ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion. Dev Cell. 2023;58(10):866&#x02013;84. 10.1016/j.devcel.2023.03.014<pub-id pub-id-type="pmid">37054706</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR199"><label>199.</label><citation-alternatives><element-citation id="ec-CR199" publication-type="journal"><person-group person-group-type="author"><name><surname>Ajoolabady</surname><given-names>A</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name></person-group><article-title>Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy</article-title><source>Br J Cancer</source><year>2023</year><volume>128</volume><issue>2</issue><fpage>190</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1038/s41416-022-01998-x</pub-id><pub-id pub-id-type="pmid">36229582</pub-id>
</element-citation><mixed-citation id="mc-CR199" publication-type="journal">Ajoolabady A, Tang D, Kroemer G, Ren J. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. Br J Cancer. 2023;128(2):190&#x02013;205. 10.1038/s41416-022-01998-x<pub-id pub-id-type="pmid">36229582</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR200"><label>200.</label><citation-alternatives><element-citation id="ec-CR200" publication-type="journal"><person-group person-group-type="author"><name><surname>Rajak</surname><given-names>S</given-names></name><name><surname>Raza</surname><given-names>S</given-names></name><name><surname>Sinha</surname><given-names>RA</given-names></name></person-group><article-title>ULK1 Signaling in the liver: Autophagy Dependent and independent actions</article-title><source>Front Cell Dev Biol</source><year>2022</year><volume>10</volume><fpage>836021</fpage><pub-id pub-id-type="doi">10.3389/fcell.2022.836021</pub-id><pub-id pub-id-type="pmid">35252196</pub-id>
</element-citation><mixed-citation id="mc-CR200" publication-type="journal">Rajak S, Raza S, Sinha RA. ULK1 Signaling in the liver: Autophagy Dependent and independent actions. Front Cell Dev Biol. 2022;10:836021. 10.3389/fcell.2022.836021<pub-id pub-id-type="pmid">35252196</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR201"><label>201.</label><citation-alternatives><element-citation id="ec-CR201" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>FL</given-names></name><name><surname>Wang</surname><given-names>YQ</given-names></name><name><surname>Wei</surname><given-names>HL</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy</article-title><source>Cell Death Dis</source><year>2023</year><volume>14</volume><issue>7</issue><fpage>451</fpage><pub-id pub-id-type="doi">10.1038/s41419-023-05989-5</pub-id><pub-id pub-id-type="pmid">37474520</pub-id>
</element-citation><mixed-citation id="mc-CR201" publication-type="journal">Wang X, Dong FL, Wang YQ, Wei HL, Li T, Li J. Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy. Cell Death Dis. 2023;14(7):451. 10.1038/s41419-023-05989-5<pub-id pub-id-type="pmid">37474520</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR202"><label>202.</label><citation-alternatives><element-citation id="ec-CR202" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma</article-title><source>Autophagy</source><year>2023</year><volume>19</volume><issue>4</issue><fpage>1221</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1080/15548627.2022.2119353</pub-id><pub-id pub-id-type="pmid">36048765</pub-id>
</element-citation><mixed-citation id="mc-CR202" publication-type="journal">Yao J, Tang S, Shi C, Lin Y, Ge L, Chen Q, et al. Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma. Autophagy. 2023;19(4):1221&#x02013;38. 10.1080/15548627.2022.2119353<pub-id pub-id-type="pmid">36048765</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR203"><label>203.</label><citation-alternatives><element-citation id="ec-CR203" publication-type="journal"><person-group person-group-type="author"><name><surname>Hessvik</surname><given-names>NP</given-names></name><name><surname>Overbye</surname><given-names>A</given-names></name><name><surname>Brech</surname><given-names>A</given-names></name><name><surname>Torgersen</surname><given-names>ML</given-names></name><name><surname>Jakobsen</surname><given-names>IS</given-names></name><name><surname>Sandvig</surname><given-names>K</given-names></name><etal/></person-group><article-title>PIKfyve inhibition increases exosome release and induces secretory autophagy</article-title><source>Cell Mol Life Sci</source><year>2016</year><volume>73</volume><issue>24</issue><fpage>4717</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2309-8</pub-id><pub-id pub-id-type="pmid">27438886</pub-id>
</element-citation><mixed-citation id="mc-CR203" publication-type="journal">Hessvik NP, Overbye A, Brech A, Torgersen ML, Jakobsen IS, Sandvig K, et al. PIKfyve inhibition increases exosome release and induces secretory autophagy. Cell Mol Life Sci. 2016;73(24):4717&#x02013;37. 10.1007/s00018-016-2309-8<pub-id pub-id-type="pmid">27438886</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR204"><label>204.</label><citation-alternatives><element-citation id="ec-CR204" publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Claude-Taupin</surname><given-names>A</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Peters</surname><given-names>R</given-names></name><name><surname>Bissa</surname><given-names>B</given-names></name><etal/></person-group><article-title>Galectin-3 coordinates a Cellular System for Lysosomal Repair and removal</article-title><source>Dev Cell</source><year>2020</year><volume>52</volume><issue>1</issue><fpage>69</fpage><lpage>e878</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.025</pub-id><pub-id pub-id-type="pmid">31813797</pub-id>
</element-citation><mixed-citation id="mc-CR204" publication-type="journal">Jia J, Claude-Taupin A, Gu Y, Choi SW, Peters R, Bissa B, et al. Galectin-3 coordinates a Cellular System for Lysosomal Repair and removal. Dev Cell. 2020;52(1):69&#x02013;e878. 10.1016/j.devcel.2019.10.025<pub-id pub-id-type="pmid">31813797</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR205"><label>205.</label><mixed-citation publication-type="other">Radulovic M, Schink KO, Wenzel EM, Nahse V, Bongiovanni A, Lafont F, et al. ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival. EMBO J. 2018;37(21). 10.15252/embj.201899753</mixed-citation></ref><ref id="CR206"><label>206.</label><mixed-citation publication-type="other">Skowyra ML, Schlesinger PH, Naismith TV, Hanson PI. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018;360(6384). 10.1126/science.aar5078</mixed-citation></ref><ref id="CR207"><label>207.</label><citation-alternatives><element-citation id="ec-CR207" publication-type="journal"><person-group person-group-type="author"><name><surname>Brisson</surname><given-names>L</given-names></name><name><surname>Banski</surname><given-names>P</given-names></name><name><surname>Sboarina</surname><given-names>M</given-names></name><name><surname>Dethier</surname><given-names>C</given-names></name><name><surname>Danhier</surname><given-names>P</given-names></name><name><surname>Fontenille</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Lactate dehydrogenase B controls lysosome activity and autophagy in Cancer</article-title><source>Cancer Cell</source><year>2016</year><volume>30</volume><issue>3</issue><fpage>418</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.08.005</pub-id><pub-id pub-id-type="pmid">27622334</pub-id>
</element-citation><mixed-citation id="mc-CR207" publication-type="journal">Brisson L, Banski P, Sboarina M, Dethier C, Danhier P, Fontenille MJ, et al. Lactate dehydrogenase B controls lysosome activity and autophagy in Cancer. Cancer Cell. 2016;30(3):418&#x02013;31. 10.1016/j.ccell.2016.08.005<pub-id pub-id-type="pmid">27622334</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR208"><label>208.</label><citation-alternatives><element-citation id="ec-CR208" publication-type="journal"><person-group person-group-type="author"><name><surname>Banales</surname><given-names>JM</given-names></name><name><surname>Marin</surname><given-names>JJG</given-names></name><name><surname>Lamarca</surname><given-names>A</given-names></name><name><surname>Rodrigues</surname><given-names>PM</given-names></name><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Roberts</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Cholangiocarcinoma 2020: the next horizon in mechanisms and management</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2020</year><volume>17</volume><issue>9</issue><fpage>557</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/s41575-020-0310-z</pub-id><pub-id pub-id-type="pmid">32606456</pub-id>
</element-citation><mixed-citation id="mc-CR208" publication-type="journal">Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557&#x02013;88. 10.1038/s41575-020-0310-z<pub-id pub-id-type="pmid">32606456</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR209"><label>209.</label><mixed-citation publication-type="other">Vita F, Olaizola I, Amato F, Rae C, Marco S, Banales JM, et al. Heterogeneity Cholangiocarcinoma Immune Biology. Cells. 2023;12(6). 10.3390/cells12060846</mixed-citation></ref><ref id="CR210"><label>210.</label><citation-alternatives><element-citation id="ec-CR210" publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>SU</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Ogmundsdottir</surname><given-names>MH</given-names></name><name><surname>Ayala</surname><given-names>C</given-names></name><name><surname>Lau</surname><given-names>BT</given-names></name><name><surname>Delacruz</surname><given-names>RGC</given-names></name><etal/></person-group><article-title>Germline variants of ATG7 in familial cholangiocarcinoma alter autophagy and p62</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>10333</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-13569-4</pub-id><pub-id pub-id-type="pmid">35725745</pub-id>
</element-citation><mixed-citation id="mc-CR210" publication-type="journal">Greer SU, Chen J, Ogmundsdottir MH, Ayala C, Lau BT, Delacruz RGC, et al. Germline variants of ATG7 in familial cholangiocarcinoma alter autophagy and p62. Sci Rep. 2022;12(1):10333. 10.1038/s41598-022-13569-4<pub-id pub-id-type="pmid">35725745</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR211"><label>211.</label><citation-alternatives><element-citation id="ec-CR211" publication-type="journal"><person-group person-group-type="author"><name><surname>Khizar</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>The role and implication of autophagy in cholangiocarcinoma</article-title><source>Cell Death Discov</source><year>2023</year><volume>9</volume><issue>1</issue><fpage>332</fpage><pub-id pub-id-type="doi">10.1038/s41420-023-01631-7</pub-id><pub-id pub-id-type="pmid">37666811</pub-id>
</element-citation><mixed-citation id="mc-CR211" publication-type="journal">Khizar H, Hu Y, Wu Y, Yang J. The role and implication of autophagy in cholangiocarcinoma. Cell Death Discov. 2023;9(1):332. 10.1038/s41420-023-01631-7<pub-id pub-id-type="pmid">37666811</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR212"><label>212.</label><citation-alternatives><element-citation id="ec-CR212" publication-type="journal"><person-group person-group-type="author"><name><surname>Palmieri</surname><given-names>M</given-names></name><name><surname>Impey</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>di Ronza</surname><given-names>A</given-names></name><name><surname>Pelz</surname><given-names>C</given-names></name><name><surname>Sardiello</surname><given-names>M</given-names></name><etal/></person-group><article-title>Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways</article-title><source>Hum Mol Genet</source><year>2011</year><volume>20</volume><issue>19</issue><fpage>3852</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr306</pub-id><pub-id pub-id-type="pmid">21752829</pub-id>
</element-citation><mixed-citation id="mc-CR212" publication-type="journal">Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 2011;20(19):3852&#x02013;66. 10.1093/hmg/ddr306<pub-id pub-id-type="pmid">21752829</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR213"><label>213.</label><citation-alternatives><element-citation id="ec-CR213" publication-type="journal"><person-group person-group-type="author"><name><surname>Sardiello</surname><given-names>M</given-names></name><name><surname>Palmieri</surname><given-names>M</given-names></name><name><surname>di Ronza</surname><given-names>A</given-names></name><name><surname>Medina</surname><given-names>DL</given-names></name><name><surname>Valenza</surname><given-names>M</given-names></name><name><surname>Gennarino</surname><given-names>VA</given-names></name><etal/></person-group><article-title>A gene network regulating lysosomal biogenesis and function</article-title><source>Science</source><year>2009</year><volume>325</volume><issue>5939</issue><fpage>473</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1126/science.1174447</pub-id><pub-id pub-id-type="pmid">19556463</pub-id>
</element-citation><mixed-citation id="mc-CR213" publication-type="journal">Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325(5939):473&#x02013;7. 10.1126/science.1174447<pub-id pub-id-type="pmid">19556463</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR214"><label>214.</label><citation-alternatives><element-citation id="ec-CR214" publication-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gucek</surname><given-names>M</given-names></name><name><surname>Puertollano</surname><given-names>R</given-names></name></person-group><article-title>MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB</article-title><source>Autophagy</source><year>2012</year><volume>8</volume><issue>6</issue><fpage>903</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.4161/auto.19653</pub-id><pub-id pub-id-type="pmid">22576015</pub-id>
</element-citation><mixed-citation id="mc-CR214" publication-type="journal">Martina JA, Chen Y, Gucek M, Puertollano R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8(6):903&#x02013;14. 10.4161/auto.19653<pub-id pub-id-type="pmid">22576015</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR215"><label>215.</label><citation-alternatives><element-citation id="ec-CR215" publication-type="journal"><person-group person-group-type="author"><name><surname>Roczniak-Ferguson</surname><given-names>A</given-names></name><name><surname>Petit</surname><given-names>CS</given-names></name><name><surname>Froehlich</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>S</given-names></name><name><surname>Ky</surname><given-names>J</given-names></name><name><surname>Angarola</surname><given-names>B</given-names></name><etal/></person-group><article-title>The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis</article-title><source>Sci Signal</source><year>2012</year><volume>5</volume><issue>228</issue><fpage>ra42</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2002790</pub-id><pub-id pub-id-type="pmid">22692423</pub-id>
</element-citation><mixed-citation id="mc-CR215" publication-type="journal">Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012;5(228):ra42. 10.1126/scisignal.2002790<pub-id pub-id-type="pmid">22692423</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR216"><label>216.</label><citation-alternatives><element-citation id="ec-CR216" publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname><given-names>C</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Medina</surname><given-names>DL</given-names></name><name><surname>Vetrini</surname><given-names>F</given-names></name><name><surname>Erdin</surname><given-names>S</given-names></name><name><surname>Erdin</surname><given-names>S</given-names></name><etal/></person-group><article-title>A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB</article-title><source>EMBO J</source><year>2012</year><volume>31</volume><issue>5</issue><fpage>1095</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.32</pub-id><pub-id pub-id-type="pmid">22343943</pub-id>
</element-citation><mixed-citation id="mc-CR216" publication-type="journal">Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012;31(5):1095&#x02013;108. 10.1038/emboj.2012.32<pub-id pub-id-type="pmid">22343943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR217"><label>217.</label><mixed-citation publication-type="other">Jiang TY, Pan YF, Wan ZH, Lin YK, Zhu B, Yuan ZG, et al. PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma. Sci Transl Med. 2020;12(562). 10.1126/scitranslmed.aay0152</mixed-citation></ref><ref id="CR218"><label>218.</label><citation-alternatives><element-citation id="ec-CR218" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group><article-title>PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice</article-title><source>J Hepatol</source><year>2024</year><volume>81</volume><issue>1</issue><fpage>120</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2024.02.018</pub-id><pub-id pub-id-type="pmid">38428643</pub-id>
</element-citation><mixed-citation id="mc-CR218" publication-type="journal">Yang Y, Wang J, Wan J, Cheng Q, Cheng Z, Zhou X, et al. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice. J Hepatol. 2024;81(1):120&#x02013;34. 10.1016/j.jhep.2024.02.018<pub-id pub-id-type="pmid">38428643</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR219"><label>219.</label><citation-alternatives><element-citation id="ec-CR219" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>NOTCH and esophageal squamous cell carcinoma</article-title><source>Adv Exp Med Biol</source><year>2021</year><volume>1287</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-55031-8_5</pub-id><pub-id pub-id-type="pmid">33034026</pub-id>
</element-citation><mixed-citation id="mc-CR219" publication-type="journal">Li Y, Li Y, Chen X. NOTCH and esophageal squamous cell carcinoma. Adv Exp Med Biol. 2021;1287:59&#x02013;68. 10.1007/978-3-030-55031-8_5<pub-id pub-id-type="pmid">33034026</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR220"><label>220.</label><citation-alternatives><element-citation id="ec-CR220" publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Otin</surname><given-names>C</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Hallmarks of aging: an expanding universe</article-title><source>Cell</source><year>2023</year><volume>186</volume><issue>2</issue><fpage>243</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.11.001</pub-id><pub-id pub-id-type="pmid">36599349</pub-id>
</element-citation><mixed-citation id="mc-CR220" publication-type="journal">Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243&#x02013;78. 10.1016/j.cell.2022.11.001<pub-id pub-id-type="pmid">36599349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR221"><label>221.</label><citation-alternatives><element-citation id="ec-CR221" publication-type="journal"><person-group person-group-type="author"><name><surname>Paquette</surname><given-names>M</given-names></name><name><surname>El-Houjeiri</surname><given-names>L</given-names></name><name><surname>L</surname><given-names>CZ</given-names></name><name><surname>Puustinen</surname><given-names>P</given-names></name><name><surname>Blanchette</surname><given-names>P</given-names></name><name><surname>Jeong</surname><given-names>H</given-names></name><etal/></person-group><article-title>AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><issue>12</issue><fpage>3957</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1080/15548627.2021.1898748</pub-id><pub-id pub-id-type="pmid">33734022</pub-id>
</element-citation><mixed-citation id="mc-CR221" publication-type="journal">Paquette M, El-Houjeiri L, L CZ, Puustinen P, Blanchette P, Jeong H, et al. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy. 2021;17(12):3957&#x02013;75. 10.1080/15548627.2021.1898748<pub-id pub-id-type="pmid">33734022</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR222"><label>222.</label><mixed-citation publication-type="other">Fernandez-Prades L, Brasal-Prieto M, Alba G, Martin V, Montserrat-de la Paz S, Cejudo-Guillen M, et al. Sulforaphane reduces the chronic inflammatory Immune response of human dendritic cells. Nutrients. 2023;15(15). 10.3390/nu15153405</mixed-citation></ref><ref id="CR223"><label>223.</label><mixed-citation publication-type="other">Huang L, Wang J, Wang X, Zheng S, Liang K, Kang YE, et al. Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation. Cancer Lett. 2024;217145. 10.1016/j.canlet.2024.217145</mixed-citation></ref><ref id="CR224"><label>224.</label><citation-alternatives><element-citation id="ec-CR224" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Elisseeff</surname><given-names>JH</given-names></name><name><surname>Demaria</surname><given-names>M</given-names></name></person-group><article-title>The senescence-associated secretory phenotype and its physiological and pathological implications</article-title><source>Nat Rev Mol Cell Biol</source><year>2024</year><pub-id pub-id-type="doi">10.1038/s41580-024-00727-x</pub-id><pub-id pub-id-type="pmid">39169166</pub-id>
</element-citation><mixed-citation id="mc-CR224" publication-type="journal">Wang B, Han J, Elisseeff JH, Demaria M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 2024. 10.1038/s41580-024-00727-x<pub-id pub-id-type="pmid">39169166</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR225"><label>225.</label><citation-alternatives><element-citation id="ec-CR225" publication-type="journal"><person-group person-group-type="author"><name><surname>Collaborators</surname><given-names>GBDPC</given-names></name></person-group><article-title>The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990&#x02013;2017: a systematic analysis for the global burden of Disease Study 2017</article-title><source>Lancet Gastroenterol Hepatol</source><year>2019</year><volume>4</volume><issue>12</issue><fpage>934</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(19)30347-4</pub-id><pub-id pub-id-type="pmid">31648972</pub-id>
</element-citation><mixed-citation id="mc-CR225" publication-type="journal">Collaborators GBDPC. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990&#x02013;2017: a systematic analysis for the global burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934&#x02013;47. 10.1016/S2468-1253(19)30347-4<pub-id pub-id-type="pmid">31648972</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR226"><label>226.</label><citation-alternatives><element-citation id="ec-CR226" publication-type="journal"><person-group person-group-type="author"><name><surname>Varsano</surname><given-names>T</given-names></name><name><surname>Taupin</surname><given-names>V</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Baterina</surname><given-names>OY</given-names><suffix>Jr</suffix></name><name><surname>Farquhar</surname><given-names>MG</given-names></name></person-group><article-title>The PDZ protein GIPC regulates trafficking of the LPA1 receptor from APPL signaling endosomes and attenuates the cell&#x02019;s response to LPA</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><issue>11</issue><fpage>e49227</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0049227</pub-id><pub-id pub-id-type="pmid">23145131</pub-id>
</element-citation><mixed-citation id="mc-CR226" publication-type="journal">Varsano T, Taupin V, Guo L, Baterina OY Jr., Farquhar MG. The PDZ protein GIPC regulates trafficking of the LPA1 receptor from APPL signaling endosomes and attenuates the cell&#x02019;s response to LPA. PLoS ONE. 2012;7(11):e49227. 10.1371/journal.pone.0049227<pub-id pub-id-type="pmid">23145131</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR227"><label>227.</label><citation-alternatives><element-citation id="ec-CR227" publication-type="journal"><person-group person-group-type="author"><name><surname>Sajid</surname><given-names>A</given-names></name><name><surname>Rahman</surname><given-names>H</given-names></name><name><surname>Ambudkar</surname><given-names>SV</given-names></name></person-group><article-title>Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters</article-title><source>Nat Rev Cancer</source><year>2023</year><volume>23</volume><issue>11</issue><fpage>762</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/s41568-023-00612-3</pub-id><pub-id pub-id-type="pmid">37714963</pub-id>
</element-citation><mixed-citation id="mc-CR227" publication-type="journal">Sajid A, Rahman H, Ambudkar SV. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nat Rev Cancer. 2023;23(11):762&#x02013;79. 10.1038/s41568-023-00612-3<pub-id pub-id-type="pmid">37714963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR228"><label>228.</label><citation-alternatives><element-citation id="ec-CR228" publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Pabon</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>R</given-names></name><name><surname>Scotto</surname><given-names>KW</given-names></name></person-group><article-title>ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stress</article-title><source>J Biol Chem</source><year>2024</year><volume>300</volume><issue>6</issue><fpage>107299</fpage><pub-id pub-id-type="doi">10.1016/j.jbc.2024.107299</pub-id><pub-id pub-id-type="pmid">38641063</pub-id>
</element-citation><mixed-citation id="mc-CR228" publication-type="journal">Shi J, Pabon K, Ding R, Scotto KW. ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stress. J Biol Chem. 2024;300(6):107299. 10.1016/j.jbc.2024.107299<pub-id pub-id-type="pmid">38641063</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR229"><label>229.</label><citation-alternatives><element-citation id="ec-CR229" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Niu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name></person-group><article-title>Analysis of extracellular vesicle DNA at the single-vesicle level by nano-flow cytometry</article-title><source>J Extracell Vesicles</source><year>2022</year><volume>11</volume><issue>4</issue><fpage>e12206</fpage><pub-id pub-id-type="doi">10.1002/jev2.12206</pub-id><pub-id pub-id-type="pmid">35373518</pub-id>
</element-citation><mixed-citation id="mc-CR229" publication-type="journal">Liu H, Tian Y, Xue C, Niu Q, Chen C, Yan X. Analysis of extracellular vesicle DNA at the single-vesicle level by nano-flow cytometry. J Extracell Vesicles. 2022;11(4):e12206. 10.1002/jev2.12206<pub-id pub-id-type="pmid">35373518</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR230"><label>230.</label><citation-alternatives><element-citation id="ec-CR230" publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>DE</given-names></name><name><surname>Pan</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Galanis</surname><given-names>G</given-names></name><name><surname>Roh</surname><given-names>YH</given-names></name><name><surname>Morales</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Double Digital Assay for single extracellular vesicle and single molecule detection</article-title><source>Adv Sci (Weinh)</source><year>2023</year><volume>10</volume><issue>33</issue><fpage>e2303619</fpage><pub-id pub-id-type="doi">10.1002/advs.202303619</pub-id><pub-id pub-id-type="pmid">37802976</pub-id>
</element-citation><mixed-citation id="mc-CR230" publication-type="journal">Reynolds DE, Pan M, Yang J, Galanis G, Roh YH, Morales RT, et al. Double Digital Assay for single extracellular vesicle and single molecule detection. Adv Sci (Weinh). 2023;10(33):e2303619. 10.1002/advs.202303619<pub-id pub-id-type="pmid">37802976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR231"><label>231.</label><citation-alternatives><element-citation id="ec-CR231" publication-type="journal"><person-group person-group-type="author"><name><surname>Saftics</surname><given-names>A</given-names></name><name><surname>Abuelreich</surname><given-names>S</given-names></name><name><surname>Romano</surname><given-names>E</given-names></name><name><surname>Ghaeli</surname><given-names>I</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Spanos</surname><given-names>M</given-names></name><etal/></person-group><article-title>Single extracellular VEsicle Nanoscopy</article-title><source>J Extracell Vesicles</source><year>2023</year><volume>12</volume><issue>7</issue><fpage>e12346</fpage><pub-id pub-id-type="doi">10.1002/jev2.12346</pub-id><pub-id pub-id-type="pmid">37422692</pub-id>
</element-citation><mixed-citation id="mc-CR231" publication-type="journal">Saftics A, Abuelreich S, Romano E, Ghaeli I, Jiang N, Spanos M, et al. Single extracellular VEsicle Nanoscopy. J Extracell Vesicles. 2023;12(7):e12346. 10.1002/jev2.12346<pub-id pub-id-type="pmid">37422692</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR232"><label>232.</label><citation-alternatives><element-citation id="ec-CR232" publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>CM</given-names></name><name><surname>Biancur</surname><given-names>DE</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Halbrook</surname><given-names>CJ</given-names></name><name><surname>Sherman</surname><given-names>MH</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion</article-title><source>Nature</source><year>2016</year><volume>536</volume><issue>7617</issue><fpage>479</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/nature19084</pub-id><pub-id pub-id-type="pmid">27509858</pub-id>
</element-citation><mixed-citation id="mc-CR232" publication-type="journal">Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016;536(7617):479&#x02013;83. 10.1038/nature19084<pub-id pub-id-type="pmid">27509858</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR233"><label>233.</label><citation-alternatives><element-citation id="ec-CR233" publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DE</given-names></name><name><surname>Burtness</surname><given-names>B</given-names></name><name><surname>Leemans</surname><given-names>CR</given-names></name><name><surname>Lui</surname><given-names>VWY</given-names></name><name><surname>Bauman</surname><given-names>JE</given-names></name><name><surname>Grandis</surname><given-names>JR</given-names></name></person-group><article-title>Head and neck squamous cell carcinoma</article-title><source>Nat Rev Dis Primers</source><year>2020</year><volume>6</volume><issue>1</issue><fpage>92</fpage><pub-id pub-id-type="doi">10.1038/s41572-020-00224-3</pub-id><pub-id pub-id-type="pmid">33243986</pub-id>
</element-citation><mixed-citation id="mc-CR233" publication-type="journal">Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92. 10.1038/s41572-020-00224-3<pub-id pub-id-type="pmid">33243986</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR234"><label>234.</label><citation-alternatives><element-citation id="ec-CR234" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Malhotra</surname><given-names>PS</given-names></name><name><surname>Thomas</surname><given-names>GR</given-names></name><name><surname>Ondrey</surname><given-names>FG</given-names></name><name><surname>Duffey</surname><given-names>DC</given-names></name><name><surname>Smith</surname><given-names>CW</given-names></name><etal/></person-group><article-title>Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer</article-title><source>Clin Cancer Res</source><year>1999</year><volume>5</volume><issue>6</issue><fpage>1369</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">10389921</pub-id>
</element-citation><mixed-citation id="mc-CR234" publication-type="journal">Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999;5(6):1369&#x02013;79.<pub-id pub-id-type="pmid">10389921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR235"><label>235.</label><citation-alternatives><element-citation id="ec-CR235" publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>EV</given-names></name><name><surname>Love-Homan</surname><given-names>L</given-names></name><name><surname>Sobhakumari</surname><given-names>A</given-names></name><name><surname>Feddersen</surname><given-names>CR</given-names></name><name><surname>Koch</surname><given-names>AT</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><etal/></person-group><article-title>EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC</article-title><source>Mol Cancer Res</source><year>2013</year><volume>11</volume><issue>12</issue><fpage>1574</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-13-0187</pub-id><pub-id pub-id-type="pmid">24048704</pub-id>
</element-citation><mixed-citation id="mc-CR235" publication-type="journal">Fletcher EV, Love-Homan L, Sobhakumari A, Feddersen CR, Koch AT, Goel A, et al. EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC. Mol Cancer Res. 2013;11(12):1574&#x02013;84. 10.1158/1541-7786.MCR-13-0187<pub-id pub-id-type="pmid">24048704</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR236"><label>236.</label><citation-alternatives><element-citation id="ec-CR236" publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasaki</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Takeyama</surname><given-names>H</given-names></name></person-group><article-title>Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction</article-title><source>Br J Cancer</source><year>2014</year><volume>110</volume><issue>2</issue><fpage>469</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/bjc.2013.748</pub-id><pub-id pub-id-type="pmid">24346288</pub-id>
</element-citation><mixed-citation id="mc-CR236" publication-type="journal">Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer. 2014;110(2):469&#x02013;78. 10.1038/bjc.2013.748<pub-id pub-id-type="pmid">24346288</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR237"><label>237.</label><citation-alternatives><element-citation id="ec-CR237" publication-type="journal"><person-group person-group-type="author"><name><surname>Coppe</surname><given-names>JP</given-names></name><name><surname>Patil</surname><given-names>CK</given-names></name><name><surname>Rodier</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Munoz</surname><given-names>DP</given-names></name><name><surname>Goldstein</surname><given-names>J</given-names></name><etal/></person-group><article-title>Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor</article-title><source>PLoS Biol</source><year>2008</year><volume>6</volume><issue>12</issue><fpage>2853</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0060301</pub-id><pub-id pub-id-type="pmid">19053174</pub-id>
</element-citation><mixed-citation id="mc-CR237" publication-type="journal">Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):2853&#x02013;68. 10.1371/journal.pbio.0060301<pub-id pub-id-type="pmid">19053174</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR238"><label>238.</label><citation-alternatives><element-citation id="ec-CR238" publication-type="journal"><person-group person-group-type="author"><name><surname>Sannigrahi</surname><given-names>MK</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Panda</surname><given-names>NK</given-names></name><name><surname>Khullar</surname><given-names>M</given-names></name></person-group><article-title>Role of autophagy in head and neck cancer and therapeutic resistance</article-title><source>Oral Dis</source><year>2015</year><volume>21</volume><issue>3</issue><fpage>283</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1111/odi.12254</pub-id><pub-id pub-id-type="pmid">24797102</pub-id>
</element-citation><mixed-citation id="mc-CR238" publication-type="journal">Sannigrahi MK, Singh V, Sharma R, Panda NK, Khullar M. Role of autophagy in head and neck cancer and therapeutic resistance. Oral Dis. 2015;21(3):283&#x02013;91. 10.1111/odi.12254<pub-id pub-id-type="pmid">24797102</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR239"><label>239.</label><citation-alternatives><element-citation id="ec-CR239" publication-type="journal"><person-group person-group-type="author"><name><surname>Sui</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Kong</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><issue>10</issue><fpage>e838</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.350</pub-id><pub-id pub-id-type="pmid">24113172</pub-id>
</element-citation><mixed-citation id="mc-CR239" publication-type="journal">Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4(10):e838. 10.1038/cddis.2013.350<pub-id pub-id-type="pmid">24113172</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR240"><label>240.</label><citation-alternatives><element-citation id="ec-CR240" publication-type="journal"><person-group person-group-type="author"><name><surname>Solitro</surname><given-names>AR</given-names></name><name><surname>MacKeigan</surname><given-names>JP</given-names></name></person-group><article-title>Leaving the lysosome behind: novel developments in autophagy inhibition</article-title><source>Future Med Chem</source><year>2016</year><volume>8</volume><issue>1</issue><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.4155/fmc.15.166</pub-id><pub-id pub-id-type="pmid">26689099</pub-id>
</element-citation><mixed-citation id="mc-CR240" publication-type="journal">Solitro AR, MacKeigan JP. Leaving the lysosome behind: novel developments in autophagy inhibition. Future Med Chem. 2016;8(1):73&#x02013;86. 10.4155/fmc.15.166<pub-id pub-id-type="pmid">26689099</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR241"><label>241.</label><mixed-citation publication-type="other">Vajda J, Milojevic M, Maver U, Vihar B. Microvascular tissue Engineering-A Review. Biomedicines. 2021;9(6). 10.3390/biomedicines9060589</mixed-citation></ref><ref id="CR242"><label>242.</label><citation-alternatives><element-citation id="ec-CR242" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC</article-title><source>Hepatology</source><year>2024</year><volume>79</volume><issue>4</issue><fpage>780</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1097/HEP.0000000000000599</pub-id><pub-id pub-id-type="pmid">37725755</pub-id>
</element-citation><mixed-citation id="mc-CR242" publication-type="journal">Chen S, Liao C, Hu H, Liao J, Chen Z, Li S, et al. Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC. Hepatology. 2024;79(4):780&#x02013;97. 10.1097/HEP.0000000000000599<pub-id pub-id-type="pmid">37725755</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR243"><label>243.</label><mixed-citation publication-type="other">Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022;132(11). 10.1172/JCI159839</mixed-citation></ref><ref id="CR244"><label>244.</label><citation-alternatives><element-citation id="ec-CR244" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Ruan</surname><given-names>W</given-names></name><name><surname>Bobrow</surname><given-names>B</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><article-title>Targeting hypoxia-inducible factors: therapeutic opportunities and challenges</article-title><source>Nat Rev Drug Discov</source><year>2024</year><volume>23</volume><issue>3</issue><fpage>175</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/s41573-023-00848-6</pub-id><pub-id pub-id-type="pmid">38123660</pub-id>
</element-citation><mixed-citation id="mc-CR244" publication-type="journal">Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2024;23(3):175&#x02013;200. 10.1038/s41573-023-00848-6<pub-id pub-id-type="pmid">38123660</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR245"><label>245.</label><citation-alternatives><element-citation id="ec-CR245" publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Tu</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Autocrine TGF-beta1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation</article-title><source>Cancer Lett</source><year>2019</year><volume>452</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2019.02.044</pub-id><pub-id pub-id-type="pmid">30851420</pub-id>
</element-citation><mixed-citation id="mc-CR245" publication-type="journal">Tang X, Tu G, Yang G, Wang X, Kang L, Yang L, et al. Autocrine TGF-beta1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation. Cancer Lett. 2019;452:79&#x02013;89. 10.1016/j.canlet.2019.02.044<pub-id pub-id-type="pmid">30851420</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR246"><label>246.</label><citation-alternatives><element-citation id="ec-CR246" publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>S</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin beta3-p38 MAPK signalling</article-title><source>Cancer Lett</source><year>2019</year><volume>442</volume><fpage>320</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2018.10.015</pub-id><pub-id pub-id-type="pmid">30391782</pub-id>
</element-citation><mixed-citation id="mc-CR246" publication-type="journal">Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin beta3-p38 MAPK signalling. Cancer Lett. 2019;442:320&#x02013;32. 10.1016/j.canlet.2018.10.015<pub-id pub-id-type="pmid">30391782</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR247"><label>247.</label><citation-alternatives><element-citation id="ec-CR247" publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion</article-title><source>J Extracell Vesicles</source><year>2021</year><volume>10</volume><issue>11</issue><fpage>e12146</fpage><pub-id pub-id-type="doi">10.1002/jev2.12146</pub-id><pub-id pub-id-type="pmid">34545708</pub-id>
</element-citation><mixed-citation id="mc-CR247" publication-type="journal">Xi L, Peng M, Liu S, Liu Y, Wan X, Hou Y, et al. Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion. J Extracell Vesicles. 2021;10(11):e12146. 10.1002/jev2.12146<pub-id pub-id-type="pmid">34545708</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR248"><label>248.</label><citation-alternatives><element-citation id="ec-CR248" publication-type="journal"><person-group person-group-type="author"><name><surname>Grunddal</surname><given-names>KV</given-names></name><name><surname>Tonack</surname><given-names>S</given-names></name><name><surname>Egerod</surname><given-names>KL</given-names></name><name><surname>Thompson</surname><given-names>JJ</given-names></name><name><surname>Petersen</surname><given-names>N</given-names></name><name><surname>Engelstoft</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Adhesion receptor ADGRG2/GPR64 is in the GI-tract selectively expressed in mature intestinal tuft cells</article-title><source>Mol Metab</source><year>2021</year><volume>51</volume><fpage>101231</fpage><pub-id pub-id-type="doi">10.1016/j.molmet.2021.101231</pub-id><pub-id pub-id-type="pmid">33831593</pub-id>
</element-citation><mixed-citation id="mc-CR248" publication-type="journal">Grunddal KV, Tonack S, Egerod KL, Thompson JJ, Petersen N, Engelstoft MS, et al. Adhesion receptor ADGRG2/GPR64 is in the GI-tract selectively expressed in mature intestinal tuft cells. Mol Metab. 2021;51:101231. 10.1016/j.molmet.2021.101231<pub-id pub-id-type="pmid">33831593</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR249"><label>249.</label><citation-alternatives><element-citation id="ec-CR249" publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>PL</given-names></name><name><surname>Huot</surname><given-names>J</given-names></name><name><surname>Auger</surname><given-names>FA</given-names></name></person-group><article-title>Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions</article-title><source>Cancer Res</source><year>2008</year><volume>68</volume><issue>13</issue><fpage>5167</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1229</pub-id><pub-id pub-id-type="pmid">18593916</pub-id>
</element-citation><mixed-citation id="mc-CR249" publication-type="journal">Tremblay PL, Huot J, Auger FA. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res. 2008;68(13):5167&#x02013;76. 10.1158/0008-5472.CAN-08-1229<pub-id pub-id-type="pmid">18593916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR250"><label>250.</label><citation-alternatives><element-citation id="ec-CR250" publication-type="journal"><person-group person-group-type="author"><name><surname>Woodward</surname><given-names>J</given-names></name></person-group><article-title>Crossing the endothelium: E-selectin regulates tumor cell migration under flow conditions</article-title><source>Cell Adh Migr</source><year>2008</year><volume>2</volume><issue>3</issue><fpage>151</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.4161/cam.2.3.6820</pub-id><pub-id pub-id-type="pmid">19262108</pub-id>
</element-citation><mixed-citation id="mc-CR250" publication-type="journal">Woodward J. Crossing the endothelium: E-selectin regulates tumor cell migration under flow conditions. Cell Adh Migr. 2008;2(3):151&#x02013;2. 10.4161/cam.2.3.6820<pub-id pub-id-type="pmid">19262108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR251"><label>251.</label><citation-alternatives><element-citation id="ec-CR251" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mechanical stress-dependent autophagy component release via Extracellular nanovesicles in Tumor cells</article-title><source>ACS Nano</source><year>2019</year><volume>13</volume><issue>4</issue><fpage>4589</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1021/acsnano.9b00587</pub-id><pub-id pub-id-type="pmid">30884224</pub-id>
</element-citation><mixed-citation id="mc-CR251" publication-type="journal">Wang K, Wei Y, Liu W, Liu L, Guo Z, Fan C, et al. Mechanical stress-dependent autophagy component release via Extracellular nanovesicles in Tumor cells. ACS Nano. 2019;13(4):4589&#x02013;602. 10.1021/acsnano.9b00587<pub-id pub-id-type="pmid">30884224</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR252"><label>252.</label><citation-alternatives><element-citation id="ec-CR252" publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Lombardi</surname><given-names>M</given-names></name><name><surname>Prada</surname><given-names>I</given-names></name><name><surname>Gabrielli</surname><given-names>M</given-names></name><name><surname>Joshi</surname><given-names>P</given-names></name><name><surname>Cojoc</surname><given-names>D</given-names></name><etal/></person-group><article-title>ATP modifies the Proteome of Extracellular vesicles released by Microglia and influences their action on astrocytes</article-title><source>Front Pharmacol</source><year>2017</year><volume>8</volume><fpage>910</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00910</pub-id><pub-id pub-id-type="pmid">29321741</pub-id>
</element-citation><mixed-citation id="mc-CR252" publication-type="journal">Drago F, Lombardi M, Prada I, Gabrielli M, Joshi P, Cojoc D, et al. ATP modifies the Proteome of Extracellular vesicles released by Microglia and influences their action on astrocytes. Front Pharmacol. 2017;8:910. 10.3389/fphar.2017.00910<pub-id pub-id-type="pmid">29321741</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR253"><label>253.</label><citation-alternatives><element-citation id="ec-CR253" publication-type="journal"><person-group person-group-type="author"><name><surname>McKnight</surname><given-names>KL</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Gonzalez-Lopez</surname><given-names>O</given-names></name><name><surname>Rivera-Serrano</surname><given-names>EE</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Lemon</surname><given-names>SM</given-names></name></person-group><article-title>Protein composition of the hepatitis a virus quasi-envelope</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><issue>25</issue><fpage>6587</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1073/pnas.1619519114</pub-id><pub-id pub-id-type="pmid">28490497</pub-id>
</element-citation><mixed-citation id="mc-CR253" publication-type="journal">McKnight KL, Xie L, Gonzalez-Lopez O, Rivera-Serrano EE, Chen X, Lemon SM. Protein composition of the hepatitis a virus quasi-envelope. Proc Natl Acad Sci U S A. 2017;114(25):6587&#x02013;92. 10.1073/pnas.1619519114<pub-id pub-id-type="pmid">28490497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR254"><label>254.</label><citation-alternatives><element-citation id="ec-CR254" publication-type="journal"><person-group person-group-type="author"><name><surname>Pallet</surname><given-names>N</given-names></name><name><surname>Sirois</surname><given-names>I</given-names></name><name><surname>Bell</surname><given-names>C</given-names></name><name><surname>Hanafi</surname><given-names>LA</given-names></name><name><surname>Hamelin</surname><given-names>K</given-names></name><name><surname>Dieude</surname><given-names>M</given-names></name><etal/></person-group><article-title>A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells</article-title><source>Proteomics</source><year>2013</year><volume>13</volume><issue>7</issue><fpage>1108</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/pmic.201200531</pub-id><pub-id pub-id-type="pmid">23436686</pub-id>
</element-citation><mixed-citation id="mc-CR254" publication-type="journal">Pallet N, Sirois I, Bell C, Hanafi LA, Hamelin K, Dieude M, et al. A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics. 2013;13(7):1108&#x02013;20. 10.1002/pmic.201200531<pub-id pub-id-type="pmid">23436686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR255"><label>255.</label><citation-alternatives><element-citation id="ec-CR255" publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>R</given-names></name><name><surname>Kaushik</surname><given-names>S</given-names></name><name><surname>Clement</surname><given-names>CC</given-names></name><name><surname>Cannizzo</surname><given-names>ES</given-names></name><name><surname>Scharf</surname><given-names>B</given-names></name><name><surname>Follenzi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Microautophagy of cytosolic proteins by late endosomes</article-title><source>Dev Cell</source><year>2011</year><volume>20</volume><issue>1</issue><fpage>131</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.12.003</pub-id><pub-id pub-id-type="pmid">21238931</pub-id>
</element-citation><mixed-citation id="mc-CR255" publication-type="journal">Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A, et al. Microautophagy of cytosolic proteins by late endosomes. Dev Cell. 2011;20(1):131&#x02013;9. 10.1016/j.devcel.2010.12.003<pub-id pub-id-type="pmid">21238931</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR256"><label>256.</label><citation-alternatives><element-citation id="ec-CR256" publication-type="journal"><person-group person-group-type="author"><name><surname>Skog</surname><given-names>J</given-names></name><name><surname>Wurdinger</surname><given-names>T</given-names></name><name><surname>van Rijn</surname><given-names>S</given-names></name><name><surname>Meijer</surname><given-names>DH</given-names></name><name><surname>Gainche</surname><given-names>L</given-names></name><name><surname>Sena-Esteves</surname><given-names>M</given-names></name><etal/></person-group><article-title>Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><issue>12</issue><fpage>1470</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/ncb1800</pub-id><pub-id pub-id-type="pmid">19011622</pub-id>
</element-citation><mixed-citation id="mc-CR256" publication-type="journal">Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470&#x02013;6. 10.1038/ncb1800<pub-id pub-id-type="pmid">19011622</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR257"><label>257.</label><citation-alternatives><element-citation id="ec-CR257" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>YX</given-names></name><name><surname>Bu</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><etal/></person-group><article-title>Piezo1 channel activation stimulates ATP production through enhancing mitochondrial respiration and glycolysis in vascular endothelial cells</article-title><source>Br J Pharmacol</source><year>2023</year><volume>180</volume><issue>14</issue><fpage>1862</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/bph.16050</pub-id><pub-id pub-id-type="pmid">36740831</pub-id>
</element-citation><mixed-citation id="mc-CR257" publication-type="journal">Jiang M, Zhang YX, Bu WJ, Li P, Chen JH, Cao M, et al. Piezo1 channel activation stimulates ATP production through enhancing mitochondrial respiration and glycolysis in vascular endothelial cells. Br J Pharmacol. 2023;180(14):1862&#x02013;77. 10.1111/bph.16050<pub-id pub-id-type="pmid">36740831</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR258"><label>258.</label><mixed-citation publication-type="other">Swain SM, Liddle RA. Mechanosensing Piezo channels in gastrointestinal disorders. J Clin Invest. 2023;133(19). 10.1172/JCI171955</mixed-citation></ref><ref id="CR259"><label>259.</label><citation-alternatives><element-citation id="ec-CR259" publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Qiao</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Qian</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Shear stress activates the Piezo1 channel to facilitate valvular endothelium-oriented differentiation and maturation of human induced pluripotent stem cells</article-title><source>Acta Biomater</source><year>2024</year><volume>178</volume><fpage>181</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2024.02.043</pub-id><pub-id pub-id-type="pmid">38447808</pub-id>
</element-citation><mixed-citation id="mc-CR259" publication-type="journal">Xie M, Cao H, Qiao W, Yan G, Qian X, Zhang Y, et al. Shear stress activates the Piezo1 channel to facilitate valvular endothelium-oriented differentiation and maturation of human induced pluripotent stem cells. Acta Biomater. 2024;178:181&#x02013;95. 10.1016/j.actbio.2024.02.043<pub-id pub-id-type="pmid">38447808</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR260"><label>260.</label><citation-alternatives><element-citation id="ec-CR260" publication-type="journal"><person-group person-group-type="author"><name><surname>Morad</surname><given-names>G</given-names></name><name><surname>Helmink</surname><given-names>BA</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Wargo</surname><given-names>JA</given-names></name></person-group><article-title>Hallmarks of response, resistance, and toxicity to immune checkpoint blockade</article-title><source>Cell</source><year>2021</year><volume>184</volume><issue>21</issue><fpage>5309</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.09.020</pub-id><pub-id pub-id-type="pmid">34624224</pub-id>
</element-citation><mixed-citation id="mc-CR260" publication-type="journal">Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2021;184(21):5309&#x02013;37. 10.1016/j.cell.2021.09.020<pub-id pub-id-type="pmid">34624224</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR261"><label>261.</label><citation-alternatives><element-citation id="ec-CR261" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Goswami</surname><given-names>S</given-names></name><name><surname>Raychaudhuri</surname><given-names>D</given-names></name><name><surname>Siddiqui</surname><given-names>BA</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Nagarajan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Immune checkpoint therapy-current perspectives and future directions</article-title><source>Cell</source><year>2023</year><volume>186</volume><issue>8</issue><fpage>1652</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.03.006</pub-id><pub-id pub-id-type="pmid">37059068</pub-id>
</element-citation><mixed-citation id="mc-CR261" publication-type="journal">Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, et al. Immune checkpoint therapy-current perspectives and future directions. Cell. 2023;186(8):1652&#x02013;69. 10.1016/j.cell.2023.03.006<pub-id pub-id-type="pmid">37059068</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR262"><label>262.</label><citation-alternatives><element-citation id="ec-CR262" publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>EW</given-names></name><name><surname>Maus</surname><given-names>MV</given-names></name><name><surname>Mackall</surname><given-names>CL</given-names></name></person-group><article-title>The Emerging Landscape of Immune Cell therapies</article-title><source>Cell</source><year>2020</year><volume>181</volume><issue>1</issue><fpage>46</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.03.001</pub-id><pub-id pub-id-type="pmid">32243795</pub-id>
</element-citation><mixed-citation id="mc-CR262" publication-type="journal">Weber EW, Maus MV, Mackall CL. The Emerging Landscape of Immune Cell therapies. Cell. 2020;181(1):46&#x02013;62. 10.1016/j.cell.2020.03.001<pub-id pub-id-type="pmid">32243795</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR263"><label>263.</label><citation-alternatives><element-citation id="ec-CR263" publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>CE</given-names></name><name><surname>Hingorani</surname><given-names>SR</given-names></name><name><surname>Mick</surname><given-names>R</given-names></name><name><surname>Combs</surname><given-names>C</given-names></name><name><surname>Tuveson</surname><given-names>DA</given-names></name><name><surname>Vonderheide</surname><given-names>RH</given-names></name></person-group><article-title>Dynamics of the immune reaction to pancreatic cancer from inception to invasion</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><issue>19</issue><fpage>9518</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-0175</pub-id><pub-id pub-id-type="pmid">17909062</pub-id>
</element-citation><mixed-citation id="mc-CR263" publication-type="journal">Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 2007;67(19):9518&#x02013;27. 10.1158/0008-5472.CAN-07-0175<pub-id pub-id-type="pmid">17909062</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR264"><label>264.</label><citation-alternatives><element-citation id="ec-CR264" publication-type="journal"><person-group person-group-type="author"><name><surname>Inman</surname><given-names>KS</given-names></name><name><surname>Francis</surname><given-names>AA</given-names></name><name><surname>Murray</surname><given-names>NR</given-names></name></person-group><article-title>Complex role for the immune system in initiation and progression of pancreatic cancer</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><issue>32</issue><fpage>11160</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i32.11160</pub-id><pub-id pub-id-type="pmid">25170202</pub-id>
</element-citation><mixed-citation id="mc-CR264" publication-type="journal">Inman KS, Francis AA, Murray NR. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol. 2014;20(32):11160&#x02013;81. 10.3748/wjg.v20.i32.11160<pub-id pub-id-type="pmid">25170202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR265"><label>265.</label><mixed-citation publication-type="other">Cotzomi-Ortega I, Rosas-Cruz A, Ramirez-Ramirez D, Reyes-Leyva J, Rodriguez-Sosa M, Aguilar-Alonso P, et al. Autophagy inhibition induces the secretion of Macrophage Migration Inhibitory factor (MIF) with Autocrine and Paracrine effects on the Promotion of Malignancy in breast Cancer. Biology (Basel). 2020;9(1). 10.3390/biology9010020</mixed-citation></ref><ref id="CR266"><label>266.</label><citation-alternatives><element-citation id="ec-CR266" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JP</given-names></name><name><surname>Foote</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Peral de Castro</surname><given-names>C</given-names></name><name><surname>Lang</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Loss of autophagy enhances MIF/macrophage migration inhibitory factor release by macrophages</article-title><source>Autophagy</source><year>2016</year><volume>12</volume><issue>6</issue><fpage>907</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1080/15548627.2016.1164358</pub-id><pub-id pub-id-type="pmid">27163877</pub-id>
</element-citation><mixed-citation id="mc-CR266" publication-type="journal">Lee JP, Foote A, Fan H, Peral de Castro C, Lang T, Jones SA, et al. Loss of autophagy enhances MIF/macrophage migration inhibitory factor release by macrophages. Autophagy. 2016;12(6):907&#x02013;16. 10.1080/15548627.2016.1164358<pub-id pub-id-type="pmid">27163877</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR267"><label>267.</label><citation-alternatives><element-citation id="ec-CR267" publication-type="journal"><person-group person-group-type="author"><name><surname>Calandra</surname><given-names>T</given-names></name><name><surname>Roger</surname><given-names>T</given-names></name></person-group><article-title>Macrophage migration inhibitory factor: a regulator of innate immunity</article-title><source>Nat Rev Immunol</source><year>2003</year><volume>3</volume><issue>10</issue><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1038/nri1200</pub-id><pub-id pub-id-type="pmid">14502271</pub-id>
</element-citation><mixed-citation id="mc-CR267" publication-type="journal">Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791&#x02013;800. 10.1038/nri1200<pub-id pub-id-type="pmid">14502271</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR268"><label>268.</label><citation-alternatives><element-citation id="ec-CR268" publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Reilly</surname><given-names>C</given-names></name><name><surname>Doroudian</surname><given-names>M</given-names></name><name><surname>Mawhinney</surname><given-names>L</given-names></name><name><surname>Donnelly</surname><given-names>SC</given-names></name></person-group><article-title>Targeting MIF in Cancer: therapeutic strategies, current developments, and Future opportunities</article-title><source>Med Res Rev</source><year>2016</year><volume>36</volume><issue>3</issue><fpage>440</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1002/med.21385</pub-id><pub-id pub-id-type="pmid">26777977</pub-id>
</element-citation><mixed-citation id="mc-CR268" publication-type="journal">O&#x02019;Reilly C, Doroudian M, Mawhinney L, Donnelly SC. Targeting MIF in Cancer: therapeutic strategies, current developments, and Future opportunities. Med Res Rev. 2016;36(3):440&#x02013;60. 10.1002/med.21385<pub-id pub-id-type="pmid">26777977</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR269"><label>269.</label><citation-alternatives><element-citation id="ec-CR269" publication-type="journal"><person-group person-group-type="author"><name><surname>Lisboa</surname><given-names>J</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Pinto</surname><given-names>RD</given-names></name><name><surname>Rodrigues</surname><given-names>IS</given-names></name><name><surname>Pereira</surname><given-names>LMG</given-names></name><name><surname>Pinheiro</surname><given-names>B</given-names></name><etal/></person-group><article-title>Unconventional structure and mechanisms for membrane interaction and translocation of the NF-kappaB-targeting toxin AIP56</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><issue>1</issue><fpage>7431</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-43054-z</pub-id><pub-id pub-id-type="pmid">37973928</pub-id>
</element-citation><mixed-citation id="mc-CR269" publication-type="journal">Lisboa J, Pereira C, Pinto RD, Rodrigues IS, Pereira LMG, Pinheiro B, et al. Unconventional structure and mechanisms for membrane interaction and translocation of the NF-kappaB-targeting toxin AIP56. Nat Commun. 2023;14(1):7431. 10.1038/s41467-023-43054-z<pub-id pub-id-type="pmid">37973928</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR270"><label>270.</label><citation-alternatives><element-citation id="ec-CR270" publication-type="journal"><person-group person-group-type="author"><name><surname>Flieger</surname><given-names>O</given-names></name><name><surname>Engling</surname><given-names>A</given-names></name><name><surname>Bucala</surname><given-names>R</given-names></name><name><surname>Lue</surname><given-names>H</given-names></name><name><surname>Nickel</surname><given-names>W</given-names></name><name><surname>Bernhagen</surname><given-names>J</given-names></name></person-group><article-title>Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter</article-title><source>FEBS Lett</source><year>2003</year><volume>551</volume><issue>1&#x02013;3</issue><fpage>78</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(03)00900-1</pub-id><pub-id pub-id-type="pmid">12965208</pub-id>
</element-citation><mixed-citation id="mc-CR270" publication-type="journal">Flieger O, Engling A, Bucala R, Lue H, Nickel W, Bernhagen J. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 2003;551(1&#x02013;3):78&#x02013;86. 10.1016/s0014-5793(03)00900-1<pub-id pub-id-type="pmid">12965208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR271"><label>271.</label><citation-alternatives><element-citation id="ec-CR271" publication-type="journal"><person-group person-group-type="author"><name><surname>Merk</surname><given-names>M</given-names></name><name><surname>Baugh</surname><given-names>J</given-names></name><name><surname>Zierow</surname><given-names>S</given-names></name><name><surname>Leng</surname><given-names>L</given-names></name><name><surname>Pal</surname><given-names>U</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>The golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><issue>11</issue><fpage>6896</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803710</pub-id><pub-id pub-id-type="pmid">19454686</pub-id>
</element-citation><mixed-citation id="mc-CR271" publication-type="journal">Merk M, Baugh J, Zierow S, Leng L, Pal U, Lee SJ, et al. The golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. J Immunol. 2009;182(11):6896&#x02013;906. 10.4049/jimmunol.0803710<pub-id pub-id-type="pmid">19454686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR272"><label>272.</label><citation-alternatives><element-citation id="ec-CR272" publication-type="journal"><person-group person-group-type="author"><name><surname>Pylayeva-Gupta</surname><given-names>Y</given-names></name><name><surname>Grabocka</surname><given-names>E</given-names></name><name><surname>Bar-Sagi</surname><given-names>D</given-names></name></person-group><article-title>RAS oncogenes: weaving a tumorigenic web</article-title><source>Nat Rev Cancer</source><year>2011</year><volume>11</volume><issue>11</issue><fpage>761</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nrc3106</pub-id><pub-id pub-id-type="pmid">21993244</pub-id>
</element-citation><mixed-citation id="mc-CR272" publication-type="journal">Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer. 2011;11(11):761&#x02013;74. 10.1038/nrc3106<pub-id pub-id-type="pmid">21993244</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR273"><label>273.</label><citation-alternatives><element-citation id="ec-CR273" publication-type="journal"><person-group person-group-type="author"><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Marchesi</surname><given-names>F</given-names></name><name><surname>Malesci</surname><given-names>A</given-names></name><name><surname>Laghi</surname><given-names>L</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name></person-group><article-title>Tumour-associated macrophages as treatment targets in oncology</article-title><source>Nat Rev Clin Oncol</source><year>2017</year><volume>14</volume><issue>7</issue><fpage>399</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2016.217</pub-id><pub-id pub-id-type="pmid">28117416</pub-id>
</element-citation><mixed-citation id="mc-CR273" publication-type="journal">Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399&#x02013;416. 10.1038/nrclinonc.2016.217<pub-id pub-id-type="pmid">28117416</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR274"><label>274.</label><citation-alternatives><element-citation id="ec-CR274" publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>E</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein</article-title><source>Autophagy</source><year>2020</year><volume>16</volume><issue>11</issue><fpage>2069</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1714209</pub-id><pub-id pub-id-type="pmid">31920150</pub-id>
</element-citation><mixed-citation id="mc-CR274" publication-type="journal">Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16(11):2069&#x02013;83. 10.1080/15548627.2020.1714209<pub-id pub-id-type="pmid">31920150</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR275"><label>275.</label><citation-alternatives><element-citation id="ec-CR275" publication-type="journal"><person-group person-group-type="author"><name><surname>Azizan</surname><given-names>N</given-names></name><name><surname>Suter</surname><given-names>MA</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Logsdon</surname><given-names>CD</given-names></name></person-group><article-title>RAGE maintains high levels of NFkappaB and oncogenic kras activity in pancreatic cancer</article-title><source>Biochem Biophys Res Commun</source><year>2017</year><volume>493</volume><issue>1</issue><fpage>592</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.08.147</pub-id><pub-id pub-id-type="pmid">28867179</pub-id>
</element-citation><mixed-citation id="mc-CR275" publication-type="journal">Azizan N, Suter MA, Liu Y, Logsdon CD. RAGE maintains high levels of NFkappaB and oncogenic kras activity in pancreatic cancer. Biochem Biophys Res Commun. 2017;493(1):592&#x02013;7. 10.1016/j.bbrc.2017.08.147<pub-id pub-id-type="pmid">28867179</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR276"><label>276.</label><citation-alternatives><element-citation id="ec-CR276" publication-type="journal"><person-group person-group-type="author"><name><surname>DiNorcia</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Moroziewicz</surname><given-names>DN</given-names></name><name><surname>Winner</surname><given-names>M</given-names></name><name><surname>Suman</surname><given-names>P</given-names></name><name><surname>Bao</surname><given-names>F</given-names></name><etal/></person-group><article-title>RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer</article-title><source>J Gastrointest Surg</source><year>2012</year><volume>16</volume><issue>1</issue><fpage>104</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s11605-011-1754-9</pub-id><pub-id pub-id-type="pmid">22052106</pub-id>
</element-citation><mixed-citation id="mc-CR276" publication-type="journal">DiNorcia J, Lee MK, Moroziewicz DN, Winner M, Suman P, Bao F, et al. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. J Gastrointest Surg. 2012;16(1):104&#x02013;12. 10.1007/s11605-011-1754-9. discussion 12.<pub-id pub-id-type="pmid">22052106</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR277"><label>277.</label><citation-alternatives><element-citation id="ec-CR277" publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>R</given-names></name><name><surname>Loux</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Schapiro</surname><given-names>NE</given-names></name><name><surname>Vernon</surname><given-names>P</given-names></name><name><surname>Livesey</surname><given-names>KM</given-names></name><etal/></person-group><article-title>The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><issue>18</issue><fpage>7031</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113865109</pub-id><pub-id pub-id-type="pmid">22509024</pub-id>
</element-citation><mixed-citation id="mc-CR277" publication-type="journal">Kang R, Loux T, Tang D, Schapiro NE, Vernon P, Livesey KM, et al. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc Natl Acad Sci U S A. 2012;109(18):7031&#x02013;6. 10.1073/pnas.1113865109<pub-id pub-id-type="pmid">22509024</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR278"><label>278.</label><citation-alternatives><element-citation id="ec-CR278" publication-type="journal"><person-group person-group-type="author"><name><surname>Kinseth</surname><given-names>MA</given-names></name><name><surname>Anjard</surname><given-names>C</given-names></name><name><surname>Fuller</surname><given-names>D</given-names></name><name><surname>Guizzunti</surname><given-names>G</given-names></name><name><surname>Loomis</surname><given-names>WF</given-names></name><name><surname>Malhotra</surname><given-names>V</given-names></name></person-group><article-title>The golgi-associated protein GRASP is required for unconventional protein secretion during development</article-title><source>Cell</source><year>2007</year><volume>130</volume><issue>3</issue><fpage>524</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.06.029</pub-id><pub-id pub-id-type="pmid">17655921</pub-id>
</element-citation><mixed-citation id="mc-CR278" publication-type="journal">Kinseth MA, Anjard C, Fuller D, Guizzunti G, Loomis WF, Malhotra V. The golgi-associated protein GRASP is required for unconventional protein secretion during development. Cell. 2007;130(3):524&#x02013;34. 10.1016/j.cell.2007.06.029<pub-id pub-id-type="pmid">17655921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR279"><label>279.</label><citation-alternatives><element-citation id="ec-CR279" publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><etal/></person-group><article-title>HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><issue>12</issue><fpage>2155</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1501134</pub-id><pub-id pub-id-type="pmid">30205729</pub-id>
</element-citation><mixed-citation id="mc-CR279" publication-type="journal">Luo P, Xu Z, Li G, Yan H, Zhu Y, Zhu H, et al. HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport. Autophagy. 2018;14(12):2155&#x02013;70. 10.1080/15548627.2018.1501134<pub-id pub-id-type="pmid">30205729</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR280"><label>280.</label><citation-alternatives><element-citation id="ec-CR280" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies</article-title><source>J Hematol Oncol</source><year>2020</year><volume>13</volume><issue>1</issue><fpage>91</fpage><pub-id pub-id-type="doi">10.1186/s13045-020-00920-3</pub-id><pub-id pub-id-type="pmid">32660524</pub-id>
</element-citation><mixed-citation id="mc-CR280" publication-type="journal">Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol. 2020;13(1):91. 10.1186/s13045-020-00920-3<pub-id pub-id-type="pmid">32660524</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR281"><label>281.</label><citation-alternatives><element-citation id="ec-CR281" publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>SH</given-names></name><name><surname>Gee</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Piao</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Specific autophagy and ESCRT components participate in the unconventional secretion of CFTR</article-title><source>Autophagy</source><year>2018</year><volume>14</volume><issue>10</issue><fpage>1761</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1489479</pub-id><pub-id pub-id-type="pmid">29969945</pub-id>
</element-citation><mixed-citation id="mc-CR281" publication-type="journal">Noh SH, Gee HY, Kim Y, Piao H, Kim J, Kang CM, et al. Specific autophagy and ESCRT components participate in the unconventional secretion of CFTR. Autophagy. 2018;14(10):1761&#x02013;78. 10.1080/15548627.2018.1489479<pub-id pub-id-type="pmid">29969945</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR282"><label>282.</label><citation-alternatives><element-citation id="ec-CR282" publication-type="journal"><person-group person-group-type="author"><name><surname>Piao</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Noh</surname><given-names>SH</given-names></name><name><surname>Kweon</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>MG</given-names></name></person-group><article-title>Sec16A is critical for both conventional and unconventional secretion of CFTR</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>39887</fpage><pub-id pub-id-type="doi">10.1038/srep39887</pub-id><pub-id pub-id-type="pmid">28067262</pub-id>
</element-citation><mixed-citation id="mc-CR282" publication-type="journal">Piao H, Kim J, Noh SH, Kweon HS, Kim JY, Lee MG. Sec16A is critical for both conventional and unconventional secretion of CFTR. Sci Rep. 2017;7:39887. 10.1038/srep39887<pub-id pub-id-type="pmid">28067262</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR283"><label>283.</label><citation-alternatives><element-citation id="ec-CR283" publication-type="journal"><person-group person-group-type="author"><name><surname>Murrow</surname><given-names>L</given-names></name><name><surname>Debnath</surname><given-names>J</given-names></name></person-group><article-title>ATG12-ATG3 connects basal autophagy and late endosome function</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><issue>6</issue><fpage>961</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1040976</pub-id><pub-id pub-id-type="pmid">25998418</pub-id>
</element-citation><mixed-citation id="mc-CR283" publication-type="journal">Murrow L, Debnath J. ATG12-ATG3 connects basal autophagy and late endosome function. Autophagy. 2015;11(6):961&#x02013;2. 10.1080/15548627.2015.1040976<pub-id pub-id-type="pmid">25998418</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR284"><label>284.</label><citation-alternatives><element-citation id="ec-CR284" publication-type="journal"><person-group person-group-type="author"><name><surname>Murrow</surname><given-names>L</given-names></name><name><surname>Malhotra</surname><given-names>R</given-names></name><name><surname>Debnath</surname><given-names>J</given-names></name></person-group><article-title>ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function</article-title><source>Nat Cell Biol</source><year>2015</year><volume>17</volume><issue>3</issue><fpage>300</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/ncb3112</pub-id><pub-id pub-id-type="pmid">25686249</pub-id>
</element-citation><mixed-citation id="mc-CR284" publication-type="journal">Murrow L, Malhotra R, Debnath J. ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 2015;17(3):300&#x02013;10. 10.1038/ncb3112<pub-id pub-id-type="pmid">25686249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR285"><label>285.</label><citation-alternatives><element-citation id="ec-CR285" publication-type="journal"><person-group person-group-type="author"><name><surname>Karmakar</surname><given-names>M</given-names></name><name><surname>Minns</surname><given-names>M</given-names></name><name><surname>Greenberg</surname><given-names>EN</given-names></name><name><surname>Diaz-Aponte</surname><given-names>J</given-names></name><name><surname>Pestonjamasp</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><etal/></person-group><article-title>N-GSDMD trafficking to neutrophil organelles facilitates IL-1beta release independently of plasma membrane pores and pyroptosis</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><issue>1</issue><fpage>2212</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-16043-9</pub-id><pub-id pub-id-type="pmid">32371889</pub-id>
</element-citation><mixed-citation id="mc-CR285" publication-type="journal">Karmakar M, Minns M, Greenberg EN, Diaz-Aponte J, Pestonjamasp K, Johnson JL, et al. N-GSDMD trafficking to neutrophil organelles facilitates IL-1beta release independently of plasma membrane pores and pyroptosis. Nat Commun. 2020;11(1):2212. 10.1038/s41467-020-16043-9<pub-id pub-id-type="pmid">32371889</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR286"><label>286.</label><citation-alternatives><element-citation id="ec-CR286" publication-type="journal"><person-group person-group-type="author"><name><surname>Kraya</surname><given-names>AA</given-names></name><name><surname>Piao</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Herlyn</surname><given-names>M</given-names></name><name><surname>Gimotty</surname><given-names>P</given-names></name><etal/></person-group><article-title>Identification of secreted proteins that reflect autophagy dynamics within tumor cells</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><issue>1</issue><fpage>60</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.4161/15548627.2014.984273</pub-id><pub-id pub-id-type="pmid">25484078</pub-id>
</element-citation><mixed-citation id="mc-CR286" publication-type="journal">Kraya AA, Piao S, Xu X, Zhang G, Herlyn M, Gimotty P, et al. Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy. 2015;11(1):60&#x02013;74. 10.4161/15548627.2014.984273<pub-id pub-id-type="pmid">25484078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR287"><label>287.</label><citation-alternatives><element-citation id="ec-CR287" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Van Grol</surname><given-names>J</given-names></name><name><surname>Subauste</surname><given-names>CS</given-names></name></person-group><article-title>Atg5 but not Atg7 in dendritic cells enhances IL-2 and IFN-gamma production by Toxoplasma gondii-reactive CD4&#x02009;+&#x02009;T cells</article-title><source>Microbes Infect</source><year>2015</year><volume>17</volume><issue>4</issue><fpage>275</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2014.12.008</pub-id><pub-id pub-id-type="pmid">25578385</pub-id>
</element-citation><mixed-citation id="mc-CR287" publication-type="journal">Liu E, Van Grol J, Subauste CS. Atg5 but not Atg7 in dendritic cells enhances IL-2 and IFN-gamma production by Toxoplasma gondii-reactive CD4&#x02009;+&#x02009;T cells. Microbes Infect. 2015;17(4):275&#x02013;84. 10.1016/j.micinf.2014.12.008<pub-id pub-id-type="pmid">25578385</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR288"><label>288.</label><citation-alternatives><element-citation id="ec-CR288" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ouyang</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>Q</given-names></name><etal/></person-group><article-title>SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1beta and contributes to LIPUS-mediated anti-inflammatory effect</article-title><source>Autophagy</source><year>2020</year><volume>16</volume><issue>7</issue><fpage>1262</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1080/15548627.2019.1664705</pub-id><pub-id pub-id-type="pmid">31500508</pub-id>
</element-citation><mixed-citation id="mc-CR288" publication-type="journal">Zhang B, Chen H, Ouyang J, Xie Y, Chen L, Tan Q, et al. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1beta and contributes to LIPUS-mediated anti-inflammatory effect. Autophagy. 2020;16(7):1262&#x02013;78. 10.1080/15548627.2019.1664705<pub-id pub-id-type="pmid">31500508</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR289"><label>289.</label><citation-alternatives><element-citation id="ec-CR289" publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>YY</given-names></name><name><surname>Pan</surname><given-names>YQ</given-names></name><name><surname>Zheng</surname><given-names>XJ</given-names></name><name><surname>Liao</surname><given-names>K</given-names></name><name><surname>Mo</surname><given-names>HY</given-names></name><etal/></person-group><article-title>IL-1beta-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance</article-title><source>Mol Cell</source><year>2023</year><volume>83</volume><issue>11</issue><fpage>1887</fpage><lpage>e9028</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.05.011</pub-id><pub-id pub-id-type="pmid">37244254</pub-id>
</element-citation><mixed-citation id="mc-CR289" publication-type="journal">Han Y, Zhang YY, Pan YQ, Zheng XJ, Liao K, Mo HY, et al. IL-1beta-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Mol Cell. 2023;83(11):1887&#x02013;e9028. 10.1016/j.molcel.2023.05.011<pub-id pub-id-type="pmid">37244254</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR290"><label>290.</label><citation-alternatives><element-citation id="ec-CR290" publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>AM</given-names></name><name><surname>Pesic</surname><given-names>M</given-names></name><name><surname>Engel</surname><given-names>E</given-names></name><name><surname>Ziegler</surname><given-names>PK</given-names></name><name><surname>Diefenhardt</surname><given-names>M</given-names></name><name><surname>Kennel</surname><given-names>KB</given-names></name><etal/></person-group><article-title>Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer</article-title><source>Cancer Cell</source><year>2022</year><volume>40</volume><issue>2</issue><fpage>168</fpage><lpage>e8413</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2022.01.004</pub-id><pub-id pub-id-type="pmid">35120600</pub-id>
</element-citation><mixed-citation id="mc-CR290" publication-type="journal">Nicolas AM, Pesic M, Engel E, Ziegler PK, Diefenhardt M, Kennel KB, et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. Cancer Cell. 2022;40(2):168&#x02013;e8413. 10.1016/j.ccell.2022.01.004<pub-id pub-id-type="pmid">35120600</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR291"><label>291.</label><citation-alternatives><element-citation id="ec-CR291" publication-type="journal"><person-group person-group-type="author"><name><surname>Loriot</surname><given-names>Y</given-names></name><name><surname>Marabelle</surname><given-names>A</given-names></name><name><surname>Guegan</surname><given-names>JP</given-names></name><name><surname>Danlos</surname><given-names>FX</given-names></name><name><surname>Besse</surname><given-names>B</given-names></name><name><surname>Chaput</surname><given-names>N</given-names></name><etal/></person-group><article-title>Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance</article-title><source>Ann Oncol</source><year>2021</year><volume>32</volume><issue>11</issue><fpage>1381</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.annonc.2021.08.1748</pub-id><pub-id pub-id-type="pmid">34416362</pub-id>
</element-citation><mixed-citation id="mc-CR291" publication-type="journal">Loriot Y, Marabelle A, Guegan JP, Danlos FX, Besse B, Chaput N, et al. Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance. Ann Oncol. 2021;32(11):1381&#x02013;90. 10.1016/j.annonc.2021.08.1748<pub-id pub-id-type="pmid">34416362</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR292"><label>292.</label><citation-alternatives><element-citation id="ec-CR292" publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lytle</surname><given-names>NK</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Dann</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring</article-title><source>Nature</source><year>2019</year><volume>569</volume><issue>7754</issue><fpage>131</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1130-6</pub-id><pub-id pub-id-type="pmid">30996350</pub-id>
</element-citation><mixed-citation id="mc-CR292" publication-type="journal">Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019;569(7754):131&#x02013;5. 10.1038/s41586-019-1130-6<pub-id pub-id-type="pmid">30996350</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR293"><label>293.</label><citation-alternatives><element-citation id="ec-CR293" publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>S</given-names></name><name><surname>Tavshanjian</surname><given-names>B</given-names></name><name><surname>Oleksy</surname><given-names>A</given-names></name><name><surname>Perisic</surname><given-names>O</given-names></name><name><surname>Houseman</surname><given-names>BT</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34</article-title><source>Science</source><year>2010</year><volume>327</volume><issue>5973</issue><fpage>1638</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1126/science.1184429</pub-id><pub-id pub-id-type="pmid">20339072</pub-id>
</element-citation><mixed-citation id="mc-CR293" publication-type="journal">Miller S, Tavshanjian B, Oleksy A, Perisic O, Houseman BT, Shokat KM, et al. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science. 2010;327(5973):1638&#x02013;42. 10.1126/science.1184429<pub-id pub-id-type="pmid">20339072</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR294"><label>294.</label><citation-alternatives><element-citation id="ec-CR294" publication-type="journal"><person-group person-group-type="author"><name><surname>Akin</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>SK</given-names></name><name><surname>Habibzadegah-Tari</surname><given-names>P</given-names></name><name><surname>Law</surname><given-names>B</given-names></name><name><surname>Ostrov</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors</article-title><source>Autophagy</source><year>2014</year><volume>10</volume><issue>11</issue><fpage>2021</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.4161/auto.32229</pub-id><pub-id pub-id-type="pmid">25483883</pub-id>
</element-citation><mixed-citation id="mc-CR294" publication-type="journal">Akin D, Wang SK, Habibzadegah-Tari P, Law B, Ostrov D, Li M, et al. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy. 2014;10(11):2021&#x02013;35. 10.4161/auto.32229<pub-id pub-id-type="pmid">25483883</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR295"><label>295.</label><citation-alternatives><element-citation id="ec-CR295" publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Z</given-names></name><name><surname>Kuhn</surname><given-names>B</given-names></name><name><surname>Aebi</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Discovery of Fluoromethylketone-based peptidomimetics as covalent ATG4B (Autophagin-1) inhibitors</article-title><source>ACS Med Chem Lett</source><year>2016</year><volume>7</volume><issue>8</issue><fpage>802</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1021/acsmedchemlett.6b00208</pub-id><pub-id pub-id-type="pmid">27563406</pub-id>
</element-citation><mixed-citation id="mc-CR295" publication-type="journal">Qiu Z, Kuhn B, Aebi J, Lin X, Ding H, Zhou Z, et al. Discovery of Fluoromethylketone-based peptidomimetics as covalent ATG4B (Autophagin-1) inhibitors. ACS Med Chem Lett. 2016;7(8):802&#x02013;6. 10.1021/acsmedchemlett.6b00208<pub-id pub-id-type="pmid">27563406</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR296"><label>296.</label><citation-alternatives><element-citation id="ec-CR296" publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>DF</given-names></name><name><surname>Chun</surname><given-names>MG</given-names></name><name><surname>Vamos</surname><given-names>M</given-names></name><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Rong</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates</article-title><source>Mol Cell</source><year>2015</year><volume>59</volume><issue>2</issue><fpage>285</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.05.031</pub-id><pub-id pub-id-type="pmid">26118643</pub-id>
</element-citation><mixed-citation id="mc-CR296" publication-type="journal">Egan DF, Chun MG, Vamos M, Zou H, Rong J, Miller CJ, et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol Cell. 2015;59(2):285&#x02013;97. 10.1016/j.molcel.2015.05.031<pub-id pub-id-type="pmid">26118643</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR297"><label>297.</label><citation-alternatives><element-citation id="ec-CR297" publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>MA</given-names></name><name><surname>Engelsen</surname><given-names>AST</given-names></name><name><surname>Sarowar</surname><given-names>S</given-names></name><name><surname>Bindesboll</surname><given-names>C</given-names></name><name><surname>Birkeland</surname><given-names>E</given-names></name><name><surname>Goplen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway</article-title><source>Front Cell Dev Biol</source><year>2022</year><volume>10</volume><fpage>1022191</fpage><pub-id pub-id-type="doi">10.3389/fcell.2022.1022191</pub-id><pub-id pub-id-type="pmid">36619857</pub-id>
</element-citation><mixed-citation id="mc-CR297" publication-type="journal">Rahman MA, Engelsen AST, Sarowar S, Bindesboll C, Birkeland E, Goplen D, et al. Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway. Front Cell Dev Biol. 2022;10:1022191. 10.3389/fcell.2022.1022191<pub-id pub-id-type="pmid">36619857</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR298"><label>298.</label><citation-alternatives><element-citation id="ec-CR298" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo</article-title><source>Chem Sci</source><year>2017</year><volume>8</volume><issue>4</issue><fpage>2687</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1039/c6sc05368h</pub-id><pub-id pub-id-type="pmid">28553505</pub-id>
</element-citation><mixed-citation id="mc-CR298" publication-type="journal">Zhang L, Fu L, Zhang S, Zhang J, Zhao Y, Zheng Y, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017;8(4):2687&#x02013;701. 10.1039/c6sc05368h<pub-id pub-id-type="pmid">28553505</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR299"><label>299.</label><citation-alternatives><element-citation id="ec-CR299" publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Berberine attenuates liver fibrosis by autophagy inhibition triggering apoptosis via the miR-30a-5p/ATG5 axis</article-title><source>Exp Cell Res</source><year>2023</year><volume>427</volume><issue>2</issue><fpage>113600</fpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2023.113600</pub-id><pub-id pub-id-type="pmid">37062521</pub-id>
</element-citation><mixed-citation id="mc-CR299" publication-type="journal">Tan Y, Li C, Zhou J, Deng F, Liu Y. Berberine attenuates liver fibrosis by autophagy inhibition triggering apoptosis via the miR-30a-5p/ATG5 axis. Exp Cell Res. 2023;427(2):113600. 10.1016/j.yexcr.2023.113600<pub-id pub-id-type="pmid">37062521</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR300"><label>300.</label><citation-alternatives><element-citation id="ec-CR300" publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname><given-names>RW</given-names></name></person-group><article-title>Anion inhibition of the proton pump in rat liver multivesicular bodies</article-title><source>J Biol Chem</source><year>1986</year><volume>261</volume><issue>34</issue><fpage>15941</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)66657-8</pub-id><pub-id pub-id-type="pmid">3023335</pub-id>
</element-citation><mixed-citation id="mc-CR300" publication-type="journal">Van Dyke RW. Anion inhibition of the proton pump in rat liver multivesicular bodies. J Biol Chem. 1986;261(34):15941&#x02013;8.<pub-id pub-id-type="pmid">3023335</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR301"><label>301.</label><citation-alternatives><element-citation id="ec-CR301" publication-type="journal"><person-group person-group-type="author"><name><surname>Tolani</surname><given-names>B</given-names></name><name><surname>Celli</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>YZ</given-names></name><name><surname>Fetter</surname><given-names>R</given-names></name><name><surname>Liem</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice</article-title><source>Nat Biotechnol</source><year>2022</year><volume>40</volume><issue>12</issue><fpage>1834</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1038/s41587-022-01386-z</pub-id><pub-id pub-id-type="pmid">35879364</pub-id>
</element-citation><mixed-citation id="mc-CR301" publication-type="journal">Tolani B, Celli A, Yao Y, Tan YZ, Fetter R, Liem CR, et al. Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice. Nat Biotechnol. 2022;40(12):1834&#x02013;44. 10.1038/s41587-022-01386-z<pub-id pub-id-type="pmid">35879364</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR302"><label>302.</label><citation-alternatives><element-citation id="ec-CR302" publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>BA</given-names></name><name><surname>Chimenti</surname><given-names>M</given-names></name><name><surname>Jacobson</surname><given-names>MP</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name></person-group><article-title>Dysregulated pH: a perfect storm for cancer progression</article-title><source>Nat Rev Cancer</source><year>2011</year><volume>11</volume><issue>9</issue><fpage>671</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nrc3110</pub-id><pub-id pub-id-type="pmid">21833026</pub-id>
</element-citation><mixed-citation id="mc-CR302" publication-type="journal">Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer. 2011;11(9):671&#x02013;7. 10.1038/nrc3110<pub-id pub-id-type="pmid">21833026</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR303"><label>303.</label><citation-alternatives><element-citation id="ec-CR303" publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy</article-title><source>Redox Biol</source><year>2020</year><volume>36</volume><fpage>101600</fpage><pub-id pub-id-type="doi">10.1016/j.redox.2020.101600</pub-id><pub-id pub-id-type="pmid">32526690</pub-id>
</element-citation><mixed-citation id="mc-CR303" publication-type="journal">Kong D, Zhang Z, Chen L, Huang W, Zhang F, Wang L, et al. Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy. Redox Biol. 2020;36:101600. 10.1016/j.redox.2020.101600<pub-id pub-id-type="pmid">32526690</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR304"><label>304.</label><citation-alternatives><element-citation id="ec-CR304" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>Q</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis</article-title><source>Acta Pharm Sin B</source><year>2022</year><volume>12</volume><issue>5</issue><fpage>2280</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2021.12.014</pub-id><pub-id pub-id-type="pmid">35646539</pub-id>
</element-citation><mixed-citation id="mc-CR304" publication-type="journal">Li X, Zhu R, Jiang H, Yin Q, Gu J, Chen J, et al. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis. Acta Pharm Sin B. 2022;12(5):2280&#x02013;99. 10.1016/j.apsb.2021.12.014<pub-id pub-id-type="pmid">35646539</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR305"><label>305.</label><citation-alternatives><element-citation id="ec-CR305" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Pharmacological targeting of vacuolar H(+)-ATPase via Subunit V1G combats Multidrug-Resistant Cancer</article-title><source>Cell Chem Biol</source><year>2020</year><volume>27</volume><issue>11</issue><fpage>1359</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2020.06.011</pub-id><pub-id pub-id-type="pmid">32649904</pub-id>
</element-citation><mixed-citation id="mc-CR305" publication-type="journal">Wang Y, Zhang L, Wei Y, Huang W, Li L, Wu AA, et al. Pharmacological targeting of vacuolar H(+)-ATPase via Subunit V1G combats Multidrug-Resistant Cancer. Cell Chem Biol. 2020;27(11):1359&#x02013;70. 10.1016/j.chembiol.2020.06.011<pub-id pub-id-type="pmid">32649904</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR306"><label>306.</label><citation-alternatives><element-citation id="ec-CR306" publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tkach</surname><given-names>D</given-names></name><name><surname>Toral-Barza</surname><given-names>L</given-names></name><name><surname>Ugwonali</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><issue>1</issue><fpage>182</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.1515617113</pub-id><pub-id pub-id-type="pmid">26677873</pub-id>
</element-citation><mixed-citation id="mc-CR306" publication-type="journal">Eng CH, Wang Z, Tkach D, Toral-Barza L, Ugwonali S, Liu S, et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci U S A. 2016;113(1):182&#x02013;7. 10.1073/pnas.1515617113<pub-id pub-id-type="pmid">26677873</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR307"><label>307.</label><citation-alternatives><element-citation id="ec-CR307" publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>H</given-names></name><name><surname>Kuchnio</surname><given-names>A</given-names></name><name><surname>Peric</surname><given-names>A</given-names></name><name><surname>Moens</surname><given-names>S</given-names></name><name><surname>Nys</surname><given-names>K</given-names></name><name><surname>De Bock</surname><given-names>K</given-names></name><etal/></person-group><article-title>Tumor vessel normalization by chloroquine independent of autophagy</article-title><source>Cancer Cell</source><year>2014</year><volume>26</volume><issue>2</issue><fpage>190</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2014.06.025</pub-id><pub-id pub-id-type="pmid">25117709</pub-id>
</element-citation><mixed-citation id="mc-CR307" publication-type="journal">Maes H, Kuchnio A, Peric A, Moens S, Nys K, De Bock K, et al. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell. 2014;26(2):190&#x02013;206. 10.1016/j.ccr.2014.06.025<pub-id pub-id-type="pmid">25117709</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR308"><label>308.</label><citation-alternatives><element-citation id="ec-CR308" publication-type="journal"><person-group person-group-type="author"><name><surname>Maycotte</surname><given-names>P</given-names></name><name><surname>Aryal</surname><given-names>S</given-names></name><name><surname>Cummings</surname><given-names>CT</given-names></name><name><surname>Thorburn</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>MJ</given-names></name><name><surname>Thorburn</surname><given-names>A</given-names></name></person-group><article-title>Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy</article-title><source>Autophagy</source><year>2012</year><volume>8</volume><issue>2</issue><fpage>200</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.4161/auto.8.2.18554</pub-id><pub-id pub-id-type="pmid">22252008</pub-id>
</element-citation><mixed-citation id="mc-CR308" publication-type="journal">Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, Thorburn A. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 2012;8(2):200&#x02013;12. 10.4161/auto.8.2.18554<pub-id pub-id-type="pmid">22252008</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR309"><label>309.</label><citation-alternatives><element-citation id="ec-CR309" publication-type="journal"><person-group person-group-type="author"><name><surname>Briceno</surname><given-names>E</given-names></name><name><surname>Reyes</surname><given-names>S</given-names></name><name><surname>Sotelo</surname><given-names>J</given-names></name></person-group><article-title>Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine</article-title><source>Neurosurg Focus</source><year>2003</year><volume>14</volume><issue>2</issue><fpage>e3</fpage><pub-id pub-id-type="doi">10.3171/foc.2003.14.2.4</pub-id><pub-id pub-id-type="pmid">15727424</pub-id>
</element-citation><mixed-citation id="mc-CR309" publication-type="journal">Briceno E, Reyes S, Sotelo J. Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg Focus. 2003;14(2):e3. 10.3171/foc.2003.14.2.4<pub-id pub-id-type="pmid">15727424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR310"><label>310.</label><citation-alternatives><element-citation id="ec-CR310" publication-type="journal"><person-group person-group-type="author"><name><surname>Rangwala</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Algazy</surname><given-names>KM</given-names></name><name><surname>Evans</surname><given-names>TL</given-names></name><name><surname>Fecher</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma</article-title><source>Autophagy</source><year>2014</year><volume>10</volume><issue>8</issue><fpage>1391</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.4161/auto.29119</pub-id><pub-id pub-id-type="pmid">24991838</pub-id>
</element-citation><mixed-citation id="mc-CR310" publication-type="journal">Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy. 2014;10(8):1391&#x02013;402. 10.4161/auto.29119<pub-id pub-id-type="pmid">24991838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR311"><label>311.</label><citation-alternatives><element-citation id="ec-CR311" publication-type="journal"><person-group person-group-type="author"><name><surname>De Leo</surname><given-names>F</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>De Marchis</surname><given-names>F</given-names></name><name><surname>Cigana</surname><given-names>C</given-names></name><name><surname>Melessike</surname><given-names>M</given-names></name><name><surname>Quilici</surname><given-names>G</given-names></name><etal/></person-group><article-title>Pamoic acid is an inhibitor of HMGB1.CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia</article-title><source>Mol Med</source><year>2022</year><volume>28</volume><issue>1</issue><fpage>108</fpage><pub-id pub-id-type="doi">10.1186/s10020-022-00535-z</pub-id><pub-id pub-id-type="pmid">36071400</pub-id>
</element-citation><mixed-citation id="mc-CR311" publication-type="journal">De Leo F, Rossi A, De Marchis F, Cigana C, Melessike M, Quilici G, et al. Pamoic acid is an inhibitor of HMGB1.CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia. Mol Med. 2022;28(1):108. 10.1186/s10020-022-00535-z<pub-id pub-id-type="pmid">36071400</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR312"><label>312.</label><citation-alternatives><element-citation id="ec-CR312" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>ZH</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>LF</given-names></name><name><surname>Cai</surname><given-names>HF</given-names></name><name><surname>Ye</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>ZM</given-names></name></person-group><article-title>Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways</article-title><source>Immunopharmacol Immunotoxicol</source><year>2021</year><volume>43</volume><issue>4</issue><fpage>461</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1080/08923973.2021.1939371</pub-id><pub-id pub-id-type="pmid">34142927</pub-id>
</element-citation><mixed-citation id="mc-CR312" publication-type="journal">Zhu ZH, Li X, He LF, Cai HF, Ye B, Wu ZM. Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways. Immunopharmacol Immunotoxicol. 2021;43(4):461&#x02013;70. 10.1080/08923973.2021.1939371<pub-id pub-id-type="pmid">34142927</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR313"><label>313.</label><citation-alternatives><element-citation id="ec-CR313" publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>ID</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calcium</article-title><source>Mol Med</source><year>2015</year><volume>20</volume><issue>1</issue><fpage>649</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.2119/molmed.2014.00039</pub-id><pub-id pub-id-type="pmid">25333921</pub-id>
</element-citation><mixed-citation id="mc-CR313" publication-type="journal">Shin JH, Kim ID, Kim SW, Lee HK, Jin Y, Park JH, et al. Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calcium. Mol Med. 2015;20(1):649&#x02013;57. 10.2119/molmed.2014.00039<pub-id pub-id-type="pmid">25333921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR314"><label>314.</label><citation-alternatives><element-citation id="ec-CR314" publication-type="journal"><person-group person-group-type="author"><name><surname>Horiuchi</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>N</given-names></name><name><surname>Narumi</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Nagano</surname><given-names>K</given-names></name><etal/></person-group><article-title>Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity</article-title><source>J Biol Chem</source><year>2017</year><volume>292</volume><issue>20</issue><fpage>8436</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.769380</pub-id><pub-id pub-id-type="pmid">28373282</pub-id>
</element-citation><mixed-citation id="mc-CR314" publication-type="journal">Horiuchi T, Sakata N, Narumi Y, Kimura T, Hayashi T, Nagano K, et al. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity. J Biol Chem. 2017;292(20):8436&#x02013;46. 10.1074/jbc.M116.769380<pub-id pub-id-type="pmid">28373282</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR315"><label>315.</label><citation-alternatives><element-citation id="ec-CR315" publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge</article-title><source>Cell Discov</source><year>2022</year><volume>8</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="doi">10.1038/s41421-021-00368-w</pub-id><pub-id pub-id-type="pmid">35075146</pub-id>
</element-citation><mixed-citation id="mc-CR315" publication-type="journal">Mao Z, Xiao H, Shen P, Yang Y, Xue J, Yang Y, et al. KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge. Cell Discov. 2022;8(1):5. 10.1038/s41421-021-00368-w<pub-id pub-id-type="pmid">35075146</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR316"><label>316.</label><citation-alternatives><element-citation id="ec-CR316" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Allen</surname><given-names>S</given-names></name><name><surname>Blake</surname><given-names>JF</given-names></name><name><surname>Bowcut</surname><given-names>V</given-names></name><name><surname>Briere</surname><given-names>DM</given-names></name><name><surname>Calinisan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identification of MRTX1133, a Noncovalent, Potent, and selective KRAS(G12D) inhibitor</article-title><source>J Med Chem</source><year>2022</year><volume>65</volume><issue>4</issue><fpage>3123</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.1c01688</pub-id><pub-id pub-id-type="pmid">34889605</pub-id>
</element-citation><mixed-citation id="mc-CR316" publication-type="journal">Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, et al. Identification of MRTX1133, a Noncovalent, Potent, and selective KRAS(G12D) inhibitor. J Med Chem. 2022;65(4):3123&#x02013;33. 10.1021/acs.jmedchem.1c01688<pub-id pub-id-type="pmid">34889605</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR317"><label>317.</label><citation-alternatives><element-citation id="ec-CR317" publication-type="journal"><person-group person-group-type="author"><name><surname>Hallin</surname><given-names>J</given-names></name><name><surname>Bowcut</surname><given-names>V</given-names></name><name><surname>Calinisan</surname><given-names>A</given-names></name><name><surname>Briere</surname><given-names>DM</given-names></name><name><surname>Hargis</surname><given-names>L</given-names></name><name><surname>Engstrom</surname><given-names>LD</given-names></name><etal/></person-group><article-title>Anti-tumor efficacy of a potent and selective non-covalent KRAS(G12D) inhibitor</article-title><source>Nat Med</source><year>2022</year><volume>28</volume><issue>10</issue><fpage>2171</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-02007-7</pub-id><pub-id pub-id-type="pmid">36216931</pub-id>
</element-citation><mixed-citation id="mc-CR317" publication-type="journal">Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, et al. Anti-tumor efficacy of a potent and selective non-covalent KRAS(G12D) inhibitor. Nat Med. 2022;28(10):2171&#x02013;82. 10.1038/s41591-022-02007-7<pub-id pub-id-type="pmid">36216931</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR318"><label>318.</label><citation-alternatives><element-citation id="ec-CR318" publication-type="journal"><person-group person-group-type="author"><name><surname>Mahadevan</surname><given-names>KK</given-names></name><name><surname>McAndrews</surname><given-names>KM</given-names></name><name><surname>LeBleu</surname><given-names>VS</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Lyu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><etal/></person-group><article-title>KRAS(G12D) inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8(+) T cells</article-title><source>Cancer Cell</source><year>2023</year><volume>41</volume><issue>9</issue><fpage>1606</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2023.07.002</pub-id><pub-id pub-id-type="pmid">37625401</pub-id>
</element-citation><mixed-citation id="mc-CR318" publication-type="journal">Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B, et al. KRAS(G12D) inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8(+) T cells. Cancer Cell. 2023;41(9):1606&#x02013;20. 10.1016/j.ccell.2023.07.002<pub-id pub-id-type="pmid">37625401</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR319"><label>319.</label><citation-alternatives><element-citation id="ec-CR319" publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>DS</given-names></name><name><surname>Fakih</surname><given-names>MG</given-names></name><name><surname>Strickler</surname><given-names>JH</given-names></name><name><surname>Desai</surname><given-names>J</given-names></name><name><surname>Durm</surname><given-names>GA</given-names></name><name><surname>Shapiro</surname><given-names>GI</given-names></name><etal/></person-group><article-title>KRAS(G12C) inhibition with Sotorasib in Advanced Solid tumors</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>13</issue><fpage>1207</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1917239</pub-id><pub-id pub-id-type="pmid">32955176</pub-id>
</element-citation><mixed-citation id="mc-CR319" publication-type="journal">Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, et al. KRAS(G12C) inhibition with Sotorasib in Advanced Solid tumors. N Engl J Med. 2020;383(13):1207&#x02013;17. 10.1056/NEJMoa1917239<pub-id pub-id-type="pmid">32955176</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR320"><label>320.</label><citation-alternatives><element-citation id="ec-CR320" publication-type="journal"><person-group person-group-type="author"><name><surname>Pece</surname><given-names>R</given-names></name><name><surname>Tavella</surname><given-names>S</given-names></name><name><surname>Costa</surname><given-names>D</given-names></name><name><surname>Varesano</surname><given-names>S</given-names></name><name><surname>Camodeca</surname><given-names>C</given-names></name><name><surname>Cuffaro</surname><given-names>D</given-names></name><etal/></person-group><article-title>Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect</article-title><source>Haematologica</source><year>2022</year><volume>107</volume><issue>4</issue><fpage>909</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.3324/haematol.2021.278469</pub-id><pub-id pub-id-type="pmid">34109776</pub-id>
</element-citation><mixed-citation id="mc-CR320" publication-type="journal">Pece R, Tavella S, Costa D, Varesano S, Camodeca C, Cuffaro D, et al. Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect. Haematologica. 2022;107(4):909&#x02013;20. 10.3324/haematol.2021.278469<pub-id pub-id-type="pmid">34109776</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR321"><label>321.</label><citation-alternatives><element-citation id="ec-CR321" publication-type="journal"><person-group person-group-type="author"><name><surname>Tosetti</surname><given-names>F</given-names></name><name><surname>Vene</surname><given-names>R</given-names></name><name><surname>Camodeca</surname><given-names>C</given-names></name><name><surname>Nuti</surname><given-names>E</given-names></name><name><surname>Rossello</surname><given-names>A</given-names></name><name><surname>D&#x02019;Arrigo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells</article-title><source>Oncoimmunology</source><year>2018</year><volume>7</volume><issue>5</issue><fpage>e1421889</fpage><pub-id pub-id-type="doi">10.1080/2162402X.2017.1421889</pub-id><pub-id pub-id-type="pmid">29721369</pub-id>
</element-citation><mixed-citation id="mc-CR321" publication-type="journal">Tosetti F, Vene R, Camodeca C, Nuti E, Rossello A, D&#x02019;Arrigo C, et al. Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells. Oncoimmunology. 2018;7(5):e1421889. 10.1080/2162402X.2017.1421889<pub-id pub-id-type="pmid">29721369</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR322"><label>322.</label><citation-alternatives><element-citation id="ec-CR322" publication-type="journal"><person-group person-group-type="author"><name><surname>Zocchi</surname><given-names>MR</given-names></name><name><surname>Camodeca</surname><given-names>C</given-names></name><name><surname>Nuti</surname><given-names>E</given-names></name><name><surname>Rossello</surname><given-names>A</given-names></name><name><surname>Vene</surname><given-names>R</given-names></name><name><surname>Tosetti</surname><given-names>F</given-names></name><etal/></person-group><article-title>ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing</article-title><source>Oncoimmunology</source><year>2016</year><volume>5</volume><issue>5</issue><fpage>e1123367</fpage><pub-id pub-id-type="doi">10.1080/2162402X.2015.1123367</pub-id><pub-id pub-id-type="pmid">27467923</pub-id>
</element-citation><mixed-citation id="mc-CR322" publication-type="journal">Zocchi MR, Camodeca C, Nuti E, Rossello A, Vene R, Tosetti F, et al. ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing. Oncoimmunology. 2016;5(5):e1123367. 10.1080/2162402X.2015.1123367<pub-id pub-id-type="pmid">27467923</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR323"><label>323.</label><citation-alternatives><element-citation id="ec-CR323" publication-type="journal"><person-group person-group-type="author"><name><surname>Petpiroon</surname><given-names>N</given-names></name><name><surname>Bhummaphan</surname><given-names>N</given-names></name><name><surname>Tungsukruthai</surname><given-names>S</given-names></name><name><surname>Pinkhien</surname><given-names>T</given-names></name><name><surname>Maiuthed</surname><given-names>A</given-names></name><name><surname>Sritularak</surname><given-names>B</given-names></name><etal/></person-group><article-title>Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis</article-title><source>Phytomedicine</source><year>2019</year><volume>58</volume><fpage>152888</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2019.152888</pub-id><pub-id pub-id-type="pmid">30901662</pub-id>
</element-citation><mixed-citation id="mc-CR323" publication-type="journal">Petpiroon N, Bhummaphan N, Tungsukruthai S, Pinkhien T, Maiuthed A, Sritularak B, et al. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis. Phytomedicine. 2019;58:152888. 10.1016/j.phymed.2019.152888<pub-id pub-id-type="pmid">30901662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR324"><label>324.</label><citation-alternatives><element-citation id="ec-CR324" publication-type="journal"><person-group person-group-type="author"><name><surname>Maiuthed</surname><given-names>A</given-names></name><name><surname>Bhummaphan</surname><given-names>N</given-names></name><name><surname>Luanpitpong</surname><given-names>S</given-names></name><name><surname>Mutirangura</surname><given-names>A</given-names></name><name><surname>Aporntewan</surname><given-names>C</given-names></name><name><surname>Meeprasert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: a new regulatory mechanism for cancer stem cell formation</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><issue>35</issue><fpage>13534</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA117.000287</pub-id><pub-id pub-id-type="pmid">29986880</pub-id>
</element-citation><mixed-citation id="mc-CR324" publication-type="journal">Maiuthed A, Bhummaphan N, Luanpitpong S, Mutirangura A, Aporntewan C, Meeprasert A, et al. Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: a new regulatory mechanism for cancer stem cell formation. J Biol Chem. 2018;293(35):13534&#x02013;52. 10.1074/jbc.RA117.000287<pub-id pub-id-type="pmid">29986880</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR325"><label>325.</label><citation-alternatives><element-citation id="ec-CR325" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>B</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway</article-title><source>Biomed Pharmacother</source><year>2016</year><volume>84</volume><fpage>1776</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.10.104</pub-id><pub-id pub-id-type="pmid">27847199</pub-id>
</element-citation><mixed-citation id="mc-CR325" publication-type="journal">Yuan S, Wang L, Chen X, Fan B, Yuan Q, Zhang H, et al. Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway. Biomed Pharmacother. 2016;84:1776&#x02013;82. 10.1016/j.biopha.2016.10.104<pub-id pub-id-type="pmid">27847199</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR326"><label>326.</label><citation-alternatives><element-citation id="ec-CR326" publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><etal/></person-group><article-title>Simvastatin delays castration&#x02013;resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin&#x02013;1</article-title><source>Int J Oncol</source><year>2019</year><volume>54</volume><issue>6</issue><fpage>2054</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.3892/ijo.2019.4774</pub-id><pub-id pub-id-type="pmid">31081050</pub-id>
</element-citation><mixed-citation id="mc-CR326" publication-type="journal">Gao Y, Li L, Li T, Ma L, Yuan M, Sun W, et al. Simvastatin delays castration&#x02013;resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin&#x02013;1. Int J Oncol. 2019;54(6):2054&#x02013;68. 10.3892/ijo.2019.4774<pub-id pub-id-type="pmid">31081050</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR327"><label>327.</label><citation-alternatives><element-citation id="ec-CR327" publication-type="journal"><person-group person-group-type="author"><name><surname>Lubetsky</surname><given-names>JB</given-names></name><name><surname>Dios</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Aljabari</surname><given-names>B</given-names></name><name><surname>Ruzsicska</surname><given-names>B</given-names></name><name><surname>Mitchell</surname><given-names>R</given-names></name><etal/></person-group><article-title>The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><issue>28</issue><fpage>24976</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1074/jbc.M203220200</pub-id><pub-id pub-id-type="pmid">11997397</pub-id>
</element-citation><mixed-citation id="mc-CR327" publication-type="journal">Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, Mitchell R, et al. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem. 2002;277(28):24976&#x02013;82. 10.1074/jbc.M203220200<pub-id pub-id-type="pmid">11997397</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR328"><label>328.</label><citation-alternatives><element-citation id="ec-CR328" publication-type="journal"><person-group person-group-type="author"><name><surname>Cournia</surname><given-names>Z</given-names></name><name><surname>Leng</surname><given-names>L</given-names></name><name><surname>Gandavadi</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Bucala</surname><given-names>R</given-names></name><name><surname>Jorgensen</surname><given-names>WL</given-names></name></person-group><article-title>Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening</article-title><source>J Med Chem</source><year>2009</year><volume>52</volume><issue>2</issue><fpage>416</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1021/jm801100v</pub-id><pub-id pub-id-type="pmid">19090668</pub-id>
</element-citation><mixed-citation id="mc-CR328" publication-type="journal">Cournia Z, Leng L, Gandavadi S, Du X, Bucala R, Jorgensen WL. Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. J Med Chem. 2009;52(2):416&#x02013;24. 10.1021/jm801100v<pub-id pub-id-type="pmid">19090668</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR329"><label>329.</label><citation-alternatives><element-citation id="ec-CR329" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>XX</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Gan</surname><given-names>HY</given-names></name><name><surname>Liu</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Macrophage migration inhibitory factor promotes colorectal cancer</article-title><source>Mol Med</source><year>2009</year><volume>15</volume><issue>1&#x02013;2</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.2119/molmed.2008.00107</pub-id><pub-id pub-id-type="pmid">19009023</pub-id>
</element-citation><mixed-citation id="mc-CR329" publication-type="journal">He XX, Chen K, Yang J, Li XY, Gan HY, Liu CY, et al. Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med. 2009;15(1&#x02013;2):1&#x02013;10. 10.2119/molmed.2008.00107<pub-id pub-id-type="pmid">19009023</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR330"><label>330.</label><citation-alternatives><element-citation id="ec-CR330" publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Siegler</surname><given-names>KL</given-names></name><name><surname>Iczkowski</surname><given-names>KA</given-names></name><name><surname>Leng</surname><given-names>L</given-names></name><name><surname>Bucala</surname><given-names>R</given-names></name><name><surname>Vera</surname><given-names>PL</given-names></name></person-group><article-title>Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><issue>12</issue><fpage>8730</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.12.8730</pub-id><pub-id pub-id-type="pmid">17142775</pub-id>
</element-citation><mixed-citation id="mc-CR330" publication-type="journal">Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol. 2006;177(12):8730&#x02013;9. 10.4049/jimmunol.177.12.8730<pub-id pub-id-type="pmid">17142775</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR331"><label>331.</label><citation-alternatives><element-citation id="ec-CR331" publication-type="journal"><person-group person-group-type="author"><name><surname>Tanese</surname><given-names>K</given-names></name><name><surname>Hashimoto</surname><given-names>Y</given-names></name><name><surname>Berkova</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Samaniego</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Cell Surface CD74-MIF interactions drive Melanoma Survival in response to Interferon-gamma</article-title><source>J Invest Dermatol</source><year>2015</year><volume>135</volume><issue>11</issue><fpage>2775</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/jid.2015.204</pub-id><pub-id pub-id-type="pmid">26039541</pub-id>
</element-citation><mixed-citation id="mc-CR331" publication-type="journal">Tanese K, Hashimoto Y, Berkova Z, Wang Y, Samaniego F, Lee JE, et al. Cell Surface CD74-MIF interactions drive Melanoma Survival in response to Interferon-gamma. J Invest Dermatol. 2015;135(11):2775&#x02013;84. 10.1038/jid.2015.204<pub-id pub-id-type="pmid">26039541</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR332"><label>332.</label><citation-alternatives><element-citation id="ec-CR332" publication-type="journal"><person-group person-group-type="author"><name><surname>Kok</surname><given-names>T</given-names></name><name><surname>Wasiel</surname><given-names>AA</given-names></name><name><surname>Cool</surname><given-names>RH</given-names></name><name><surname>Melgert</surname><given-names>BN</given-names></name><name><surname>Poelarends</surname><given-names>GJ</given-names></name><name><surname>Dekker</surname><given-names>FJ</given-names></name></person-group><article-title>Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders</article-title><source>Drug Discov Today</source><year>2018</year><volume>23</volume><issue>11</issue><fpage>1910</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2018.06.017</pub-id><pub-id pub-id-type="pmid">29936245</pub-id>
</element-citation><mixed-citation id="mc-CR332" publication-type="journal">Kok T, Wasiel AA, Cool RH, Melgert BN, Poelarends GJ, Dekker FJ. Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders. Drug Discov Today. 2018;23(11):1910&#x02013;8. 10.1016/j.drudis.2018.06.017<pub-id pub-id-type="pmid">29936245</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR333"><label>333.</label><citation-alternatives><element-citation id="ec-CR333" publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>A</given-names></name><name><surname>Pal</surname><given-names>C</given-names></name><name><surname>Goyal</surname><given-names>M</given-names></name><name><surname>Kundu</surname><given-names>MK</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Iqbal</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent</article-title><source>Bioorg Med Chem</source><year>2011</year><volume>19</volume><issue>24</issue><fpage>7365</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.10.056</pub-id><pub-id pub-id-type="pmid">22088307</pub-id>
</element-citation><mixed-citation id="mc-CR333" publication-type="journal">Alam A, Pal C, Goyal M, Kundu MK, Kumar R, Iqbal MS, et al. Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent. Bioorg Med Chem. 2011;19(24):7365&#x02013;73. 10.1016/j.bmc.2011.10.056<pub-id pub-id-type="pmid">22088307</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR334"><label>334.</label><citation-alternatives><element-citation id="ec-CR334" publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannou</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>KF</given-names></name><name><surname>Crichlow</surname><given-names>GV</given-names></name><name><surname>Birmpilis</surname><given-names>AI</given-names></name><name><surname>Lolis</surname><given-names>EJ</given-names></name><name><surname>Tsitsilonis</surname><given-names>OE</given-names></name><etal/></person-group><article-title>ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models</article-title><source>Int J Oncol</source><year>2014</year><volume>45</volume><issue>4</issue><fpage>1457</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.3892/ijo.2014.2551</pub-id><pub-id pub-id-type="pmid">25050663</pub-id>
</element-citation><mixed-citation id="mc-CR334" publication-type="journal">Ioannou K, Cheng KF, Crichlow GV, Birmpilis AI, Lolis EJ, Tsitsilonis OE, et al. ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models. Int J Oncol. 2014;45(4):1457&#x02013;68. 10.3892/ijo.2014.2551<pub-id pub-id-type="pmid">25050663</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR335"><label>335.</label><citation-alternatives><element-citation id="ec-CR335" publication-type="journal"><person-group person-group-type="author"><name><surname>Dziedzic</surname><given-names>P</given-names></name><name><surname>Cisneros</surname><given-names>JA</given-names></name><name><surname>Robertson</surname><given-names>MJ</given-names></name><name><surname>Hare</surname><given-names>AA</given-names></name><name><surname>Danford</surname><given-names>NE</given-names></name><name><surname>Baxter</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor</article-title><source>J Am Chem Soc</source><year>2015</year><volume>137</volume><issue>8</issue><fpage>2996</fpage><lpage>3003</lpage><pub-id pub-id-type="doi">10.1021/ja512112j</pub-id><pub-id pub-id-type="pmid">25697265</pub-id>
</element-citation><mixed-citation id="mc-CR335" publication-type="journal">Dziedzic P, Cisneros JA, Robertson MJ, Hare AA, Danford NE, Baxter RH, et al. Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor. J Am Chem Soc. 2015;137(8):2996&#x02013;3003. 10.1021/ja512112j<pub-id pub-id-type="pmid">25697265</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR336"><label>336.</label><citation-alternatives><element-citation id="ec-CR336" publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>WL</given-names></name><name><surname>Gandavadi</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Hare</surname><given-names>AA</given-names></name><name><surname>Trofimov</surname><given-names>A</given-names></name><name><surname>Leng</surname><given-names>L</given-names></name><etal/></person-group><article-title>Receptor agonists of macrophage migration inhibitory factor</article-title><source>Bioorg Med Chem Lett</source><year>2010</year><volume>20</volume><issue>23</issue><fpage>7033</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.09.118</pub-id><pub-id pub-id-type="pmid">20971005</pub-id>
</element-citation><mixed-citation id="mc-CR336" publication-type="journal">Jorgensen WL, Gandavadi S, Du X, Hare AA, Trofimov A, Leng L, et al. Receptor agonists of macrophage migration inhibitory factor. Bioorg Med Chem Lett. 2010;20(23):7033&#x02013;6. 10.1016/j.bmcl.2010.09.118<pub-id pub-id-type="pmid">20971005</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR337"><label>337.</label><citation-alternatives><element-citation id="ec-CR337" publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Cheung</surname><given-names>BB</given-names></name><name><surname>Tsang</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>O</given-names></name><name><surname>Herath</surname><given-names>M</given-names></name><name><surname>Ciampa</surname><given-names>OC</given-names></name><etal/></person-group><article-title>Withaferin A activates TRIM16 for its anti-cancer activity in melanoma</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><issue>1</issue><fpage>19724</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-76722-x</pub-id><pub-id pub-id-type="pmid">33184347</pub-id>
</element-citation><mixed-citation id="mc-CR337" publication-type="journal">Nagy Z, Cheung BB, Tsang W, Tan O, Herath M, Ciampa OC, et al. Withaferin A activates TRIM16 for its anti-cancer activity in melanoma. Sci Rep. 2020;10(1):19724. 10.1038/s41598-020-76722-x<pub-id pub-id-type="pmid">33184347</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR338"><label>338.</label><citation-alternatives><element-citation id="ec-CR338" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction</article-title><source>Cell Death Dis</source><year>2021</year><volume>12</volume><issue>4</issue><fpage>373</fpage><pub-id pub-id-type="doi">10.1038/s41419-021-03664-1</pub-id><pub-id pub-id-type="pmid">33828078</pub-id>
</element-citation><mixed-citation id="mc-CR338" publication-type="journal">Xu J, Zhang J, Zhang Z, Gao Z, Qi Y, Qiu W, et al. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Death Dis. 2021;12(4):373. 10.1038/s41419-021-03664-1<pub-id pub-id-type="pmid">33828078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR339"><label>339.</label><citation-alternatives><element-citation id="ec-CR339" publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>TWM</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>WY</given-names></name><name><surname>Arnold</surname><given-names>S</given-names></name><etal/></person-group><article-title>Exosomal lipids for classifying early and late stage non-small cell lung cancer</article-title><source>Anal Chim Acta</source><year>2018</year><volume>1037</volume><fpage>256</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.aca.2018.02.051</pub-id><pub-id pub-id-type="pmid">30292300</pub-id>
</element-citation><mixed-citation id="mc-CR339" publication-type="journal">Fan TWM, Zhang X, Wang C, Yang Y, Kang WY, Arnold S, et al. Exosomal lipids for classifying early and late stage non-small cell lung cancer. Anal Chim Acta. 2018;1037:256&#x02013;64. 10.1016/j.aca.2018.02.051<pub-id pub-id-type="pmid">30292300</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR340"><label>340.</label><citation-alternatives><element-citation id="ec-CR340" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>DA</given-names></name><name><surname>Tao</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Szczepaniak</surname><given-names>M</given-names></name><name><surname>Rames</surname><given-names>M</given-names></name><etal/></person-group><article-title>A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><issue>1</issue><fpage>6883</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-42661-0</pub-id><pub-id pub-id-type="pmid">37898620</pub-id>
</element-citation><mixed-citation id="mc-CR340" publication-type="journal">Liu DA, Tao K, Wu B, Yu Z, Szczepaniak M, Rames M, et al. A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion. Nat Commun. 2023;14(1):6883. 10.1038/s41467-023-42661-0<pub-id pub-id-type="pmid">37898620</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR341"><label>341.</label><citation-alternatives><element-citation id="ec-CR341" publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Fei</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Construction of a human cell landscape at single-cell level</article-title><source>Nature</source><year>2020</year><volume>581</volume><issue>7808</issue><fpage>303</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2157-4</pub-id><pub-id pub-id-type="pmid">32214235</pub-id>
</element-citation><mixed-citation id="mc-CR341" publication-type="journal">Han X, Zhou Z, Fei L, Sun H, Wang R, Chen Y, et al. Construction of a human cell landscape at single-cell level. Nature. 2020;581(7808):303&#x02013;9. 10.1038/s41586-020-2157-4<pub-id pub-id-type="pmid">32214235</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR342"><label>342.</label><citation-alternatives><element-citation id="ec-CR342" publication-type="journal"><person-group person-group-type="author"><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Single-cell RNA sequencing to explore immune cell heterogeneity</article-title><source>Nat Rev Immunol</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.76</pub-id><pub-id pub-id-type="pmid">28787399</pub-id>
</element-citation><mixed-citation id="mc-CR342" publication-type="journal">Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18(1):35&#x02013;45. 10.1038/nri.2017.76<pub-id pub-id-type="pmid">28787399</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR343"><label>343.</label><citation-alternatives><element-citation id="ec-CR343" publication-type="journal"><person-group person-group-type="author"><name><surname>Garreta</surname><given-names>E</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name><name><surname>Chuva de Sousa Lopes</surname><given-names>SM</given-names></name><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Trepat</surname><given-names>X</given-names></name><etal/></person-group><article-title>Rethinking organoid technology through bioengineering</article-title><source>Nat Mater</source><year>2021</year><volume>20</volume><issue>2</issue><fpage>145</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/s41563-020-00804-4</pub-id><pub-id pub-id-type="pmid">33199860</pub-id>
</element-citation><mixed-citation id="mc-CR343" publication-type="journal">Garreta E, Kamm RD, Chuva de Sousa Lopes SM, Lancaster MA, Weiss R, Trepat X, et al. Rethinking organoid technology through bioengineering. Nat Mater. 2021;20(2):145&#x02013;55. 10.1038/s41563-020-00804-4<pub-id pub-id-type="pmid">33199860</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR344"><label>344.</label><citation-alternatives><element-citation id="ec-CR344" publication-type="journal"><person-group person-group-type="author"><name><surname>Gjorevski</surname><given-names>N</given-names></name><name><surname>Nikolaev</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>TE</given-names></name><name><surname>Mitrofanova</surname><given-names>O</given-names></name><name><surname>Brandenberg</surname><given-names>N</given-names></name><name><surname>DelRio</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Tissue geometry drives deterministic organoid patterning</article-title><source>Science</source><year>2022</year><volume>375</volume><issue>6576</issue><fpage>eaaw9021</fpage><pub-id pub-id-type="doi">10.1126/science.aaw9021</pub-id><pub-id pub-id-type="pmid">34990240</pub-id>
</element-citation><mixed-citation id="mc-CR344" publication-type="journal">Gjorevski N, Nikolaev M, Brown TE, Mitrofanova O, Brandenberg N, DelRio FW, et al. Tissue geometry drives deterministic organoid patterning. Science. 2022;375(6576):eaaw9021. 10.1126/science.aaw9021<pub-id pub-id-type="pmid">34990240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR345"><label>345.</label><mixed-citation publication-type="other">Vazquez-Armendariz AI, Tata PR. Recent advances in lung organoid development and applications in disease modeling. J Clin Invest. 2023;133(22). 10.1172/JCI170500</mixed-citation></ref><ref id="CR346"><label>346.</label><citation-alternatives><element-citation id="ec-CR346" publication-type="journal"><person-group person-group-type="author"><name><surname>Compter</surname><given-names>I</given-names></name><name><surname>Eekers</surname><given-names>DBP</given-names></name><name><surname>Hoeben</surname><given-names>A</given-names></name><name><surname>Rouschop</surname><given-names>KMA</given-names></name><name><surname>Reymen</surname><given-names>B</given-names></name><name><surname>Ackermans</surname><given-names>L</given-names></name><etal/></person-group><article-title>Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial</article-title><source>Autophagy</source><year>2021</year><volume>17</volume><issue>9</issue><fpage>2604</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1816343</pub-id><pub-id pub-id-type="pmid">32866424</pub-id>
</element-citation><mixed-citation id="mc-CR346" publication-type="journal">Compter I, Eekers DBP, Hoeben A, Rouschop KMA, Reymen B, Ackermans L, et al. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy. 2021;17(9):2604&#x02013;12. 10.1080/15548627.2020.1816343<pub-id pub-id-type="pmid">32866424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR347"><label>347.</label><citation-alternatives><element-citation id="ec-CR347" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>KC</given-names></name><name><surname>Go</surname><given-names>NE</given-names></name><name><surname>Colborne</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>CJ</given-names></name><name><surname>Hosseini-Beheshti</surname><given-names>E</given-names></name><etal/></person-group><article-title>Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations</article-title><source>Autophagy</source><year>2022</year><volume>18</volume><issue>11</issue><fpage>2547</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1080/15548627.2022.2039535</pub-id><pub-id pub-id-type="pmid">35220892</pub-id>
</element-citation><mixed-citation id="mc-CR347" publication-type="journal">Xu J, Yang KC, Go NE, Colborne S, Ho CJ, Hosseini-Beheshti E, et al. Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations. Autophagy. 2022;18(11):2547&#x02013;60. 10.1080/15548627.2022.2039535<pub-id pub-id-type="pmid">35220892</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR348"><label>348.</label><citation-alternatives><element-citation id="ec-CR348" publication-type="journal"><person-group person-group-type="author"><name><surname>Gamez-Chiachio</surname><given-names>M</given-names></name><name><surname>Molina-Crespo</surname><given-names>A</given-names></name><name><surname>Ramos-Nebot</surname><given-names>C</given-names></name><name><surname>Martinez-Val</surname><given-names>J</given-names></name><name><surname>Martinez</surname><given-names>L</given-names></name><name><surname>Gassner</surname><given-names>K</given-names></name><etal/></person-group><article-title>Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation</article-title><source>J Exp Clin Cancer Res</source><year>2022</year><volume>41</volume><issue>1</issue><fpage>285</fpage><pub-id pub-id-type="doi">10.1186/s13046-022-02497-w</pub-id><pub-id pub-id-type="pmid">36163066</pub-id>
</element-citation><mixed-citation id="mc-CR348" publication-type="journal">Gamez-Chiachio M, Molina-Crespo A, Ramos-Nebot C, Martinez-Val J, Martinez L, Gassner K, et al. Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation. J Exp Clin Cancer Res. 2022;41(1):285. 10.1186/s13046-022-02497-w<pub-id pub-id-type="pmid">36163066</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR349"><label>349.</label><citation-alternatives><element-citation id="ec-CR349" publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>JM</given-names></name><name><surname>Ordureau</surname><given-names>A</given-names></name><name><surname>Swarup</surname><given-names>S</given-names></name><name><surname>Paulo</surname><given-names>JA</given-names></name><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><etal/></person-group><article-title>RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway</article-title><source>Sci Adv</source><year>2018</year><volume>4</volume><issue>11</issue><fpage>eaav0443</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aav0443</pub-id><pub-id pub-id-type="pmid">30627666</pub-id>
</element-citation><mixed-citation id="mc-CR349" publication-type="journal">Heo JM, Ordureau A, Swarup S, Paulo JA, Shen K, Sabatini DM, et al. RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway. Sci Adv. 2018;4(11):eaav0443. 10.1126/sciadv.aav0443<pub-id pub-id-type="pmid">30627666</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR350"><label>350.</label><citation-alternatives><element-citation id="ec-CR350" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Sutton</surname><given-names>MN</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>CH</given-names></name><name><surname>Liao</surname><given-names>WS</given-names></name><etal/></person-group><article-title>ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7</article-title><source>Cell Death Differ</source><year>2014</year><volume>21</volume><issue>8</issue><fpage>1275</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.48</pub-id><pub-id pub-id-type="pmid">24769729</pub-id>
</element-citation><mixed-citation id="mc-CR350" publication-type="journal">Lu Z, Yang H, Sutton MN, Yang M, Clarke CH, Liao WS, et al. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7. Cell Death Differ. 2014;21(8):1275&#x02013;89. 10.1038/cdd.2014.48<pub-id pub-id-type="pmid">24769729</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR351"><label>351.</label><citation-alternatives><element-citation id="ec-CR351" publication-type="journal"><person-group person-group-type="author"><name><surname>Ndeboko</surname><given-names>B</given-names></name><name><surname>Lemamy</surname><given-names>GJ</given-names></name><name><surname>Nielsen</surname><given-names>PE</given-names></name><name><surname>Cova</surname><given-names>L</given-names></name></person-group><article-title>Therapeutic potential of cell penetrating peptides (CPPs) and Cationic polymers for Chronic Hepatitis B</article-title><source>Int J Mol Sci</source><year>2015</year><volume>16</volume><issue>12</issue><fpage>28230</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.3390/ijms161226094</pub-id><pub-id pub-id-type="pmid">26633356</pub-id>
</element-citation><mixed-citation id="mc-CR351" publication-type="journal">Ndeboko B, Lemamy GJ, Nielsen PE, Cova L. Therapeutic potential of cell penetrating peptides (CPPs) and Cationic polymers for Chronic Hepatitis B. Int J Mol Sci. 2015;16(12):28230&#x02013;41. 10.3390/ijms161226094<pub-id pub-id-type="pmid">26633356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR352"><label>352.</label><mixed-citation publication-type="other">Yokoo H, Oba M, Uchida S. Cell-penetrating peptides: emerging tools for mRNA delivery. Pharmaceutics. 2021;14(1). 10.3390/pharmaceutics14010078</mixed-citation></ref><ref id="CR353"><label>353.</label><citation-alternatives><element-citation id="ec-CR353" publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Bujanda</surname><given-names>ZA</given-names></name><name><surname>Haffner</surname><given-names>MC</given-names></name><name><surname>Chaimowitz</surname><given-names>MG</given-names></name><name><surname>Chowdhury</surname><given-names>N</given-names></name><name><surname>Venturini</surname><given-names>NJ</given-names></name><name><surname>Patel</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression</article-title><source>Nat Cancer</source><year>2021</year><volume>2</volume><issue>8</issue><fpage>803</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/s43018-021-00227-3</pub-id><pub-id pub-id-type="pmid">35122025</pub-id>
</element-citation><mixed-citation id="mc-CR353" publication-type="journal">Lopez-Bujanda ZA, Haffner MC, Chaimowitz MG, Chowdhury N, Venturini NJ, Patel RA, et al. Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nat Cancer. 2021;2(8):803&#x02013;18. 10.1038/s43018-021-00227-3<pub-id pub-id-type="pmid">35122025</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR354"><label>354.</label><citation-alternatives><element-citation id="ec-CR354" publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt-Arras</surname><given-names>D</given-names></name><name><surname>Rose-John</surname><given-names>S</given-names></name></person-group><article-title>IL-6 pathway in the liver: from physiopathology to therapy</article-title><source>J Hepatol</source><year>2016</year><volume>64</volume><issue>6</issue><fpage>1403</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.02.004</pub-id><pub-id pub-id-type="pmid">26867490</pub-id>
</element-citation><mixed-citation id="mc-CR354" publication-type="journal">Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016;64(6):1403&#x02013;15. 10.1016/j.jhep.2016.02.004<pub-id pub-id-type="pmid">26867490</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR355"><label>355.</label><citation-alternatives><element-citation id="ec-CR355" publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>R</given-names></name><name><surname>Groth</surname><given-names>C</given-names></name><name><surname>Lasser</surname><given-names>S</given-names></name><name><surname>Arkhypov</surname><given-names>I</given-names></name><name><surname>Petrova</surname><given-names>V</given-names></name><name><surname>Altevogt</surname><given-names>P</given-names></name><etal/></person-group><article-title>IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy</article-title><source>Cell Immunol</source><year>2021</year><volume>359</volume><fpage>104254</fpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2020.104254</pub-id><pub-id pub-id-type="pmid">33296753</pub-id>
</element-citation><mixed-citation id="mc-CR355" publication-type="journal">Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol. 2021;359:104254. 10.1016/j.cellimm.2020.104254<pub-id pub-id-type="pmid">33296753</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR356"><label>356.</label><citation-alternatives><element-citation id="ec-CR356" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>N</given-names></name><name><surname>Faggioni</surname><given-names>R</given-names></name><name><surname>Fung</surname><given-names>M</given-names></name><etal/></person-group><article-title>Targeting interleukin-6 in inflammatory autoimmune diseases and cancers</article-title><source>Pharmacol Ther</source><year>2014</year><volume>141</volume><issue>2</issue><fpage>125</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.09.004</pub-id><pub-id pub-id-type="pmid">24076269</pub-id>
</element-citation><mixed-citation id="mc-CR356" publication-type="journal">Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2):125&#x02013;39. 10.1016/j.pharmthera.2013.09.004<pub-id pub-id-type="pmid">24076269</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR357"><label>357.</label><citation-alternatives><element-citation id="ec-CR357" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer</article-title><source>Cancer Lett</source><year>2019</year><volume>454</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2019.04.002</pub-id><pub-id pub-id-type="pmid">30978440</pub-id>
</element-citation><mixed-citation id="mc-CR357" publication-type="journal">Zhai J, Shen J, Xie G, Wu J, He M, Gao L, et al. Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 2019;454:37&#x02013;43. 10.1016/j.canlet.2019.04.002<pub-id pub-id-type="pmid">30978440</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR358"><label>358.</label><citation-alternatives><element-citation id="ec-CR358" publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Engineered Exosome for Drug Delivery: recent development and clinical applications</article-title><source>Int J Nanomed</source><year>2023</year><volume>18</volume><fpage>7923</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.2147/IJN.S444582</pub-id></element-citation><mixed-citation id="mc-CR358" publication-type="journal">Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z, et al. Engineered Exosome for Drug Delivery: recent development and clinical applications. Int J Nanomed. 2023;18:7923&#x02013;40. 10.2147/IJN.S444582</mixed-citation></citation-alternatives></ref><ref id="CR359"><label>359.</label><citation-alternatives><element-citation id="ec-CR359" publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Lv</surname><given-names>G</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name></person-group><article-title>Engineering exosomes to reshape the immune microenvironment in breast cancer: molecular insights and therapeutic opportunities</article-title><source>Clin Transl Med</source><year>2024</year><volume>14</volume><issue>4</issue><fpage>e1645</fpage><pub-id pub-id-type="doi">10.1002/ctm2.1645</pub-id><pub-id pub-id-type="pmid">38572668</pub-id>
</element-citation><mixed-citation id="mc-CR359" publication-type="journal">Cao J, Lv G, Wei F. Engineering exosomes to reshape the immune microenvironment in breast cancer: molecular insights and therapeutic opportunities. Clin Transl Med. 2024;14(4):e1645. 10.1002/ctm2.1645<pub-id pub-id-type="pmid">38572668</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR360"><label>360.</label><citation-alternatives><element-citation id="ec-CR360" publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy</article-title><source>Biomaterials</source><year>2014</year><volume>35</volume><issue>7</issue><fpage>2383</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.11.083</pub-id><pub-id pub-id-type="pmid">24345736</pub-id>
</element-citation><mixed-citation id="mc-CR360" publication-type="journal">Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383&#x02013;90. 10.1016/j.biomaterials.2013.11.083<pub-id pub-id-type="pmid">24345736</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR361"><label>361.</label><citation-alternatives><element-citation id="ec-CR361" publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery: preparation, characterization, in vitro, and in vivo evaluation</article-title><source>J Drug Target</source><year>2024</year><volume>32</volume><issue>3</issue><fpage>325</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1080/1061186X.2024.2309566</pub-id><pub-id pub-id-type="pmid">38269592</pub-id>
</element-citation><mixed-citation id="mc-CR361" publication-type="journal">Cui X, He Z, Liang J, Wei M, Guo Z, Zhou Y, et al. Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery: preparation, characterization, in vitro, and in vivo evaluation. J Drug Target. 2024;32(3):325&#x02013;33. 10.1080/1061186X.2024.2309566<pub-id pub-id-type="pmid">38269592</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR362"><label>362.</label><citation-alternatives><element-citation id="ec-CR362" publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><etal/></person-group><article-title>Hyaluronan Nanogel co-loaded with chloroquine to enhance intracellular cisplatin delivery through lysosomal permeabilization and lysophagy inhibition</article-title><source>Carbohydr Polym</source><year>2024</year><volume>323</volume><fpage>121415</fpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2023.121415</pub-id><pub-id pub-id-type="pmid">37940248</pub-id>
</element-citation><mixed-citation id="mc-CR362" publication-type="journal">Gao M, Deng H, Zhang Y, Wang H, Liu R, Hou W, et al. Hyaluronan Nanogel co-loaded with chloroquine to enhance intracellular cisplatin delivery through lysosomal permeabilization and lysophagy inhibition. Carbohydr Polym. 2024;323:121415. 10.1016/j.carbpol.2023.121415<pub-id pub-id-type="pmid">37940248</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR363"><label>363.</label><citation-alternatives><element-citation id="ec-CR363" publication-type="journal"><person-group person-group-type="author"><name><surname>Dekkers</surname><given-names>JF</given-names></name><name><surname>van Vliet</surname><given-names>EJ</given-names></name><name><surname>Sachs</surname><given-names>N</given-names></name><name><surname>Rosenbluth</surname><given-names>JM</given-names></name><name><surname>Kopper</surname><given-names>O</given-names></name><name><surname>Rebel</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids</article-title><source>Nat Protoc</source><year>2021</year><volume>16</volume><issue>4</issue><fpage>1936</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-00474-1</pub-id><pub-id pub-id-type="pmid">33692550</pub-id>
</element-citation><mixed-citation id="mc-CR363" publication-type="journal">Dekkers JF, van Vliet EJ, Sachs N, Rosenbluth JM, Kopper O, Rebel HG, et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021;16(4):1936&#x02013;65. 10.1038/s41596-020-00474-1<pub-id pub-id-type="pmid">33692550</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR364"><label>364.</label><citation-alternatives><element-citation id="ec-CR364" publication-type="journal"><person-group person-group-type="author"><name><surname>LeSavage</surname><given-names>BL</given-names></name><name><surname>Suhar</surname><given-names>RA</given-names></name><name><surname>Broguiere</surname><given-names>N</given-names></name><name><surname>Lutolf</surname><given-names>MP</given-names></name><name><surname>Heilshorn</surname><given-names>SC</given-names></name></person-group><article-title>Next-generation cancer organoids</article-title><source>Nat Mater</source><year>2022</year><volume>21</volume><issue>2</issue><fpage>143</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1038/s41563-021-01057-5</pub-id><pub-id pub-id-type="pmid">34385685</pub-id>
</element-citation><mixed-citation id="mc-CR364" publication-type="journal">LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater. 2022;21(2):143&#x02013;59. 10.1038/s41563-021-01057-5<pub-id pub-id-type="pmid">34385685</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR365"><label>365.</label><citation-alternatives><element-citation id="ec-CR365" publication-type="journal"><person-group person-group-type="author"><name><surname>Sachs</surname><given-names>N</given-names></name><name><surname>de Ligt</surname><given-names>J</given-names></name><name><surname>Kopper</surname><given-names>O</given-names></name><name><surname>Gogola</surname><given-names>E</given-names></name><name><surname>Bounova</surname><given-names>G</given-names></name><name><surname>Weeber</surname><given-names>F</given-names></name><etal/></person-group><article-title>A living biobank of breast Cancer Organoids captures Disease Heterogeneity</article-title><source>Cell</source><year>2018</year><volume>172</volume><issue>1&#x02013;2</issue><fpage>373</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.010</pub-id><pub-id pub-id-type="pmid">29224780</pub-id>
</element-citation><mixed-citation id="mc-CR365" publication-type="journal">Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A living biobank of breast Cancer Organoids captures Disease Heterogeneity. Cell. 2018;172(1&#x02013;2):373&#x02013;86. 10.1016/j.cell.2017.11.010<pub-id pub-id-type="pmid">29224780</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR366"><label>366.</label><citation-alternatives><element-citation id="ec-CR366" publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriques</surname><given-names>SG</given-names></name><name><surname>Stickels</surname><given-names>RR</given-names></name><name><surname>Goeva</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Murray</surname><given-names>E</given-names></name><name><surname>Vanderburg</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution</article-title><source>Science</source><year>2019</year><volume>363</volume><issue>6434</issue><fpage>1463</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1126/science.aaw1219</pub-id><pub-id pub-id-type="pmid">30923225</pub-id>
</element-citation><mixed-citation id="mc-CR366" publication-type="journal">Rodriques SG, Stickels RR, Goeva A, Martin CA, Murray E, Vanderburg CR, et al. Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution. Science. 2019;363(6434):1463&#x02013;7. 10.1126/science.aaw1219<pub-id pub-id-type="pmid">30923225</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR367"><label>367.</label><citation-alternatives><element-citation id="ec-CR367" publication-type="journal"><person-group person-group-type="author"><name><surname>Segeren</surname><given-names>HA</given-names></name><name><surname>Andree</surname><given-names>KC</given-names></name><name><surname>Oomens</surname><given-names>L</given-names></name><name><surname>Westendorp</surname><given-names>B</given-names></name></person-group><article-title>Collection of cells for single-cell RNA sequencing using high-resolution fluorescence microscopy</article-title><source>STAR Protoc</source><year>2021</year><volume>2</volume><issue>3</issue><fpage>100718</fpage><pub-id pub-id-type="doi">10.1016/j.xpro.2021.100718</pub-id><pub-id pub-id-type="pmid">34401784</pub-id>
</element-citation><mixed-citation id="mc-CR367" publication-type="journal">Segeren HA, Andree KC, Oomens L, Westendorp B. Collection of cells for single-cell RNA sequencing using high-resolution fluorescence microscopy. STAR Protoc. 2021;2(3):100718. 10.1016/j.xpro.2021.100718<pub-id pub-id-type="pmid">34401784</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>